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Abstract
Energy homeostasis and metabolic processes have been shown to be under 24-hour 
control. Hormones secreted from adipocytes and about 20% of the genes in white 
adipose tissue exhibit daily variations. Changes in metabolism are able to influence 
the clock in adipose tissue and disruption of the clock mechanism has been shown to 
lead to metabolic consequences. The aims of this PhD are firstly to investigate links 
between peripheral clocks and metabolism by using in vivo human and in vitro 
experimental models and secondly to investigate a cell model, which might reflect 
adipocyte biology better than the currently available cell lines.
The influence of overweight and type 2 diabetes mellitus on plasma hormones was 
investigated in men over a 24-hour time course under highly controlled conditions. 
Significantly higher nocturnal plasma melatonin concentrations were observed in 
obese compared to lean or diabetic subjects. All participants showed clear diurnal 
variation in plasma leptin, but there was surprisingly no significant difference 
between the groups, irrespective of whether the data were plotted relative to external 
clock time or endogenous melatonin phase. Rhythmicity and phase of the expression 
of core clock genes and clock controlled genes, in a novel adipocyte model derived 
from IMMORTO^'^ mouse pre-adipocyte cells, support the presence of a molecular 
oscillator in those cells. Rliythms were phase advanced by about 5 hours in 
adipocytes, compared to the pre-adipocytes. Preliminary results revealed that lipolysis 
in those cells may be gated by the adipocyte clock.
Our results suggest that the timing of the leptin secretion into the blood is not 
influenced by the metabolic state under well controlled conditions whilst the 
concentration of plasma melatonin is increased in overweight participants. The in 
vitro results show for the first time a molecular clock in primary-like murine adipose 
cells. The IMWAT cells appear to be a better model because of the robust rhythmicity 
of the clock genes. Moreover, the preliminary lipolysis data suggests circadian gating 
for lipolysis. The different phasing of gene expression in pre-adipocytes and 
adipocytes suggests possible differences in the response to entraining stimuli and that 
the molecular oscillator may be infiuenced by the metabolic or differentiation state of 
the cell.
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Chapter 1: Introduction
1.1 Overview
Food has become abundant during the last century in industrialised countries; 
snacking frequency has increased and feeding has shifted towards the end of the day. 
The necessity for physical effort on the other hand has become considerably reduced 
and does not need to coincide with the light period anymore. This phase shifting has 
been called an environmental ‘mutation’ (Buijs and Kreier, 2006). Obesity is not just 
an increasing health problem in industrialised countries; there are increasing numbers 
all around the world. In 2007 there were 1.6 billion overweight (OW) adults in the 
world. This meant that every 7**^ adult human being on this planet was OW or obese. 
The World Health Organisation (WHO) predicted a growth of this number by 40% 
within the next 10 years. Increased white adipose tissue (WAT), and with it an 
increased body weight, is the key feature of obesity. Obesity is one of the risk factor 
for developing type 2 diabetes mellitus (T2DM).
The mammalian circadian timing system has been shown to influence most metabolic 
processes in the body. The biology of WAT is no exception. It recognises signals in a 
circadian fashion and secrets hormones and other signalling molecules in a circadian 
manner (La Fleur et al, 1999, La Fleur et a l, 2003, Davidson et a l, 2004). Disruption 
of the clock mechanism has been found to lead to diseases. A better understanding of 
the chronobiology of adipose tissue on the molecular level as well as on the whole 
organism could deepen the understanding of the pathophysiology of obesity and 
T2DM. This review will provide links between obesity, T2DM and the function of 
circadian clocks. It will also discuss links between circadian clocks and adipose 
biology.
1.2 The mammalian circadian timing system
The mammalian circadian timing allocates specific time frames in the 24 h of the day 
to different physiological processes (Pittendrigh, 1993). This is permitted by a cross- 
linked network of clocks in most cells of the body (Schibler et a l, 2003). The 
possession of a circadian timing system resulted in evolutionary benefits. On a 
molecular level this means that enzymes for certain metabolic pathways are just 
synthesised at times of the day when they are needed. On a behavioural level this 
means that the animal goes hunting at a time of day when there are fewer predators.
Not just the metabolism in the healthy animal follows a circadian rhythm, also 
incidence of acute diseases such as myocardial infarction show a peak at a certain 
times of day (Muller et a l, 1985, Maemura et a l, 2007).
1.2.1 The network of body clocks
1.2.1.1 The central circadian oscillator
The central ‘master’ internal clock in mammals is located within the hypothalamic 
suprachiasmatic nuclei (SCN) (Moore and Eichler, 1972, Stephan and Zucker, 1972). 
The SCN are two densely packed nuclei in the anterior hypothalamus above the optic 
chiasm. Each nucleus consists of a core (ventral) which is rich in vasoactive intestinal 
polypeptide (VIP) neurons and a shell (dorsomedial) region which is rich in 
vasopressin containing neurons (Moore et a l, 2002). Both areas contain 
y-aminobutyric acid (GABA) containing neurons.
Light is the most potent zeitgeber to synchronise the SCN to the solar day (Quintero et 
al, 2003, Pendergast and Yamazaki, 2011). Light is received by opsins in rods and 
cones and melanopsin in photo-responsive retinal ganglion cells (RGCs) (Hattar et al, 
2002, Provencio et a l, 2002, Berson, 2003). The signal is then transmitted via 
glutamatergic neurons (De Haro and Panda, 2006) in the retino-hypothalamic tract 
(RHT) to the core region of the SCN (Gooley et al, 2001). As a result, VIP, an 
intrinsic SCN factor, acutely activates and synchronises SCN neurons and coordinates 
behavioural rhythms (Ralph et al, 1990, Harmar et a l, 2002, Maywood et a l, 2006).
The SCN do not just receive neuronal and humoral input, they also control many 
physiological and behavioural rhythms such as, body temperature, sleep / wakefulness 
(Deboer et a l, 2007), activity, water intake, eating times, plasma glucose 
concentrations and the excretion of hormones (Lehman et al, 1987, Bartness et a l, 
2001, Cailotto et al, 2005). The basic period of the endogenous circadian rhythm is 
dictated by the SCN. This was shown by SCN transplantation experiments (Lehman et 
al, 1987) in which the transplanted animals showed the period of the SCN donor 
animal (Ralph et al, 1990). The described processes are presented in Figure 1.1.
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1.2.1.2 Circadian oscillators in peripheral organs
The first oscillators outside the SCN were detected in ex vivo cultured hamster retinas 
(Tosini and Menaker, 1996) and not much later in heart, brain, lung, liver, skeletal 
muscle and testis by murine Periods {mPerS) northern blot in tissue from mice (Zylka 
et al., 1998b). Oscillators found outside the SCN were termed ‘peripheral clocks’. 
Constructs where the gene for firefly luciferase is linked to the Period {Per) genes 
helped to identify and to prove the existence of circadian oscillators in peripheral 
tissues. Tissue explants of those transgenic mice or rats were kept in culture for 
several days and the bioluminescence of the Per gene was detected, or the target 
tissue was investigated directly. Using those methods rhythmic expression in Per 
genes could not only be detected in rat SCN in vitro (Yamazaki et al, 2002) and in 
vivo in mice SCN (Yamaguchi et al, 2001) but also in rat lung (Yamazaki et a l,
2000) and rat liver (Stokkan et al, 2001). Peripheral oscillators were also found in 
explants from human vascular smooth muscle cells (McNamara et al, 2001b, Nonaka 
et al, 2001), rat pancreas (Miihlbauer et al, 2004) and murine adipose tissue (Zvonic 
et al, 2006).
Circadian oscillators were not just found in tissue explants, but also in cell culture 
such as rat fibroblasts (Balsalobre et a l, 1998, Ueda et a l, 2002), mouse fibroblasts 
(Akashi and Nishida, 2000), rat leukocytes (Oishi et al, 1998) and human 
osteosarcoma cells (Vollmers et a l, 2008). Rhythms were even detected in rat 
fibroblasts after they had been cultured in vitro for about 30 years when treated with a 
serum shock (Balsalobre et al, 1998). In summary it seems that most mammalian cell 
types contain the molecular machinery which is needed to achieve circadian gene 
expression.
More than 20% of the expressed messenger ribonucleic acid (mRNA) in bone and 
adipose tissue oscillates in a circadian manner (Ptitsyn et al, 2006). It is assumed that 
these oscillations regulate localised physiological processes and help to keep, e.g. 
metabolic processes in synchronisation with each other. This hypothesis is supported 
by the fact that approximately 50% of the knovm nuclear receptors in adipose tissue in 
mice exhibit rhythmic expression (Yang et a l, 2006).
The clocks in the SCN as well as the clocks in the periphery are affected by restriction 
of food. The food entrained oscillator (FEO) is independent of the SCN clock 
(Martinez-Merlos et a l, 2004, Mendoza and Challet, 2009). The FEO is a diffuse 
operating network of neuronal areas and does not reside in a discrete anatomical 
structure. Food has been shown to be the dominant zeitgeber for peripheral clocks 
(Damiola et a l, 2000, Stokkan et a l, 2001). The effects of food on clocks are 
mediated by food metabolites or hormones whose secretion is controlled by food or its 
absence. Nuclear receptors that regulate clock transcription factors and clock- 
controlled genes are involved in fuel utilization (Boden et al, 1999) and have been 
shovm to be expressed in a rhythmic manner (Duez and Staels, 2010). Glucose 
(Stephan and Davidson, 1998, Hirota et a l, 2002), amino acids (Iwanaga et a l, 2005), 
sodium (Mohri, 2003), ethanol (Chen, 2004, Spanagel et al, 2005), caffeine (Antle, 
2005), thiamine (Langlais and Hall, 1998, Bennett and Schwartz, 1999) and retinoic 
acid (McNamara et a l, 2001b, Shirai et al, 2006) have been shown to shift the timing 
of endogenous clocks. Glucocorticoids were also shown to transiently change phase 
of circadian gene expression in the liver (Reddy et a l, 2007) and retinoic acid was 
shovm to phase shift mPer2 expression in vivo and in serum induced smooth muscle 
cells in vitro (McNamara et a l, 2001a).
Temporally restricting feeding to the light phase has been shown to advance the phase 
of expression of clock gene mRNA in mice liver, kidney, heart, pancreas and some 
brain structures (Damiola et a l, 2000, Hara et a l, 2001, Stokkan et a l, 2001), hearts 
of mice (Oishi et a l, 2002) and in visceral murine adipose tissue (Zvonic et a l, 2006). 
These experiments showed that proximal cues such as feeding can override the phase 
control of peripheral oscillators by the SCN.
The core feedback loop (section 1.2.2) is not just dependent on the rhythmical 
appearance of clock gene mRNA, but is also dependent on the rhythmical 
transcription of this mRNA into clock proteins. Clock protein expression was 
analysed by (Lee et a l, 2001). Liver expiants from mice were analysed in time course 
experiments. The proteins mPERl, mPER2, mCRYl, mCRY2 and BMALl showed 
rhythmicity in their abundance. This finding supported the hypothesis of biological 
clocks in peripheral tissues.
1.2.1.3 Synchronisation of cell-autonomous oscillators and hierarchical order
Circadian endogenous clocks are capable of self sustained rhythms which persist in 
the absence of time cues. A cell-autonomous circadian oscillatory mechanism has 
been known in unicellular organisms for a long time (section 1.2.2.3). Welsh and co­
workers showed that individual cultured SCN neurons possess oscillatory machinery 
(Welsh et a l, 1995, Herzog et a l, 1998). Later the same was shown for murine 
fibroblasts (Welsh et al, 2004). The cell-autonomous oscillators in an organ need to 
be synchronised to each other to create an output signal. The cell-autonomous 
oscillators in peripheral tissues have been shovm to be synchronised to each other by 
signals from the SCN (Yoo et al, 2004). It was shovm that peripheral oscillators in 
the periphery of SCN lesioned mice maintain circadian rhythms of gene expression 
for a few days. The signal, however is not longer detectable than a few cycles, 
because the cell autonomous oscillators loose synchrony among each other due to the 
missing input from the SCN (Yoo et a l, 2004).
Self-sustained circadian pacemakers in the SCN, which get synchronised to each other 
by photic input via the RHT, entrain circadian oscillators in peripheral tissues with the 
aim to maintain phase control (Yamazaki et a l, 2000). The SCN controls the phase of 
clock gene expression in peripheral oscillators if the food is not restricted
(section 1.2.1.2, Buijs et al, 2003, Cailotto et al, 2005, Kalsbeek et al, 2006a, 
Kalsbeek et a l, 2006b, Kuhlman and McMahon, 2006). The SCN has hierarchical 
dominance over the docks in the periphery (Figure 1.2). This was shown by 
implanting fibroblasts from a Perl'^' mutant mice which exhibits a 20 h phase 
compared to wild-type mice (24 h phase). The transplanted fibroblasts were shown to 
adapt themselves to the 24 h phase of the host animal (Pando et a l, 2002).
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Figure 1.2: Hierarchical dominance o f the SCN over peripheral oscillators.
It is poorly understood how the SCN signals to peripheral organs to entrain their 
oscillators. However, daily feeding-fasting cycles, the oscillations in body 
temperature, sleep time and SCN-controlled circadian hormone rhythms (e.g. 
melatonin, cortisol) are assumed to play a role (Balsalobre et a l, 2000, Le Minh et al, 
2001, Stokkan et al, 2001, Brown et al, 2002). The systemic function of melatonin 
(see section 1.2.3.1) might be to convey information about the photoperiod from the 
SCN to the peripheral oscillators (Korf et al, 1998, von Gall et al, 2002a, Dardente et 
al, 2003, Hazlerigg et a l, 2004, Wagner et al, 2007). Differences in the phasing of 
clock genes between the SCN and peripheral tissues have been noted in several 
studies leading to the suggestion that, the circadian organisation is flexible 
(Mrosovsky, 2003).
Cells in culture are not able to receive synchronisation signals from the SCN. An 
artificial synchronisation signal is therefore needed for the cells to get synchronised to 
each other (Balsalobre et al, 1998, Nagoshi et al, 2004). The signal phase of the 
individual cell oscillator would otherwise interfere with other cell phases in a way to
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flatten any detectable rhythm. The synchronisation gradually gets lost (Welsh et al, 
2004) resulting in a undetectable rhythm.
1.2.2 Biological clocks at the molecular level
Endogenous self-sustained central and peripheral oscillators share a common 
molecular organisation (Yagita et al, 2001, Kohsaka and Bass, 2007), with several 
interlocked transcriptional and post-translational auto-regulatory feedback loops 
generating and sustaining circadian fluctuations in their own expression (Figure 1.3).
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kinase 1 s/ô.
1.2.2.1 Clock genes and the core feedback loop
Genes or proteins directly involved in the core feedback loop are termed clock genes; 
the resulting proteins are termed clock proteins. In mammalian clocks these genes
include the three basic helix-loop-helix (bHLH)-PAS (PER-ARNT -SIM (PAS)) 
transcription factors (Clock locomotor output cycles kaput {Clock), neuronal PAS 
domain-containing protein 2 {NpasI) and brain and muscle ARNt like protein 1 
{Email, Arntl; Mop3)), the two period genes {Perl and Per2), and the two 
cryptochrome genes {Cryl and Cry2).
The main stimulators of transcription within the mammalian clock mechanism are 
circadian CLOCK (Vitatema et a l, 1994, King et a l, 1997), and BMALl. As a 
heterodimer they bind deoxyribonucleic acid (DNA) at E-boxes, and activate the 
transcription of Perl-3, Cryl-2 (Lowrey and Takahashi, 2004) and other clock 
controlled output genes. NPAS2 (DeBruyne et a l, 2007) and BMAL2 (Okano et al, 
2001) are paralogs of CLOCK and BMALl, respectively and may functionally 
substitute for CLOCK and BMALl in some tissues. Translated PER2, CRY2 and 
BMALl proteins get phosphorylated by glycogen synthase kinase Sp (GSK3p) (Sahar 
et al, 2010). PER proteins are specific substrates for the casein kinases lô/e (CKIô/e) 
(Akashi et a l, 2002). The CKIô/e also phosphorylate BMALl and CRY to prime 
them for the degradation in the proteasome (Eide et al, 2005). The F-box and leucine- 
rich repeat protein 3 (FBXL3) are essential for the phosphorylation of CRY proteins, 
which itself primes them for degradation (Busino et a l, 2007, Godinho et a l, 2007, 
Siepka et a l, 2007). The adenosine monophosphosphate-activated protein kinase 
(AMPK) is also able to phosphorylate the CRYl protein (Lamia et a l, 2009). Only 
phosphorylated PER and CRY proteins can be tagged for degradation in the 
proteasome by ubiquitin ligases (Miyazaki et a l, 2004) and CKI is therefore a key 
regulator of period length (Fish et al, 1995). In their phosphorylated state CRY and 
PER proteins build multimeric complexes and translocate into the nucleus. Once in 
the nucleus they inhibit the activation of transcription by the CLOCK / BMALl 
heterodimer and thus inhibit their own transcription. The cycle starts again after 
degradation of the PER and CRY proteins. The retinoic acid -  related orphan nuclear 
receptor (REV-ERBa) is phosphorylated by GSK3P, this phosphorylation stabilises 
the protein (Sahar et a l, 2010).
1.2.2.2 Clock controlled genes and secondary feedback loops
Genes under the control of clock proteins are termed clock controlled genes (CCG). 
Clock proteins regulate their expression by binding to circadian promoter elements 
including E-boxes and retinoic acid-related orphan receptor-response elements 
(ROREs) (Ripperger et a l, 2000, Ueda et al, 2005). More than 500 CCGs exist in the 
liver and heart (Storch et al, 2002) and some of those CCGs play a role in 
metabolism and energy homeostasis of the body (Monteleone et a l, 2008, Scott et al, 
2008). Examples for CCGs are the two orphan nuclear receptors REV-ERBa and 
RORa (Preitner et a l, 2002, Sato et al, 2004).
The best characterised secondary feedback loop involves RORa and REV-ERBa. The 
CLOCK / BMALl heterodimer activates the transcription of Rev-erba (Preitner et a l, 
2002, Triqueneaux et al, 2004, Guillaumond e/ al, 2005, Ripperger, 2006, Kakizawa 
et a l, 2007). This Rev-erba transcription is also trans-repressed by the PER / CRY 
heterodimer, resulting in circadian oscillations of REV-ERBa. REV-ERBa and 
RORa compete to bind to ROREs, which are present in the Email promoter. RORa 
as well a s related proteins RORp and y activate transcription of BMALl and REV- 
ERBa represses it. The receptor REV-ERBa is post-translationally stabilised by 
GSKp-mediated phosphorylation (Yin et al, 2006). REV-ERBa couples the so-called 
positive and negative limb of the molecular oscillator.
The cellular redox-state is capable of influencing rhythms. Binding of the CLOCK / 
BMALl heterodimer to E-boxes on the deoxyribonucleic acid (Bednarczuk et a l, 
1991) is only effective in the presence of reduced nicotinamide adenine dinucleotides 
(NADH, NADPH); in contrast NAD"^  and NADP^ inhibit the binding (Rutter et a l ,
2001). Changes in the redox equilibrium could therefore result in a phase-shift in 
clock gene expression.
The AMPK is another sensor of the metabolic state of the cell. The AMPK is 
activated by adenosine monophosphate (AMP) and has been found to phosphorylate 
Ser-389 of CKIs, resulting in increased CKIs activity and degradation of mPER2 
protein (Um et a l, 2007). This leads to a phase advance in the circadian expression 
pattern of clock genes in wild-type mice. AMPK has been implicated in feeding
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regulation (Martin et a l, 2006) and levels of mAMPK decline under a high-fat (HF) 
diet (Bamea et al, 2009). Changes seen in the timing of gene expression under a HF 
diet are therefore in part mediated by changes in AMPK activity.
Sirtuin 1 (SIRTl) aNAD^ dependent de-acetylase interacts directly and in a circadian 
manner with CLOCK / BMALl. It de-acetylases BMALl and degenerates PER2 
(Asher et al, 2008, Nakahata et al, 2008). BMALl acétylation potentiates its binding 
to the repressive PER / CRY complex (Hirayama et a l, 2007) and therefore inhibits 
the transcription of clock and CCGs. SIRTl is expressed in a circadian manner and 
regulates the rhythmic expression of Email, RORy, Per2 and Cryl. When SIRTl 
becomes activated it de-acetylates BMALl, PER2, and histones (Belden and Dunlap,
2008). It has been shown that AMPK enhances SIRTl activity by increasing cellular 
NAD"*" levels, resulting in the de-acetylation and modulation of the activity of 
downstream SIRTl targets (Canto et al, 2009).
Heme oscillates in a circadian manner (Ben-Shlomo et a l, 2005) and its biosynthesis 
is under circadian regulation (Kaasik and Chi Lee, 2004). NPAS2, a homologue of 
CLOCK, binds heme and carbon monoxide (CO) can regulate the DNA binding of the 
NPAS2 / BMALl dimer (Dioum, 2002). Heme binds directly to the ligand binding 
domain of REV-ERBa and regulates the ability of the receptor to repress its target 
genes including Emal 1 (Raghuram et a l , 2007).
The purpose of these secondary loops is unclear but may provide additional 
robustness and precision to the primary loop or perhaps provide mechanisms through 
which external processes (e.g. metabolic state) may interact with circadian biology.
1.2.2.3 Non transcriptional oscillators
The transcription / translation loop is the core feature of the current model of the 
molecular oscillator. There have been reports about systems oscillating in a circadian 
rhythm without the need for any transcription. Red blood cells do not possess a 
nucleus and do not exhibit transcription, but rhythmicity has been detected in these 
cells. Transcription / translation therefore does not seem to be essential for circadian 
oscillations, and non-transcriptional events seem to be sufficient to sustain cellular 
rhythms (O'Neill and Reddy, 2011). Another example for a circadian system without
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transcription is that a mixture of KaiA, KaiB, KaiC proteins together with adenosine 
triphosphate (ATP) is able to show a temperature-compensated circadian rhythm in 
KaiC phosphorylation in vitro (Nakajima et a l, 2005).
1.2.3 Central circadian output rhythms
Output rhythms of the SCN include core body temperature, sleep / wake cycle, 
activity, feeding / fasting, plasma glucose, water intake, and rhythmic hormone 
production (Bartness et a l, 2001, Cailotto et a l, 2005). Hormones (melatonin and 
cortisol) regulated by the SCN are discussed in the following sections.
1.2.3.1 Melatonin
Melatonin is produced and released by the pineal gland (Lemer and Nordlund, 1978) 
and gets degraded in liver (Kopin et a l, 1960). The dim light melatonin onset 
(DLMO) of the indolamine hormone melatonin (Mallo et al, 1990) is considered to 
be the most reliable phase marker for the endogenous phase in humans (Lewy and 
Sack, 1989). Melatonin is produced at night (21:00 h -  7:00 h), with a maximum 
around 02:00 h - 04:00 h (Arendt, 1988, Morgan et a l, 1998). The peak of plasma 
melatonin at night is closely associated with the nadir of the core body temperature, 
alertness and performance (Skene and Arendt, 2006).
It is assumed that melatonin communicates information about the length of day and 
night to the rest of the body (Arendt et a l, 1985, Arendt, 1995, von Gall et a l, 
2002b). Melatonin might also aid in entraining peripheral clocks. The best 
characterised cellular effect of melatonin is its inhibition of adenyl cyclase (AC) 
through the melatonin receptors 1 and 2 (MTl, MT2) (Carlson et a l, 1989, von Gall 
et al, 2002b). MT2 receptors have been detected on adipocytes (Zalatan et a l, 2001) 
which suggests that melatonin controls fat cell hormone expression (Alonso-Vale et 
al, 2005, Alonso-Vale et a l, 2006, Alonso-Vale et al, 2008). Melatonin may directly 
regulate lipolysis and leptin expression. Melatonin receptors MTl and MT2 were 
found in rodent pancreatic islet cells (Peschke et al, 2000, Muhlbauer and Peschke, 
2007), another possible link between circadian rhythm regulation and glucose 
homeostasis through the melatonin signalling pathway (Peschke et a l, 2002, Bouatia- 
Naji et a l, 2009). There is also evidence for an influence of melatonin on systems 
such as glucose homeostasis (La Fleur et a l, 2001), the immune system (Maestroni,
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1998), and cardiovascular function (Scheer et a l, 2004), energy balance (Alonso-Vale 
et a l, 2004) and a wide range of signalling pathways (Dupre et a l, 2008, Fustin et al,
2009).
1.2.3.2 Cortisol
The secretion of glucocorticoids from the adrenal cortex exhibit a clear circadian 
rhythms (Dallman et al, 1978, Bomstein and Chrousos, 1999, Engeland and Amhold, 
2005, Torres-Farfan et al, 2008b). Cortisol shows increasing concentrations at the 
start of the wake period, acting as an alerting signal to begin the day (Buckley and 
Schatzberg, 2005). Ablation of the SCN blocks diurnal rhythmicity in plasma cortisol 
(Ruiter et a l, 2003). The circadian rhythmicity in plasma cortisol is therefore 
regulated by light, stress and by food availability.
The secretion of cortisol is controlled by the SCN via the hypothalamo-pituitary- 
adrenal axis (HPA-axis) (Engeland and Amhold, 2005, Kalsbeek et a l, 2006a, 
Torres-Farfan et al, 2008a). Either via the paraventricular nucleus (PVN) or directly 
to Corticotropin-releasing hormone (CRH)-containing endocrine neurons (Kalsbeek 
and Buijs, 2002). CRH then induces the rhythmic release of adrenocorticotropic 
hormone (ACTH) which itself triggers the release of cortisol by the adrenal gland. 
Neuronal signals generated by the SCN spread through the autonomic nervous system 
to add to the circadian regulation of cortisol (Buijs et a l, 2003). Another factor is 
added by the fact that that the sensitivity to adrenocorticotropic hormone (ACTH) is 
driven by the local adrenal clock (Oster et a l, 2006). Additional regulatory factors 
may include the neurohormone melatonin (Torres-Farfan et al, 2003).
1.3 White adipose tissue
WAT does not just store energy in the form of triglycerides (TG) it is also an 
endocrine organ secreting substances which control the energy balance, body fat 
composition, appetite and much more.
1.3.1 Composition and input signals
The most prevalent cells in WAT are adipocytes and pre-adipocytes. Other cell types 
include fibroblasts, immune cells like macrophages, dentritic cells, mast cells.
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granulocytes, lymphocytes, nervous cells and endothelial cells (Rosen and 
Spiegelman, 2000, Haugen and Drevon, 2007).
Adipose tissue is equipped with a well-organised vasculature (Fliers et a l , 2003) and 
it is highly innervated with neurons (Attie and Scherer, 2008). The SCN has been 
shown to regulate pathways controlling diverse physiological functions in adipose 
tissue through neuronal as well as humoral signals (Green et a l, 2008, Takahashi et 
al, 2008). The humoral factors include hormones, feeding behaviour, fluctuations in 
the body temperature (Saper et a l, 2005), transforming growth factor (TGF) (Kramer 
et a l, 2001) and cardiotrophin-like cytokines (Kraves and Weitz, 2006). Humoral 
signals, such as macrophage cytokines from other cells close by adipocytes can also 
influence adipose tissue physiology. The sympathetic nervous system (SNS) directly 
innervates adipose tissue (Slavin and Ballard, 1978). It was shown that this 
innervation is able to modulate glucose and lipid metabolism (Dodt et a l, 2003). 
There is controversy in the literature regarding the parasympathetic control of WAT 
(Giordano et al, 2006, Kreier et a l, 2006). Those factors show that rhythms detected 
in adipose tissue can be influenced by many factors.
1.3.2 Different depots of white adipose tissue
Adipose tissue occurs as areas of loose connective tissue (e.g. subcutaneous WAT 
(sWAT)) and around body organs visceral WAT (vWAT), where it plays a protective 
role (Rosen and Spiegelman, 2000). Both depots store energy. Oscillating patterns of 
clock gene mRNA was found in murine brown, inguinal, perigonodal and epidermal 
white (BAT, iWAT, pWAT and eWAT) and human sWAT and vWAT adipose tissue 
(Ando et a l, 2005, Zvonic et al, 2006, Gomez-Santos et al, 2009). The different 
adipose tissue depots show differences in metabolism, size of the adipocytes, basal 
metabolic activity, the secretion profiles of genes and adipokines and hormonal 
responsiveness (Lafontan and Langin, 2009, Wozniak et a l, 2009). It has also been 
shown that WAT depots in humans and rodents respond different to lipolytic stimuli 
(Jensen, 1997, Bartness and Bamshad, 1998, Bartness and Song, 2007). Different 
depots of adipose tissue may therefore confer different risks for diseases (Peiris et a l, 
1989, Cousin et al, 1993). These differences are likely to result from divergent SNS 
innervations of the adipose depots (Youngstrom and Bartness, 1995, Kreier et a l,
2006).
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1.3.3 Storage and release of free fatty acids
Besides storing energy in the form of TG, WAT also cushions and insulates the body. 
Its major duty is to store energy during calorie abundance and facilitate retrieval of 
free fatty acids (FFA) (Schaefer et al, 1983, Carraro et al, 1994) in periods of food 
shortage and calorie deficit which cannot be met by circulating carbohydrate, such as 
fasting, starvation and long-term exercise (Spiegelman and Flier, 1996). Adipose 
tissue is therefore linked to the control of energy homeostasis, feeding behaviour, 
reproduction function and metabolic regulation (Grégoire et al, 1998).
The release of FFA and glycerol in a process called lipolysis can be triggered by a 
variety of endocrine, autocrine and paracrine humoral and neuronal effectors. Basal 
lipolysis is catalysed by an enzyme called adipose triglyceride lipase (ATGL) 
(Zimmermann et a l, 2004).
Catecholamines such as noradrenaline and adrenaline are the most potent ones to 
trigger lipolysis via the hormone sensitive lipase (HSL) under stressful and energy 
demanding conditions. Most of the triggers of lipolysis increase the cellular 
concentration of cyclic adenosine monophosphate (cAMP) (Bartness and Bamshad, 
1998) which in turn activates protein kinase A (PKA) (Honnor et a l, 1985). PKA then 
phosphorylates and activates the HSL (Belfrage et al, 1984, 1985, Brasaemle a/ al, 
2000) which is the first and rate limiting enzyme of lipolysis. The phosphorylated 
HSL also translates to the fat droplets (Egan et al, 1992). The two other enzymes 
involved in lipolysis are diglyceride lipase and monoglyceride lipase (Langin et al,
2005). Insulin activates the enzyme phosphodiesterase (PDE) which hydrolyses 
cAMP into AMP. Insulin therefore inhibits lipolysis (Degerman et a l, 1990).
Gender and adiposity as well as the time of day influence the sensivity of adipocytes 
to adrenaline-induced lipolysis (Large et a l, 2004). Resistance to lipolysis induced by 
catecholamines was demonstrated in abdominal sWAT of obese adults and children 
(Jensen et al, 1989, Bougneres et al, 1997). The reason for this was found in a 
decreased number of lipolytic P2-adrenoceptors (Reynisdottir et a l, 1994) and 
increased number of anti-lipolytic a 2-adrenoceptors (Mauriege et a l, 1991), as well as 
a decreased expression of the HSL enzyme (Large et al, 2004).
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Catecholamines bind to adrenergic receptors. There are two main groups of 
adrenoceptors on adipocytes (a], Pi, P2 and ps), the a-subtype represses lipolysis by 
reducing the cAMP concentrations, the p-subtypes support lipolysis by increasing 
cellular concentration of cAMP. Adrenaline and noradrenaline bind to all 
adrenoceptors, but with different potencies (Carey, 1998). The P2 and P3. 
adrenoceptors are the most important adrenoceptor subtypes for activating lipolysis 
The p3-adrenoceptor is not fully active in the subeutaneous adipose region in humans 
(Carpene et al, 1998, Large and Amer, 1998).
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Figure 1.4: Lipolysis in adipocytes. The signalling pathway o f catecholam ines via adrenoceptors 
and the inhibitory pathway o f insulin are shown. Gs, stim ulating G protein coupled receptor; Gi, 
inhibiting G protein coupled receptor; FFA, free fatty acid; PKA, protein kinase A; IR, Insulin 
receptor; PDE, Phosphodiesterase; TG, triglyceride; P, phosphorylation; Pi, P?, P3, P- 
adrenoreceptors; ag, a^-adrenoceptor; HSL, hormone sensitive lipase; cAMP, cyclic adenosin 
monophosphate; AC adenylate cyclase.
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The lipolytic response to catecholamines is therefore determined by the balance 
between p- and ai-adrenoceptors (Lafontan et a l, 1995, Pages et a l, 1999). Fasting 
increases P-adrenoceptor activity and reduces the number of a-adrenoceptors 
(Ostman et a l, 1984). Exercise acutely increases the p-adrenoceptor-mediated 
lipolytic effect (Wahrenberg et a l, 1987). The more p-adrenoceptor activity in 
relation to a 2-receptor activity, the greater the lipolytic effect (Lafontan et a l, 1995). 
These processes are summarised in Figure 1.4.
1.3.4 White adipose tissue as a secretory organ
The importance of adipose tissue as an endocrine organ that secretes numerous 
protein hormones such as leptin and adiponectin, was shown in mouse models where 
the gene for leptin, the gene for the leptin receptor and the gene for adiponectin were 
missing (Ingalls et a l, 1950, Chung et a l, 1996, Nawrocki et al, 2006). These cell-to- 
cell signalling secretions are termed adipokines. Biologically active adipokines 
include; FFA, Interleukin-6 (IL-6), adipsin, adiponectin, leptin, tumor necrosis factor 
a  (TNFa), plasminogen activator inhibitor-1 (PAI-1), restidin and visfastin, some of 
which were shown to be secreted in a rhythmic manner (Hotamisligil, 1999, Shulman, 
2000, Kalsbeek et a l, 2001, Gavrila et a l, 2003, van der Bom et a l, 2003). It needs to 
be mentioned that not all of these rhythms are truly circadian. The plasma 
concentrations of several adipokines, including adiponectin and leptin, have been 
correlated with visceral fat accumulation (Sinha et a l, 1996a, Fasshauer and Paschke, 
2003, Calvani et a l , 2004, Matsuzawa et a l , 2004).
1.3.4.1 Leptin
Leptin is a 16 kDa peptide produced in mature adipocytes. Leptin signals information 
about dietary status from the adipocytes to the brain. The obesity {ob) gene which 
codes for leptin is located on chromosome 7 in humans (Green et a l, 1995). The 
concentration of leptin in the blood can be correlated with the amount of TG in the 
body (Maffei et al, 1995, Considine, 1996, Langendonk et a l, 1998). Leptin 
concentrations in the cerebrospinal fluid (CSF) are correlated, in nonlinear manner, 
with plasma leptin levels and body mass index (BMI) (Schwartz et al, 1996). In vitro, 
FFA inhibited the release of leptin (Shintani et a l, 2000, Cammisotto et a l, 2003), 
however, this could not be documented in vivo (Peino et a l, 1998, Stumvoll et a l,
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2000). Leptin activates receptors in the hypothalamus to suppress appetite (Mark et 
al, 2002) and increase metabolism (Campfield et a l, 1995, Caro et al, 1996b). The 
major metabolic roles of leptin are the regulation of glucose uptake and fat storage 
(Meier and Gressner, 2004, Mistry et a l, 2004). Leptin administration has been 
shown to reduce TG stores and promote the oxidation of FFA in mice and rats (Muoio 
et a l, 1997, Shimabukuro et a l, 1997, Atkinson et a l, 2002) by increased expression 
of enzymes such as acyl-coenzyme A oxidase (AGO) and carnitine palmitoyl 
transferase 1 (CPT-1), uncoupling protein 2 (UCP2) and peroxisome proliferator- 
activated receptor a  (PPARa). Other studies suggest that the leptin-induced depletion 
of fat is not only due to the mobilization of lipid stores, but also to adipocyte 
apoptosis (Della-Fera et a l, 2001). Leptin enhances fatty acid catabolism in muscle, 
liver and adipose tissue (Shimabukuro et a l, 1997, Bjorbaek and Kahn, 2004). Leptin 
inhibits the biosynthesis of FFAs by inhibiting expression of sterol regulatory 
element-binding protein (SREBPl). The suppressed expression of this transcription 
factor results in reduced lipogenesis (Frühbeck et a l, 1997, Yu and Ginsberg, 2005).
Leptin displays a diurnal and pulsatile variation in the blood (Licinio, 1998, Saad et 
al, 1998), with a nocturnal decline starting in the late evening and continuing 
throughout the night in humans (Sinha et a l, 1996a). Lowest values of leptin are 
measured in plasma in the early morning (Gavrila et a l, 2003). The SCN control the 
diurnal expression of leptin because the diurnal rhythmicity of leptin concentrations in 
the blood of rodents is eliminated by ablation of the SCN (Kalsbeek et a l, 2001, Shen 
et a l, 2007). Feeding time was shown to greatly influence leptin production and the 
diurnal leptin rhythm (Fogteloo et al, 2004). Those findings lead to the assumption 
that the input from SCN clock can be overwritten by the peripheral clock in 
adipocytes.
1.3.5 Adipogenesis
The process in which fibroblast-like precursor cells undergo phenotypic changes to 
become mature spherical adipocytes is termed adipogenesis (Rosen, 2005). This 
process is presented in Figure 1.5. The numbers of pre-adipocytes and adipocytes 
within adipose tissue are kept in a dynamic equilibrium in response to the hormonal 
and dietary status (Rosen and MacDougald, 2006). Differentiation of pre-adipocytes
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to adipocytes, apoptosis and / or necrosis of adipocytes and adipogenesis occur to 
keep this equilibrium.
Adipocytes are thought to arise from multi - potent mesodermal stem cells residing in 
the adipose tissue stroma (Farmer, 2006). These cells lose their ability to differentiate 
into other cell types and become pre-adipocytes. This process is called determination. 
The resulting adipoblast pre-adipocyte is morphologically identical to its precursor, 
but can no longer be differentiated into any other cell type. In the later stages of 
adipogenesis the preadipocytes adopt characteristics of mature adipocytes; they 
acquire lipid droplets and the ability to respond to hormones such as insulin. As part 
of this differentiation process pre-adipocytes acquire lipogenic and lipolytic 
capability, become insulin sensitive and acquire other features of differentiated 
adipocytes (Faust et a l, 1978). In the terminal differentiation fibroblast-like pre­
adipocytes undergo phenotypic changes and become mature spherical adipocytes 
(Grégoire et a l , 1998, Kubo et a l , 2000).
Differentiation of multi-potent mesodermal stem cells into mature adipocytes is 
regulated by an extensive network of transcription factors that coordinate the 
expression of proteins responsible for establishing the mature fat-cell phenotype. At 
the centre of this network are three principal adipogénie factors, PPARy, CCAAT / 
enhancer binding protein (C/EBPa) as well as bHLH families such as SREBP, which 
oversee the entire differentiation process (Rosen et a l, 2002, Fève, 2005).
Without PPARy precursor cells are incapable of differentiating into adipocytes (El- 
Jack et al, 1999, Wu et a l, 1999). This is because PPARy plays a central role in the 
differentiation of precursor cells into adipocytes, it induces genes which promote the 
uptake of fatty acids, TG synthesis and insulin sensivity (Lehrke and Lazar, 2005). 
Precursor cells which are C/EBPa deficient are capable of differentiation; but they are 
insulin resistant (Wu et al, 1999). The gene expression of Rev-erba as well as Small 
is induced during adipocyte differentiation (Chawla, 1993), and the over expression of 
Small increases lipid synthesis activity in adipocytes (Shimba et a l, 2005).
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1.3.6 Models of white adipose tissue physiology and the clock in adipose 
tissue
The physiology of adipose tissue has been analysed using different methods. Lots of 
work has been done on murine adipose tissue. Experiments on human explants are 
limited. Accessible depots for explants in humans are sWAT and other depots during 
surgical procedures. These explants have been either taken in time courses, or taken 
once and kept in cell culture. These cell cultures were then analysed in equal periods. 
Cell lines originating from mice or humans and kept in culture as well as primary cell 
cultures have been used extensively. Human adipose-derived stem cells (Wu et al, 
2007, Huang et al, 2009), murine 3T3-L1 (Otway et al, 2009) and immortalised pre­
adipocytes from murine WAT (IMWAT) (Morganstein et al, 2008) are the cell lines 
important for this thesis.
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Figure 1.5: Overview o f stages in adipocyte differentiation. With appropriate environmental and 
gene expression cues, preadipocytes undergo clonal expansion and subsequent term inal 
differentiation. Selected m olecular events accompanying this process are indicated, with their 
approximate duration reflected by a line. PPARy, peroxisome proliferator-activated receptor y; 
C /EB Pa, CCAAT/enhancer binding protein-a; ECM, extra cellular matrix; modified from 
Grégoire et al, (1998).
20
1.3.6.1 The 3T3-L1 cell line
The 3T3-L1 cell line dérivâtes originally from Swiss mouse embryo fibroblasts. They 
are aneuploid and were derived from embryo fibroblasts rather than pre-adipocytes. 
3T3-L1 cells have fibroblast morphology but can be differentiated to mature 
adipocytes with an adipocyte phenotype. They are sensitive to hormones and drugs 
like adrenaline, isoproterenol (ISO) and insulin inducing lipolysis (Green and 
Kehinde, 1975). Differentiated 3T3-L1 cells have been used as a model to investigate 
adipogenesis and later to investigate the physiology of differentiated adipocytes 
(Prusty et a l, 2002, Roberts et a l, 2009). Differentiated 3T3-L1 cells express rhythms 
of Per2, Dbp and Rev-erba after serum pulse synchronisation (Otway et a l, 2009). 
The Rev-erba profiles did not differ between the pre-adipocytes and the adipocytes. 
The amplitude of Per2 and Dbp was smaller in pre-adipocytes compared to 
adipocytes.
1.3.6.2 The IMWAT cell line
The modification of a genome by introducing an immortalizing gene, can alter the 
normal physiology of the cell (Brinster et a l, 1984, Spanopoulou et al, 1989, Mellon 
et al, 1990). The functionality of the retinoblastoma susceptibility protein (Rb) which 
plays a major role in controlling the cell cycle is also used in the IMWAT cells. 
Studies have shown that Rb null pre-adipocytes differentiate preferentially into brown 
adipocytes (Scime et a l, 2005). Members of the E2F family, which are regulated by 
Rb, have roles in adipogenesis (Fajas et al, 2002) and there is also evidence that wild- 
type simian virus 40 (SV40) large T-antigen can block the differentiation of pre­
adipocytes (Cherington et al, 1988). The IMWAT cell line tries to overcome these 
problems.
The H-2k^-tsA58 mouse (also known as IMMORTO™ mouse) is derived from 
CBA/CaxC57BL/10 mice which were genetically modified to express a mutated, 
temperature-sensitive SV40 large T-antigen under the control of a major histo­
compatibility complex class II promoter (Jat et a l, 1991). This thermo-labile SV40 
large tumor antigen is capable of immortalisation only at the permissive temperatures 
(Tegtmeyer, 1975, Petit et al, 1983, Zaret et a l, 1988, Jat and Sharp, 1989). This 
allows proliferation of the pre-adipocytes at 33°C in the presence of interferon y
21
(INFy). The cells get differentiated into mature adipocytes after the inactivation of the 
immortalising gene SV40 large t-antigen at 37°C in the absence of INFy (Morganstein 
et al, 2008). The normal function of the Rb gene is restored after inactivation of the 
SV40 T-large antigen. IMWAT pre-adipocytes cells are derived from pre-adipocytes 
of the IMMORTO™ mouse and not from fibroblasts.
The IMWAT cells express markers of white fat such as PPARy and adipocyte protein 
2 (aP2) (a carrier protein for fatty acids) but not brown fat markers, have an intact 
insulin signalling pathway and express pro-inflammatory cytokines (Morganstein et 
aA,2008).
1.4 Pathophysiology of obesity, metabolic syndrome and type 2 
diabetes mellitus
Diseases like the metabolic syndrome and T2DM are increasing in numbers all over 
the planet (Cameron et a l , 2004, Ogden et a l , 2006).
1.4.1 Obesity
Obesity is commonly defined as a BMI of 30 kg/m^ or more (WHO, 1999). A BMI of 
30 may have adverse effects on health and may lead to a reduced life expectancy and 
increased health problems (Haslam and James, 2005). The likelihood of various 
diseases such as coronary heart diseases, T2DM, obstructive sleep apnea, 
hypertension, certain types of cancer and osteoarthritis are increased in patients with 
obesity (Willett et a l, 1999, Haslam and James, 2005). Increases of different adipose 
depots underlie different risks for developing diseases, for example especially vWAT 
has been found to be harmful (Pasanisi et al., 2001, Janssen et a l, 2002). The 
dyslipidaemia seen in obesity is characterised by chronically elevated levels of FFAs, 
TG and low-density lipoproteins (LDL), along with reduced levels of high density 
lipoproteins (HDL) (Denke, 2001, Reilly and Rader, 2003). The obesity-associated 
increased infiltration of immune cells, especially macrophages is well-established 
(Weisberg et a l , 2003, Curat et a l , 2004).
Adipose tissue secretions of peptide hormones such as leptin and adiponectin, are 
disturbed in obesity, which in turn is associated with diseases such as metabolic 
syndrome, insulin resistance (Guzik et al, 2006) and cardiovascular disease (CVD)
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(Saltiel, 2000). Weight loss restores leptin pulsatility (Saad et a l, 1998) and reverses 
insulin resistance (Gumbiner et al, 1996). The mesor and amplitude of the 24 h leptin 
rhythm remains lower as compared to the baseline situation in the obesity state, 
reflecting the loss of WAT (Langendonk et a l, 1998).
Obesity is associated with increased adipocyte differentiation (hyperplasia) of new 
adipocytes from precursor cells (adipogenesis, section 1.3.5) and hypertrophy 
(increased cell size) of pre-existing adipocytes (Hausman et al, 2001, Tchoukalova et 
al, 2004). Adipocytes accumulate TG up to a maximum, after which proliferation is 
triggered (Smith et al, 2006). Different humoral factors are able to stimulate pre­
adipocyte differentiation. Glucocorticoids are potent inducers of differentiation as 
hypercortisolism leads to obesity (Fève, 2005). Insulin is a stimulant of clonal 
expansion and induces differentiation (Bost et a l, 2005).
1.4.1.1 Leptin in obesity
The use of leptin to prevent obesity in humans is limited by the development of leptin 
resistance (section 1.4.1.1, Cohen et a l, 2002). The mRNA expression levels of 
adiponectin, resistin and visfatin have been shown to be greatly blunted in mice 
models of mild obesity Kuo Kondo (KK) and severe obese diabetes (KK-A^) (Ando et 
al, 2005). This was not true for leptin mRNA. Hypertrophic adipocytes secrete higher 
levels of leptin (hyperleptinaemia). The ratio of CSF leptin levels to serum leptin 
levels was four times greater in lean than obese individuals (Caro et a l, 1996a, 
Schwartz et al, 1996). These data suggest that human obesity could be secondary to a 
central resistance to leptin action causing a relative leptin deficiency in the central 
nervous system (CNS) rather than inadequate production of leptin (Banks et a/., 1996, 
Halaas et a l, 1997, Flier and Maratos-Flier, 1998). Obese individuals show increased 
concentrations of leptin in their blood (Considine, 1996). This high concentration of 
leptin throughout the day is assumed to be the reason why obese humans do not have 
the satiety feeling subsequent to eating. The increase in the leptin concentrations after 
a meal does not get recognised in these individuals.
A phase difference in plasma leptin concentrations (2:30 h ± 2.5 h) between lean, OW 
participants and T2DMs was reported by Sinha and co-workers (Sinha et a l, 1996a). 
A difference in phase, however, could not be found in another study investigating lean
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and obese participants (Saad et a l, 1998). Both studies lack a pre-study protocol, 
control in food intake and timing and the sleep / wake cycle was not controlled.
1.4.1.2 Leptin resistance
The loss of leptin signalling results in hyperphagia, primarily by increased meal size 
(McLaughlin and Baile, 1981, Alingh Prins et a l, 1986). This was shown in early 
mouse models lacking either leptin or the leptin receptor (Ingalls et a l, 1950, Chung 
et a l, 1996). Hyperleptinaemia rapidly depletes fat stored in adipocytes of lean rats. 
Hypertrophic adipocytes in a mouse model of obesity were shown to be resistant 
against leptin induced fat depletion (Wang et al, 2005). Leptin resistance has been 
shown to involve defects in the transport of leptin to the hypothalamus and impaired 
intracellular leptin signalling (El-Haschimi et a l, 2000).
1.4.2 Metabolic syndrome
The number of patients diagnosed with the metabolic syndrome is increasing. This is 
partly due to a rise in obesity and a change to a less physical challenging lifestyle. The 
term metabolic syndrome is the term for a group of risk factors for developing T2DM 
and CVD (Grundy et a l, 2004).
Different definitions of the metabolic syndrome are in use. This shows how 
diversified those risk factors are, and how difficult it is to define the term metabolic 
syndrome. The International Diabetes Federation defined raised fasting plasma 
glucose, high cholesterol, high blood pressure and abdominal obesity as features of 
the metabolic syndrome. The Adult Treatment Panel III included atherogenic 
dyslipidemia, raised blood pressure, insulin resistance with or without glucose 
intolerance, proinflammatory state, prothrombic state as well as abdominal obesity to 
the risk factors of the metabolic syndrome which might lead to the CVD. Both 
definitions included abdominal obesity. This highlights the central role of obesity and 
WAT in the pathogenesis of T2DM.
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1.4.3 Type 2 diabetes mellitus
T2DM (non-insulin -  dependent diabetes mellitus (NIDDM), adult-onset diabetes) is 
the most common form of diabetes and it is characterised by high levels of glucose in 
the blood and usually occurs gradually. Most people with this disease are OW at the 
time of diagnosis, which might be due to the fact that the likelihood of developing 
T2DM is increased 10-fold at a BMI of 30 kg/m^ (Haugen and Drevon, 2007). 
However, T2DM can also develop in lean humans, especially the elderly. Other risk 
factors include a family history of T2DM, low physical activity, poor diet and all the 
risk factors for the metabolic syndrome (section 1.4.2). Daily cycles in insulin 
secretion and glucose tolerance have been shown to be lost in patients with T2DM 
(Calvani e/a/., 2004).
The WHO (1999) defined the following recommendations to diagnose diabetes 
mellitus: A single raised blood glucose reading with symptoms. Raised glucose values 
on two occasions, of either: fasting plasma glucose > 7 mmol/1 (126 mg/dl) or a 
plasma glucose >11 mmol/1 (200 mg/dl), two hours after an oral dose of 75 g glucose 
(glucose tolerance test).
T2DM patients suffer from long term complications such as retinopathy, nephropathy, 
neuropathy, macrovascular diseases (stroke), myocardial infarction and autonomic 
peripheral neuropathy (O’Brien et al, 1986). Neuropathy affects approximately 50% 
of patients around the world (Pirart, 1977, Dyck et a l,\9 9 \) .
1.4.3.1 Insulin resistance
In healthy insulin-sensitive humans the liver, muscle and fat cells take up glucose 
from the blood in response to insulin stimulation. These cells are insensitive to the 
insulin stimulus in T2DM patients. These patients have insulin resistance. Different 
factors which are all related to the lifestyle are able to influence the insulin sensivity 
of these cells. Dietary fats have been shown to create insulin resistance (Kraegen et 
al, 1991, Boden et al, 1994) and insulin sensivity has been shown to be negatively 
correlated with fat intake in humans (Lovejoy and DiGirolamo, 1992). Physical 
activity has been reported to increase the insulin sensivity (Ivy, 1997, Mayer-Davis et 
al, 1998). Insulin sensivity shows reduction at night (Morgan et a l, 1998). The
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European Group for the Study of Insulin Resistance (EGIR, 1999) (Megirian et al, 
1998) defined insulin resistance as the top 25% of the fasting insulin values among 
non-diabetic individuals and two or more of the following criteria; central obesity (> 
94 cm (male), > 80 cm (female), dyslipidaemia TG > 2 mmol/1 and / or HDL < 
1 mmol/1, hypertension > 140/90 mmHg, fasting plasma glucose >6.1 mmol/1).
As a result of insulin resistance the concentration of glucose in the blood increases. 
This is called hyperglycaemia. The high blood glucose levels trigger the P-cells of the 
pancreas to produce insulin to compensate the insulin resistance (hyperinsulinaemia). 
The increased concentrations of insulin in the blood stream are not able to overcome 
the demand of insulin, as the cells become more and more resistant to insulin. Insulin 
resistance in adipocytes cells does not just affect their ability to take up glucose but 
also results in the reduced uptake of circulating lipids and increased hydrolysis of 
stored TG. These FFAs accumulate and get converted into ceramides in p-cells of the 
pancreas which leads to production of nitric oxide (NO) and results in p-cell apoptosis 
(Kaneki et a l, 2007, Guilherme et a l, 2008). Inflammation markers which are 
elevated in obesity such as TNFa (Ishizuka et a l, 2007) and IL-6 (Makino et al, 
1998, Bastard et a l, 2002, Rotter et al, 2003) have been found to play a role in the 
development of insulin resistance.
1.4.3.2 Glycated haemoglobin
Glycated haemoglobin (HbAlc) is a form of haemoglobin which is used to estimate 
the average glucose plasma concentration over the last months. Haemoglobin is 
glycated by a non-enzymatic reaction (Misciagna et a l, 2007). With increasing 
plasma levels of glucose the amount of HbAlc increases. The American Diabetes 
Association added a HbAlc value of > 48 mmol/mol (6.5%) to the criteria to diagnose 
diabetes (American Diabetes Association, 2010). The higher the amount of HbAlc the 
less well controlled is the T2DM disease.
1.4.3.3 Medication
Metformin is an oral anti-diabetic drug of the biguanide class. It is the first-line drug 
of choice for the treatment of T2DM, particularly in OW and obese people and those 
with normal kidney function (Bailey and Turner, 1996). It improves hyperglycaemia
26
primarily through its suppression of hepatic glucose production (Kirpichnikov et al,
2002). Metformin activates AMPK (Zhou et al, 2001), a liver enzyme that plays an 
important role in insulin signalling, whole body energy balance, and the metabolism 
of glucose and fats (Towler and Hardie, 2007). Metformin increases insulin 
sensitivity, enhances peripheral glucose uptake (by phosphorylation of the glucose 
transporter type 4 (GLUT-4) enhancer factor), increases FFA oxidation (Collier et al.,
2006) and decreases absorption of glucose from the gastrointestinal tract. Metformin 
lowers both fasting and postprandial blood glucose levels (Bailey and Turner, 1996).
Metformin activates the AMPK which might modulate circadian rhythms (Um et al,
2007). CKIs is activated by AMPK-dependent phosphorylation and stimulates 
mPER2 degradation. Activation of AMPK by metformin injection shifted the 
circadian expression pattern of clock genes in wild-type mice. It is hypothesized that 
metformin can interrupt the apoptotic cascade in primary neurons when exposed to 
oxidative stress (El-Mir et a l, 2008). This is of clinical interest because metformin, 
beyond its hyperglycaemic function, could also act as a pharmacological agent in the 
treatment of neurodegenerative diseases and diabetes-associated neuropathy, provided 
that metformin can be made to pass the blood-brain-barrier (BBB).
Statins are used in the treatment of T2DM patients to lower their risk in CVDs, and 
also to weaken the risk factor leading to T2DM. Statins are drugs inhibiting 
3-hydroxy-3-methyl-glutaryl-CoA reductase (HMG-CoA reductase), which plays a 
central role in the biosynthesis of cholesterol in the liver. Increased levels of 
cholesterol are the major risk factor for the development of CVDs (Lewington et a l,
2007).
1.5 Obesity and diabetes type 2 diabetes; cause or effect of a 
disturbed clock in adipose tissue?
Circadian clocks mediate the expression and / or activity of certain metabolic 
enzymes and transport systems (Hirota and Fukada, 2004, Kohsaka and Bass, 2007) 
which are involved in cholesterol metabolism, amino acid regulation, drug and toxin 
metabolism, the citric acid cycle and glycogen and glucose metabolism (La Fleur et 
al, 1999, La Fleur et a l, 2003, Ramsey et al, 2007). Disruption of circadian rhythms 
in the SCN and peripheral tissues may lead to higher insulin concentrations, growth of
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intra-abdominal fat tissue and high blood pressure, manifestations of obesity and 
T2DM (Buijs and Kreier, 2006).
1.5.1 The clock in white adipose tissue
The heterogeneity of WAT was described in (section 1.3.1). A circadian oscillator 
mechanism was not only found in most of the cells of WAT (Table 1.1), but also in 
different depots of WAT. Explants taken in a time course from mice showed 
rhythmicity of core clock geneses in BAT, iWAT, pWAT, eWAT (Ando et a l, 2005, 
Zvonic et al, 2006). Rhythmic expression of the core clock genes was also found in 
cultured sWAT and vWAT explants of white adipose depots from morbidly obese 
female humans (Gomez-Santos et al, 2009). These findings are supported by the 
finding that approximately. 20% of the murine WAT transcriptome is estimated to 
exhibit 24 h variation (Ptitsyn et a l, 2006, Zvonic et a l, 2006). However, there are 
differences in the amplitude of clock genes between different adipose depots. It was 
shown that murine eWAT expresses higher amplitudes in the clock genes {Email, 
Cryl-2, Per 1-3, Rev-erba and Dbp) than murine sWAT tissue (Bray and Young,
2007). However, it is still unclear whether a clock resides in the adipocytes.
Table 1.1: Presence o f circadian clocks in adipose tissue cell types.
Cell type Reference
Fibroblasts Balsalobre et al, 1998,
Nagoshi et al, 2004, Welsh et al, 2004
Macrophages Hayashi et al, 2007
Vascular Schoenhard et al, 2003, Wang et al, 2006,
endothelial cell Takeda et al, 2007,
Viswambharan et al, 2007
Leucocytes Takata et al, 2002, Archer et al, 2008
Pre-adipocytes Aoyagi et al, 2005, Wu et al, 2007
From Johnston et al, (2009).
1.5.2 Clocks, energy metabolism and adipose tissue biology
The components of the metabolic syndrome (higher TG, low HDL and high 
cholesterol levels) occur at higher frequency in humans living in conditions of 
circadian misalignment. Clock genes such as Email and Clock have been shown to
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play a role in energy homeostasis and metabolism (Rudic et a l, 2004, Scott et al,
2008).
The components of the metabolic syndrome, the incidence of T2DM and an increased 
BMI occur at higher frequency in shift workers (Knutsson, 2003, Akerstedt et al,
2004), under short sleep duration (< 6 h) or extended sleep duration (> 9 h) (Karlsson 
et a l, 2001, Spiegel et a l, 2005, Chaput et al, 2006). Sleep deprivation may also lead 
to obesity (Sekine et a l, 2002) and has been shown to effect plasma leptin levels 
(Mullington et a l, 2003).
Daily cycles of insulin secretion and glucose tolerance have been reported to be lost in 
patients with T2DM (Van Cauter et a l, 1997, Boden et al, 1999). These findings 
suggest that loss of circadian rhythmicity of glucose metabolism may contribute to the 
development of metabolic disorders, such as T2DM, in both rodents (Oster et al, 
1988, Velasco et al, 1988, Shimomura et al, 1990) and humans (Spallone et al, 
1993, Van Cauter et a l, 1997).
1.5.2.1 Animal models of circadian clock disruption
Animal models with mutations in genes directly or indirectly involved in the 
molecular oscillator mechanism, single nucleotide polymorphisms (SNPs) as well as 
mutations in clock genes in humans have lightened the importance of a functional 
clock mechanism.
In 1994 random mutagenesis with N-ethyl-N-nitrosourea (ENU) in C57BL/6J mice 
and behavioural screening afterwards led to the first animal model with a mutation in 
the core clock gene Clocl^^^ (Vitatema et a l, 1994). The Clocl^^^ gene lacks 51 
amino acids on exon 19 (Antoch et al, 1997, King et a l, 1997) in the CIPC-binding 
domain (Zhao et al, 2007). CLOCK is still able to bind to BMALl but the 
heterodimer is not able to promote transcription. Turek and co-workers detected 
features of obesity and metabolic syndrome in these mice (hyperphagia, abnormal 
feeding rhythms hyperglycaemia, reduced activity, obesity, metabolic syndrome, 
hypercholesterolemia, hyperleptimia, hypoinsulinaemia) (Turek et a l, 2005). The 
parental C57BL/6J strain of the mice used in the Ando study was analysed for 
mutations. The nicotinamide nucleotide transhydrogenase enzyme was found to be
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mutated and markedly decreased glucokinase enzyme activity were reported in the 
mice, as well as impaired glucose tolerance (Toye et a l, 2005, Freeman et al, 2006a, 
Freeman et a l, 2006b). Kennaway and co-workers subsequently implanted the 
Clockf^^  ^ mutation into the CBA genetic background (Kennaway et a l, 2007). This 
genetic background showed melatonin production (Kennaway et a l, 2003) and that 
the clock gene expression in liver and muscles were arrhythmic (Kennaway et al, 
2006). The CBA mouse-strain is not prone to spontaneous insulin resistance or 
obesity independent of the mutation. This mouse model was so-called
Clockf^^^+MEL (Kennaway et a l, 2007). These mice showed impaired glucose 
tolerance (Kennaway et a l, 2007) and altered insulin secretion. In Clockf^^  ^ mutant 
mice with a JchlCR background less obesity on a HF diet was compared to wild-type 
mice on the same diet (Oishi et a l, 2006a, Oishi et a l, 2006b). In these mice serum 
levels of insulin and leptin did not differ between wild-type and Clock mutant mice 
(Kudo et a l, 2004a). Under normal diet conditions no difference could be found 
between Clochf^^  ^ (ICRiJcl) and wild-type mice, the mutants got slightly less obese 
under a HF diet. A difference in food intake could not be detected and Clock-mutant 
mice tended to have a higher serum TG than wild-type mice under HF diet but this 
finding was not significant (Kudo et a l, 2007). It seems that the Clock mutation 
enhances obesity in the C57BL/6J and attenuates obesity in mutant mice with the ICR 
background. The differences between the strains, e.g. in serum cholesterol and 
glucose levels, appears to be different enough to change the influence of the mutation 
in Clock.
A Bmair^' mouse model was established in 2000 (Bunger et a l, 2000). Mice lacking 
the BMALl protein age quickly (Kondratov et a l, 2006), have problems to reproduce 
(Boden and Kennaway, 2006), suffer from progressive arthropathy (Bunger et al,
2005), myopathy and altered hepatic carbohydrate metabolism (Rudic et a l, 2004, 
Bunger et al, 2005, Kondratov et al, 2006). BMALl links the core clock mechanism 
with lipogenic pathways. Diurnal variations in the rhythm of plasma glucose and TG 
concentrations get blunted (Rudic et a l, 2004); this can lead to impaired glucose 
tolerance (Kennaway et a l, 2007) and insulin resistance (Morikawa et a l, 2005). 
BMALl has been shown to regulate lipogenesis and lipid storage in skeletal muscle 
(Takahashi et a l, 2008). Email deficiency also impairs adipogenesis in vitro (Shimba 
et a l, 2005).
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Rev-erba^' mice express Small in an abnormal fashion and the mice also exhibit 
alterations in the phase and period of their circadian behaviour patterns (Preitner et 
al., 2002). Rev-erba mutation or disruption in hepatocytes has been linked to elevated 
plasma TG levels (Raspe et al, 2002).
Per2'^' mice exhibit no glucocorticoid rhythm, although the corticosterone response to 
hypoglycaemia is intact. These mice did not show a diurnal feeding rhythm and are 
more likely to develop obesity (Yang et al, 2009). mPer2 expression has been 
recently related with tumour suppression because over-expression of mPer2 in some 
mouse carcinoma cell lines results in reduced cellular proliferation and rapid 
apoptosis (Hua et al, 2006).
1.5.2.2 Clock gene polymorphisms in humans
Various clock gene SNPs of human clock genes have been linked with metabolic 
dysfunction and obesity (Monteleone et al, 2008, Scott et a l, 2008, Sookoian et a l,
2008). Familial studies have shovm that BMALl haplotypes are linked to T2DM 
(Woon et al, 2007). Sookoian et al, (2007) reported that CLOCK polymorphisms in 
human subjects are associated with susceptility to non-alcoholic fatty liver disease, a 
common abnormality observed in obese patients. CLOCK haplotypes have also been 
linked to protection from, or susceptibility to metabolic syndrome (Scott et al, 2008). 
Studies of both British (Scott et al, 2008) and Argentinean (Sookoian et a/., 2008) 
populations have investigated polymorphisms of the CLOCK gene and found 
significant relationships between CLOCK haplotypes and the presence of obesity and 
metabolic syndrome. The 3111T/C CLOCK gene SNP in OW / obese individuals 
carrying the CC genotype were shovm to be prone to higher BMI compared to CT and 
TT genotypes (Monteleone et al, 2008). One haplotype of the SREBPl gene has been 
associated with morbidly obesity, T2DM and dyslipidemia in French Caucasian 
cohorts (Eberle et a l, 2004). Genomic variants of NPAS2 and PER2 have also been 
linked to components of metabolic syndrome, including hypertension and glucose 
dysregulation (Englund et a l , 2009).
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1.5.2.3 Adipose tissue specific clock gene mutations
An adipose tissue specific mutation in one of the clock genes would be a useful tool to 
find out how much the adipocyte clock influences the biology of the adipocytes. A 
mutant mouse strain was engineered in which the expression of the Cloch^^^ mutation 
was under the control of the aP2 promoter executively in adipocytes. This mouse 
model strain which does possess a non-functional clock in adipocytes was called 
adipocyte clock mutant (ACM) (Rees et a l, 1986, Mileni et al, 2006, Bray and 
Young, 2007). Microarray analysis showed genes promoting lipogenesis were induced 
in the eWAT of the ACM mice. But the aP2-promoter cassette is not exclusive to 
adipocytes. Therefore aP2 is not exclusively expressed in adipose tissue, but also in 
macrophages and cardiomyocytes (Wang et al, 2010). In addition the aP2 -  promoter 
is also unevenly distributed in the different depots of AT (Halberg et al, 2009).
Another group has used an adiponectin specific promoter-eassette to achieve adipose 
tissue specific mutations (Wang et a l, 2010). They reported an even distribution 
within adipose tissue depots. The gene expression triggered by the adiponectin 
promoter cassette is weak this is the disadvantage of the system. Up to now there is no 
reliable animal model with a specific disruption of the adipose tissue clock.
1.5.3 Effect of diet and metabolic state on the adipose tissue clock
1.5.3.1 Influence of high-fat diet on the adipose clock
The relationship between nutrition and circadian synchrony was analysed by 
(Kohsaka and Bass, 2007). Male mice (C57BL/6J) fed a HF diet for 6 weeks showed 
changes in amplitude and rhythmic expression of core clock genes, CCGs, nuclear 
receptors, circulating metabolic markers, hypothalamic expression of neuropeptides 
and adipokines compared to their counterparts fed a normal diet (Figure 1.6 a and b). 
The same strain of mice fed a HF diet showed changes in their locomotor activity 
cycle under free-running conditions already after 1 week of the HF diet (Rehfeld, 
1998). These mice also showed increased feeding during the light period under 12 h 
light / 12 h dark conditions. The changes in the locomotor activity happened 
independent of the gain in body weight because of the HF diet. A similar study with 
male mice (C57BL/6) on a HF diet induced a phase delay of 3 h in mPer2 expression 
(Bamea et a l, 2009). Another study investigated the effect of HF diet on rhythmic
32
mRNA expression of the elock genes {Clock, Email, Perl, Per2, Cryl, Cry2 and 
Dbp) in female mouse visceral adipose tissue and liver. The mice developed a mild 
metabolic syndrome (obesity, hyperlipidaemia, hyperglycaemia) after they were fed a 
HF diet for 8 weeks. This diet had minimal effects on the rhythmic expression of the 
clock genes (Figure 1.6 c), but daily rhythmieity in the expression of cholesterol 7a- 
hydoxylase in liver disappeared in mice on HF chow (Yanagihara et a l, 2006). Both 
studies showed that a HF diet influences the function of the mammalian circadian 
clock network, but it appears there is a gender specific difference.
1.5.3.2 Obesity, type 2 diabetes, rhythmic (clock) gene expression and adipokine 
secretion
Male CSlBL/KsJ-db/db Jcl (db/db) mice lacking a functional leptin receptor (Chen et 
al, 1996, Chua et al, 1996) are recognised as an animal model for obese T2DM. The 
animals show a first phase of hyperinsulinaemia in which the daily locomotor activity 
is moderately attenuated. In the second phase which is characterised by 
hypoinsulinaemia the daily rhythm in locomotor activity gets completely lost. The 
expression profiles of the core clock genes {mPerl, mPer2 and mBmall) are more 
severely attenuated in the second phase in phase and expression level compared with 
their non-obese littermate mice (C57BL/KsJ-<76/+w Jcl {db!+)) (Kudo et a l, 2004a). 
The mRNA levels of clock genes and adipokines were analysed in perigonadal fat of 
10 week old female KK (mild spontaneous obese diabetes) and KK-A^ (severe 
spontaneous obese diabetes (polygenetic) obvious hyperglycaemia and 
hyperinsulinaemia detected) mice (Suto et a l, 1998, Ando et al, 2005) (Figure 1.7). 
The clock genes in vWAT showed significant rhythmieity and no change in the phase 
in all three analysed strains under HF diet and with normal chow. However, the 
amplitude of the gene expression was blunted with the severity of the diabetes. 
Rhythms of adipokine mRNA expressions were also reduced in the mice with 
diabetes. Thus, obesity and T2DM appears to have an effect on the intracellular clock 
system in visceral adipose tissue. A more recent study by the same authors in a non- 
obese diabetes model (Goto-Kakizaki (GK) rats) showed that clock gene expression 
was not altered in vWAT (Ando, 2009). They therefore hypothesised that the 
impairment of the clock mechanism in peripheral tissues in obese diabetic animals is 
caused by obesity-related factors.
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Figure 1.6: Influence on high-fat diet on metabolic markers and clock genes
a. HF diet alters diurnal patterns o f metabolic markers and transcription networks. Mice were 
maintained on a 12 h light / 12 h dark cycle and fed either regular chow (RC) (black lines) or HF 
diet (gray dotted lines) ad libitum for 6 weeks (n = 6 -8  per group per time point). A Diurnal 
variation in serum leptin, glucose, insulin, free fatty acid (Carraro et a l,  1994), and 
corticosterone levels. B Mediobasal hypothalamus sections were used to measure the mRNA 
expression levels o f orexigenic (Agrp and Npy) and anorexigenic (Pome and Cart) neuropeptides, 
as well as orexin (Orx) transcript levels. C The diurnal distribution o f  various circadian clock 
gene-regulating nuclear receptors (NRs; R ev-erba, R ora, R xra, Ppara, and Ppary) was measured 
in fat and liver. D Transcripts involved in lipid metabolism (Srebp-lc, Acc, Fas, and Fabp) were 
measured in fat and liver. Results are expressed as means ± SEM (*p < 0.05). From (Kohsaka and 
Bass, 2007). b. HF diet attenuates the amplitude o f clock gene expression. Transcripts o f the core 
circadian clock genes Clock, Bmall, and Per2 in the mediobasal hypothalamus, fat, and liver 
were analyzed by qtPCR. Tissues were harvested every 4 h from mice fed either RC (black lines) 
or HF diet (gray dotted lines) for 6 weeks; values are displayed as relative abundance (mean ± 
SEM) after norm alization to Gapdh (*p < 0.05 between groups at each time point). From 
(Kohsaka and Bass, 2007) c. Daily mRNA expression profiles o f  the clock genes in the visceral 
adipose tissue o f mice fed a RC ( • - • )  or HF diet (o -o ) for 8 weeks. Data are mean ± SEM o f 4 
mice at each time point and are expressed as relative values to the lowest values in control mice 
for each gene. *p < 0.05,**p < 0.01 vs. control mice. From (Yanagihara et a l, 2006).
34
C 57B L /6J KK-AV C 5 7 B U 6 J
B m all
Z e itgeber Time Zeitgeber Time
A d ip o n e c tin  i 
R e s is t in  8  1
L ep tin
o T '  12 18
P e rz
(ZT 12)(ZT 12) ZT 18)
Z eitg eb e r Tim e
Figure 1.7: Daily mRNA expression profiles o f the clock genes (A and B) and adipokines (C) in 
the visceral adipose tissues o f C57BL/6J, KK, and KK-Ay mice. Female mice were maintained 
under a 12 h light / 12 h dark cycle and fed a standard diet with (o — o) or w ithout ( • — • )  0.02% 
pioglitazone for 2 weeks. Thereafter, perigonadal fat samples were obtained at ZT 0, 6, 12, and 
18. Transcript levels o f  the target genes were determined by real-tim e quantitative qtPCR. D, 
mRNA levels o f the representative gene {Dbp, Per2, or Cryl) at the time that its level peaked in 
C57BL/6J mice were compared among groups using an ANOVA with a post hoc test o f F isher’s 
Protected least Significant Difference. All data are means and SEM of five mice at each time 
point and are expressed as relative values to the lowest values in C57BL/6J mice for each gene. 
*p < 0.05; tp  < 0.01 vs. untreated KK mice; Jp < 0.05 vs. untreated KK-Ay mice. From (Ando et 
a/., 2005).
Another study analysed the circadian expression of the mRNA of adiponectin and the 
adiponectin receptors 1 + 2 in omental (vWAT) and subcutaneous (abdominal) AT, 
from 6 morbidly obese OW women (BMI 44.1 kg/m^ ±5.5 kgW ). Food time was 
controlled the day before the study. The adipose tissue explants were kept in culture 
overnight, and were analysed at 4 time points over 24 h the next day. It is not clear if 
they detected a rhythm in the genes, due to their low number of time points (n = 4) 
(Gomez-Abelian et al, 2010).
Adipokines might provide a molecular link between the increased adiposity and 
development of T2DM and / or metabolic syndrome (Fasshauer and Pasehke, 2003). 
Obesity has been shown to blunt the diurnal rhythm of plasma adiponectin 
concentrations (Calvani et al, 2004, Yildiz et a l, 2004). This is also true in patients 
with CVDs (Hotta et a l, 2000), hypertension or metabolic syndrome (Trujillo and 
Scherer, 2005). Reasons for these findings could be that local adipose hypoxia 
deregulates the production of adipokines (Hosogai et al, 2007).
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1.6 Summary
Plenty of evidence has been produced in the last years to link circadian clock 
disruption with metabolic diseases such as obesity and T2DM. Examples are the 
increased incidences of metabolic syndrome and diabetes in shift workers (section
1.5.2, Knutsson, 2003), metabolic abnormalities in mouse models with clock gene 
mutations (section 1.5.2.1, Turek et al, 2005, Oishi et a l, 2006a, Kudo et a l, 2007) 
and the reported associations between clock gene haplotypes and T2DM (section
1.5.2.2, Woon et a l, 2007, Scott et al, 2008). The clearest physiological link comes 
from studies of rhythmieity in AT and its hormonal products, termed adipokines 
(section 1.3.4).
The humoral and neuronal influence of the SCN cannot be turned off in a study with 
living animals. This makes it virtually impossible to investigate the exclusive 
influence of the AT timing system on the metabolism. The variety of cells in adipose 
tissue adds another level of complexity (section 1.3.1). Rhythms analysed in adipose 
tissue explants, or cultured explants might be due to cells other than adipocytes 
(section 1.3.6). Adipocyte cell lines avoid this problem by consisting solely of 
adipocytes. However, immortalised cell culture cells might not be valid to investigate 
adipocyte physiology because of their truncated genomes and influence of the 
immortalising genes.
The current work tries to provide new insights into the effect of the metabolic states of 
obesity and T2DM mellitus on human adipose tissue physiology. Furthermore it tries 
to detect and characterise a molecular oscillator in a new cell line whose physiology is 
closer to the adipocyte in the animal than generally used cell lines. It also tries to test 
if lipolysis in these cells is gated by the endogenous clock.
1.7 Hypotheses and objectives
The overall aim of this PhD is to investigate links between circadian clocks and 
metabolism. The adipose tissue is of special interest because it plays a key role in 
obesity and diabetes. The following hypotheses will be tested:
1.7.1 Central hypotheses
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Hypothesis 1: The rhythmic adipokine secretion is altered in humans who are obese 
or suffer from T2DM compared to normal lean controls.
Hypothesis 2: IMWAT adipocytes possess an endogenous clock as pre-adipocytes as 
well as when they are differentiated into adipocytes, and that lipolysis in these cells is 
gated by this clock mechanism.
Hypothesis 3: The expression profiles of the proteins involved in the core loop of the 
cellular clocks are detectable via the western blot method in murine adipose tissue. 
Tissues of different metabolic states show a difference in the amount of protein 
expression and the amount of clock proteins oscillates in a diurnal manner.
1.7.2 Objectives
Objective 1: Quantify plasma melatonin, leptin and cortisol levels across 24 h in 
normal, obese and T2DM men.
Objective 2: Analyse the core clock genes in serum pulsed IMWAT pre-adipocytes 
and adipocytes.
Objective 3: Assess whether lipolysis in differentiated IMWAT cells is gated by the 
endogenous timing system.
Objective 4: Establish a western blot protocol to detect core clock proteins.
Objective 5: Quantify protein and analyse differences in phasing between protein 
extractions from lean and obese mice together with mice showing symptoms of 
metabolic syndrome.
Objective 6: Investigate differences in the phasing between gene and protein 
expression.
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Chapter 2: Material and methods
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2.1 Manufacturers
The manufacturers of items and products are described in Table 2.1, with either their 
UK or international headquarters.
Table 2.1: Manufacturers o f reagents and products.
Name Address Name Address
Abgene Epsom Microsoft Reading
abserotec
Puchheim,
Germany Millipore
Billerica, MA, 
USA
aDiagnostics San Antonio, USA
Molnlycke
Healthcare Dunstable
Amersham Buckinghamshire
New England 
biolab Ipswich
Applied
Biosystems Warrington Nikon Langen, Germany
B&K Universal 
Ltd Hull Nutricia Ltd. Wiltshire
Bio Cision London
Omron Automotive 
Electronics
Kingswinford, 
West Midlands
BioRad Hertfordshire Perkin Elmer
Massachusetts,
USA
Canon Woodhatch Pierce Cramlington
DAKO Glostrup, Denmark Promega Southampton
Danone Trowbridge SAS Cay,NK%F%kk
Fisher Scientific Leicestershire Sigma St. Louis, USA
GE Healthcare Buckinghamshire Sonics, Vibra Cell
Meyrin/Satigm,
Switzerland
GIBCO Leicestershire Stockgrand Guildford
Graphpad Ja Jolie, Ca USA Teklab Collinsville, USA
Instrumentation
Laboratory Warrington Tesco Cheshunt
Invitrogen Pasley Thermo Scientific Loughborough
Kellog's Manchester Wallac Milton Keynes
Kem-En-Tec Destin, USA YSl Life Science Fleet
Kodak Hertfordshire Zen-bio East Hwy, USA
I f  no country is stated then the company has its headquarters in the UK.
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2.2 Human study
All procedures had a favourable ethical opinion from the University of Surrey Ethics 
Committee. Ethical application as well as recruiting and pre-screening were carried 
out by Dr. Daniella Otway (University of Surrey). Detailed information of these 
procedures can be found in her thesis. A favourable ethical opinion was obtained from 
the Surrey Research Ethics Committee (08/H1109/117, submission 19^  ^August 2008) 
and the University of Surrey Ethics Committee (EC/2008/82/FHMS/Fast-track). All 
volunteers gave written informed consent.
2.2.1 Power calculation
The power calculation for the study described in this thesis is based on a study by 
Ando et al. (2005). The power calculation was based on the results of the clock gene 
mRNA of this study in male C57BL/6J mice. Based on the mRNA rhythms of Per 
and Dbp clock genes and Adiponectin a difference of the peak expression of >1.5 SD 
between the lean healthy control group and the obese-diabetes groups was expected. 
For a  ^ 0.05 and 80% power and an expected drop-out rate of 10% therefore 9 
participants were needed per group to be able to gain a statistically significant result. 
All used parameters are visualised in Table 2.2.
Sample size calculation parameters Comparison between cohorts
Type of study ANOVA
Design Repeated measures
Alpha -  Error 0.05
Power 80%
SD between the means 1.5
Mean standard deviation 1.5
Drop-out rate 10%
Sample size per cohort 9
Table 2.2: Calculation o f sample size based on results between subjects.
2.2.2 Participants
Males aged between 40 and 65 years of age were recruited into three groups which 
were matched for age. Participants were free of any diseases (hepatic, cardiac and 
kidney). Medication details were based on information obtained from both the 
participants and their general practitioner.
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2.2.2.1 Group 1: Lean healthy
Participants in this group were not allowed to show any of the criteria for metabolic 
syndrome as described by the EGIR. The BMI of this group was between 19 and 25 
kg/m^. This group consisted of eight participants. The average age was 53.8 years 
(± 2.1 years SEM).
2.2.2.2 Group 2: Overweight and insulin sensitive
Participants in this group needed to meet the criteria for insulin resistance defined by 
the EGIR. The BMI of this group was between 27 and 35 kg/m^. Ten participants took 
part in this group. The average age was 50.8 years (± 2.9 years SEM).
2.2.2.3 Group 3: Type 2 diabetes mellitus
Participants with T2DM under diet and exercise control were preferred to patients 
under a medication regime. Participants on medications which are known to influence 
the endogenous timing system or plasma insulin level were excluded. The BMI in this 
group was between 25 and 35 kg/m^. Eight T2DM participants took part in the study. 
Participants with hypoglycaemic episodes were excluded as well as participants with a 
HbAlc > 8.5%. The average age was 57.1 years (± 1.6 years SEM).
2.2.3 Physical measurements
Height, weight and waist circumference were also measured on the pre-screen day. 
Blood pressure was measured (OMRON Mx3 Plus Digital Automatic Pressure 
Monitor, Omron Automotive Electronics). The equation used for the BMI calculation 
is shown in equation 2.1.
{h eigh t{m )Ÿ
Equation 2.1: BMI calculation.
Questionnaires about general health (Becks Depression Index (BDl)) and chronotype 
(Home-Ostberg (HO) and sleep and sleepiness (Pittsburgh Sleep Quality Index 
(PSQl) and Epworth sleepiness score) were completed.
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2.2.4 Inclusion / exclusion criteria
2.2.4.1 Fasting blood tests
Participants were asked to provide a 13 ml fasted blood sample on the pre-screen day. 
Ten ml were transferred into a serum tube (Teklab) and send to the Clinical 
Biochemistry Department at the Royal Surrey County Hospital for analysis of HbAlc 
and insulin. Two ml were transferred into a di-potassium-EDTA tube (Teklab) and 
spun (3000 g, 10 min, 4°C) to produce blood plasma for measurement of TG and 
cholesterol. The samples were stored at -80°C until analysis. Whole blood glucose 
(YSl 2300 STAT Plus, YSl Incorporation) and iron (GEM OPL Oxygenation Portable 
Lab, Instrumentation Laboratory) were measured in another millilitre of the 13 ml 
blood. Participants were excluded if any of these measurements showed any 
abnormalities.
2.2.4.2 Quantification of insulin resistance (HOMA-IR)
The Homeostatic Model Assessment (HOMA-IR) is a method to quantify insulin 
resistance and p-cell function. It estimates insulin sensivity as a percentage of the 
normal. The SI unit picomolar (pM) divided by a factor of 6.945 leads to pU/ml 
(McAuley et a l, 2001). The HOMAR-IR was calculated as shown by equation 2.2 
(Matthews e /ûf/., 1985).
HOMA IR f  1 glucose (mM)x fasting insulin {juU/ ml)
\  ml )  22.5
Equation 2.2: HOMA-IR calculation.
2.2.4.3 Inclusion criteria
Participants needed to be male and between 40 and 65 year of age. They needed to be 
able and willing to give oral and written consent. In addition their medical practitioner 
should see no reason why they should not participate in the study. Participants needed 
to have a regular sleep/wake cycle with sleep duration between 6 and 8 h. They 
needed to pass the pre-screen questionnaires and screens. They needed to agree to the 
rules for the pre-study time (one week prior the study), a constant sleep / wake cycle 
(awakening 6:30 h, going to bed 22:30 h), obtain 15 min of natural sunlight in the first
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90 min after awakening and report bedtimes and awakening times to the laboratory 
voicemail. They further needed to agree to just take naps in the 3 h window in the 
afternoon and to wear the Actiwatches (AWL) continuously and complete daily sleep 
diaries. Participants also needed to refrain from smoking, caffeine, heavy exercise and 
food components high in fat or sugar and to complete a daily diet diary. They also 
needed to agree to eat the provided food in the last three days prior to the study and to 
agree to refrain from prescription and 'over the counter' medication (other than that 
previously discussed with the team for the T2DM group) and food / vitamin 
supplements for a wash-out period two weeks before and during the study.
2.2.4.4 Exclusion criteria
Participants were excluded if the HO questionnaire revealed an extreme morning or 
evening type (Home and Ostberg, 1976). They were excluded if they were taking 
regular medication or food supplements which they could not refrain from and are 
known to influence either sleep / alertness / the circadian timing system (e.g 
p-blockers, barbiturates, antidepressants, benzodiazepines, melatonin, ritalin, 
modafrnil, soporifics, St John's WORT) or any metabolic function of the thyroid, 
kidney, liver or gastrointestinal function or any of the inflammatory markers 
(e.g. aspirin, ibuprofen, antibiotics, hay fever medication, medication for sore throats 
and colds) and / or many of the endothelial markers (e.g. angiotensin (receptor) 
blockers, diuretics, beta-blockers, anti-thrombosis medication).
Participants were excluded if they had a history of psychiatric or neuronal disease, 
dmg and alcohol abuse, or any circadian or sleep disorder, or metabolic (excluding 
T2DM participants), cardiovascular or chronic infectious / inflammatory disease. 
They were also excluded if they were anaemic or had donated over 400 ml of blood in 
the three months preceding the study. Participants were excluded if they did not keep 
a regular sleep-wake cycle; this included shift work as well as travels across more 
than two time zones within one month of the study. Participants were excluded if they 
did not refrain from alcohol, caffeine, heavy exercise, HF and high sugar food and 
smoking in the week prior the laboratory study.
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2.2.5 The pre-study protocol
2.2.5.1 Daily activity routine
To remove the confounding factor of subjects having different phasing of rest-activity 
rhythms, they needed to follow a prescribed daily activity routine. This routine 
included to stay in bed for precisely eight hours, trying to sleep and not deviating 
from sleep onset (22:30 h) and offset (06:30 h) by more than 15 min. Naps were 
allowed in a three hour window in the afternoon (centered 12 h away from midpoint 
of their night-time sleep), as these naps do not appear to shift the phase of the 
endogenous timing system (Buxton et a l, 2000). They were advised to avoid 
excessive exercise, and were advised to obtain at least 15 min of natural outdoor light 
within 90 min after waking time.
This daily activity routine was monitored by actigraphy. Actiwatches L or AWL 
(Cambridge Neurotechnology Ltd) were worn like a wrist watch and measured 
activity constantly. Participants were advised to wear the AWL on their non dominant 
wrist. They needed to call the laboratory voice mail when going to bed and when 
getting up as well as keep daily sleep diaries.
2.2.5.2 Meals
Time windows were given to consume meals. Breakfast from 07:00 h to 09:00 h, 
lunch from 12:00 h to 14:00 h and dinner from 17:30 h to 19:30 h. For the three days 
prior to the study food was provided by the research team. This food consisted of light 
choice range meals (Tesco) with similar macronutrient content. Shape fruit yoghurts 
(Danone), cornflakes (Kellog's), and Nutrition Soft Bake snack bars (Kellog's). 
Neither alcohol nor caffeine was allowed in their diet the week prior to the study, as 
they are known to influence the endogenous timing system. Food diaries needed to be 
filled in for the week prior the study.
2.2.6 The laboratory-study
The protocol of the study conducted is presented in Figure 2.1.
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Figure 2.1: Protocol for human study. Lights were switched on from ZT 0 to ZT 16 and subjects were 
in the dark trying to sleep from ZT 16 to ZT 24. Participants arrived at the CRC on Day 0 at ZT 8.5 and 
were provided with hourly Fortisip feedings during the day (blue) for the duration o f the study. 
Subjects were cannulated at ZT 0 on day 1 and hourly blood samples were taken for 25 h (purple). 
Biopsies were taken every 6 hours at the times indicated in red.
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2.2.6.1 Feeding
Participants received 16 equal caloric Fortisip feedings during waking hours. The first 
feed was at 15:30 h on the first day in the laboratory and the last one at 06:30 h in the 
morning of day 3. The Schofield equation (Schofield, 1985) was used to estimate the 
basal metabolic rate (BMR) in calories. This amount of calories is required to 
maintain current body mass. BMR was used because the participants were in a fairly 
inactive semi-recumbent position for most of the time during the study. Throughout 
the study, water was provided ad libitum. Body weight was used (Equation 2.3) to 
calculate the BMR. There are 150 calories per 100 ml of Fortisip. The amount of total 
Fortisip was calculated using equation 2.3.
basal metabolic rate [calories^ = 11.5 x weight [kg'] + 873 
Equation 2.3: Calculation o f the basal metabolic rate.
fortisip[ml] required over = (1804.5 [calories]!\5t) [calories~\)x\()0 [m/] = 1203 ml 
Equation 2.4: Amount o f Fortisip needed during the day.
2.2.6.2 Facility / light conditions
Light was approximately 500 mWm^ (160 lux in the direction of gaze and 
1600 mW/m^ (550 lux)) on the horizontal plane during lights on (6:30 h -  22:30 h). 
Sleep occurred in complete darkness during lights off (Zeitgeber time (ZT 16 - ZT 
24), with subjects wearing eye masks. ZT 0 was defined as lights on. The temperature 
in the ward was contained constant. Eye masks also were worn during the biopsy at 
night.
2.2.6.3 Body posture
Body position affects hormonal parameters measured in the study (Deacon and 
Arendt, 1994). Thus throughout the study participants remained in a semi-recumbent 
position. During the day participants were allowed to go to the toilet following a 
blood sample but were required to be back at least 30 min before each blood 
sampling.
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2.2.6.4 Blood sampling
Twelve ml blood was taken by a trained nurse every hour over a total period of 25 h. 
At 07:00 h (ZT 0) on day one an indwelling cannula was inserted into the participants 
forearm vein. Blood was then taken at the full hour until 07:00 h (ZT 0) in the 
morning on the third day. The two values from 07:00 h were averaged for some of the 
analysis.
The whole blood was aliquoted into tubes with anti-coagulation reagent (lithium 
heparin or di-potassium-EDTA) and spun (3000 g, 10 min, 4°C) to produce blood 
plasma. The plasma was aliquoted (Table 2.3). Samples were snap frozen and stored 
at -80°C until the analysis was performed. A maximum of 320 ml blood was taken 
from each subject during the whole study.
2.2.6.5 Adipose tissue biopsies
Four small open adipose biopsies were taken from the participant’s upper buttock 
depot at ZT 4.5; ZT 10.5; ZT 16.5 and ZT 22.5 by a trained medical doctor. Local 
anaesthetic (lidocaine) was used and Unisept antiseptic solution (Molnlycke Health 
Care) was used to clean the site. The incision was approx. 1.5 cm long and a pea-sized 
section of adipose tissue approx. 0.5 g mass was removed. Biopsies were cleaned with 
saline (to remove blood and connective tissue) and snap frozen in liquid nitrogen. The 
biopsies were stored at -80°C until they were analysed by quantitative real-time 
polymerase chain reaction (qtPCR).
Table 2.3: Blood plasma collection during the study.
Measurement Collection tube Aliquot size [pi]
Cortisol Lithium heparin 125
Melatonin Lithium heparin 1200
Leptin Di-potassium EDTA 225
Amounts and anticoagulant used for the different analyses. Two vials o f each aliquot size were frozen.
47
2.2.7 Analysis of melatonin, cortisol and leptin in human plasma
2.2.7.1 Basic principles of radioimmunoassay
A sample containing an unknown amount of antigen is incubated with a fixed amount 
of antiserum specific to the antigen and a fixed amount of radio-labelled antigen. 
Labelled and unlabelled antigens compete for the fixed number of antibody (ab) 
binding sites. Once equilibrium is reached the free and antibody bound fractions of 
the antigen is separated using e.g. charcoal which binds small molecules. The 
radioactivity is measured in the free or bound fractions and is compared to the 
standard curve, which is constructed using a set of standards of known antigen 
concentrations. This provides the concentration of unknown antigen in the samples.
All radioimmunoassays (RIA) were performed in a similar manner with the tubes 
being set up in duplicate. The zero point of the standard curve was always set up in 
quadruplicate to allow calculations of the limit of detection of the assay.
At the start of each assay there were duplicate tubes containing only the radio-labelled 
antigen giving a measure of total radioactivity present in each tube. Preceding the 
standard curve were non-specific binding tubes that did not contain the antibody. 
Therefore, any binding of the antigen in these tubes will be due to physical or matrix 
effects. The non-specific binding of the labelled melatonin should be less than 5%. 
The standard curve, against which the samples were measured, was constructed fresh 
for each assay. Following the standard curve, tubes for quality controls (QC) were 
included in order to access intra-assay and inter-assay variability. The QC samples 
contained known concentrations of antigen. A range of QCs were used in the RIA 
(low, medium and high QC) to cover the range of concentrations of the antigen being 
measured. The QC tubes were also placed after the samples, at the end of the assay, to 
measure any intra-assay drift.
2.2.T.2 Melatonin
Levels of melatonin in plasma were determined by direet RIA using the method 
described by (Fraser et a l, 1983). All plasma samples for each subject were analysed 
in one assay. The samples were assayed in order of the time they were taken. This 
assay sequence was performed in order to minimize the effect of any assay drift. The
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samples were defrosted before assay. Once defrosted and vortex mixed, 500 pi of 
sample was aliquoted into each LP4 tube. As each sample rneasurement was 
performed in duplicate a total of 1 ml of plasma was required. The matrix for the 
standard curve consisted of affinity stripped melatonin free plasma (Stockgrand) 
which was supplied in freeze-dried form and reconstituted with 12.5 ml of double- 
glass-distilled-water (DGDW). The standard curve was made up fresh for each assay. 
The total volume in each tube was 500 pi with standard melatonin concentrations of 
0.5, 10, 25, 50, 100, 200 and 500 pg/ml.
Sheep antiserum (Stockgrand) was supplied in 50 pi aliquots and diluted with 20 ml 
of DGDW. 200 pi of this antiserum solution was added to each tube, apart from the 
total and non-specific binding tubes. The tubes were vortexed and incubated for 
30 min at room temperature. Radiolabeled antigen, 50 pi of the ^H-melatonin 
(Amersham), was diluted in 10 ml of tricine buffer (0.1 M tricine, 0.9% NaCl, 0.1% 
gelatine and bottled water). Labelled antigen (100 pi) was added to each tube, 
vortexed and left to incubate overnight at 4°C.
Following the overnight incubation, charcoal (20 g charcoal, 0.2 g dextran, in 1 1 
tricine buffer) was stirred continuously for at least 30 min and 500 pi were added to 
each tube, apart from the total tubes. The tubes were mixed by vortexing. The bound 
and free components were separated by the charcoal. Following incubation 
(4°C, 12 h) the tubes were centrifuged (2500 g, 15 min, 4°C). After centrifugation the 
supernatant, containing bound antigen-antibody complexes, was decanted into plastic 
scintillation vials. Four ml of scintillation fluid (2.5 1 toluene, 12.5 g 2.5- 
diphenoxyloxazole, 0.75 g l,4-bis-[2-(5-phenyloxazolyl]benzene)) was added to each 
vial, which were than shaken at room temperature for 1 h in order to extract the 
^H-melatonin into the organic phase. The radioactivity was measured using a 
P-counter (Wallac 1409 DSA p-counter). The concentrations of the standard curve 
were determined by the P-counter. The inter-assay coefficients of variance were 25% 
at 9 pg/ml (n = 13), 15% at 21 pg/ml (n = 21), 17% at 94 pg/ml (n = 16) and 12% at 
114 pg/ml (n = 15). The average detection limit was 5.8 ± 0.6 (mean ± SEM).
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12.13  Cortisol
The cortisol quantification analysis was carried out by Dr Benita Middelton 
(University of Surrey). The analysis was carried out as described in Read et al, 
(1977) and Montagnese et al, (2011). The inter-assay coefficients of variance were 
12% at 97 nM (n = 5), 21% at 348 nM (n = 5) and 15% at 606 nM (n = 5).
2.2.7.4 Leptin
The Human Leptin RIA Kit (Millipore) containing I^^^-Iodine labelled tracer was 
used. All working solutions were provided in the kit. The blood samples were 
collected in di-potassium-EDTA containing tubes (Table 2.3) to avoid heparin which 
would lead to falsely high values. Tracers get labelled on the Monday of every 
month. Kits were ordered just before the first Monday of November to make sure the 
latest batch was received.
One hundred pi of blood plasma were needed per sample. The standard curve ranged 
from 0.5 ng/ml up to 100 ng/ml. The lower limit of detection was 500 pg/ml and the 
upper limit was 100 ng/ml. The standard curves were generated by the y-counter 
(1470 automatic gamma counter, Perkin Elmer). All samples for a single individual 
were measured in the same assay run. The inter-assay coefficients of variance were 
10% at 4 ng/ml (n = 6) and 19% at 15 ng/ml (n = 7).
On day one the assay was set up. Assay buffer (300 pi) was pipette into the two non­
specific binding tubes (NSB), 200 pi into the two tubes for the zero value of the 
standard curve and 100 pi in all other glass LP4 tubes. Standards, quality controls and 
samples (100 pi) were added in duplicate to tubes with 100 pi assay buffer. 
^^^I-Human leptin was added to all tubes (100 pi). Human leptin antibody (100 pi) of 
was added to all tubes except the total count tubes and the NSB tubes. The samples 
were vortexed, covered and incubated for 20 h at 4°C.
On day two 1 ml of cold (4°C) precipitation reagent was added to all tubes except the 
total count tubes. The samples were vortexed and incubated for 20 min at 4°C. All 
samples except the total count tubes were centrifuged (3000 g, 20 min, 4°C). The 
supernatant was immediately detected after the centrifugation. The tubes were left
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upside down for about 60 s. This time was consistent within each set of samples 
analysed. The tubes were counted for 1 min in a y-counter (1470 Automatic y 
Counter, Perkin Elmer).
2.2.8 Calculation of profile features and fittings
2.2.8.1 Dim light melatonin onset, offset, duration and mid melatonin
The DEMO was calculated using the 25% of the maximum method (Benloucif et a l, 
2008). Six values of the baseline were used and the difference between the baseline 
and to the average of the three highest points was calculated. The value of 25% of the 
difference was added onto the value of the baseline. The two time points with values 
surrounding the calculated value were selected. The earlier lower value was 
subtracted from the later higher value. The difference between both these values were 
divided by 60, to obtain the increase per min. The final calculation involved to 
subtract the value of the lower value from the value at 25% and dividing this whole 
term by the per min value. The dim light melatonin offset (DLMOff) was calculated 
in the same way. The duration of melatonin was calculated as the time between 
DEMO and DLMOff. Mid melatonin was calculated as the value at the time between 
DLMO and DLMOff.
2.2.5.2 Phase angle
The phase angle was calculated as the difference between the self reported time the 
participants tried to sleep in the week before the study and the calculated DLMO from 
the laboratory study.
2.2.5.3 Correction by the individual dim light melatonin onset
To normalise the leptin profile of each participant to their individual DLMO the time 
in minutes between the DLMO and midnight was calculated for each participant. The 
personal leptin profile of each participant was then shifted by the calculated amount of 
minutes. The shifted leptin profiles of one group of participants were plotted together. 
The resulting x-values were binned around half past the hour and the average y-value 
was plotted at half past the hour.
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2.2.S.4 Fitting of a cosine wave
A cosinor wave was fitted to the time course values of leptin and cortisol analysed in 
the sections 3.5.4 and 3.5.3. A statistics program (SAS) was used to run a dampening 
cosine wave regression procedure (Nelson et a l, 1979) on the cortisol, leptin and 
qtPCR data of the IMWAT cells. Equation 2.6 was used. A p-value describing the 
statistical significance and goodness of fit was provided by the program. The 
programs used in SAS can be found in the Appendix E. Since the program cannot deal 
with missing data points, these missing time points were therefore extrapolated.
7 =
f
m + axcos
V
((2 X7r)x{t- n)) 
P
Value = {Mesor + Amplitude • cos (((2;r) • {Time -  Acrophase)) -f- Period) • exp^
Equation 2.5: Cosine wave equation, y, value; t, time; m, mesor; a, amplitude; n, acrophase; p, period; 
d, damping.
2.2.8.5 Analysis of variance / procedure mixed
One-way analysis of variance (ANOVA) was carried out with Prism (Graphpad) to 
find statistical differences in data sets with one variable. The p value makes a 
statement if there is a significant difference between the groups being compared. The 
F value makes a statement about how likely it is that the difference detected is due to 
the treatment and not due to experimental error. A high F value means that the 
treatment is most likely to be the reason for the detected difference. Two-way 
ANOVA was carried out with Prism (Graphpad) and as procedure mixed with the 
SAS program. In the two-way ANOVA two independent variables factors can be 
analysed.
2.2.8.6 Correlations
The correlation analysis as well as the linear regression analysis was carried out with 
Prism (Graphpad). The p value shows if the correlation is statistically significant. The 
quality of the correlation is described by the r^  value, with values from zero to one. 
60% in the variance in Y corresponds to the variation in X, if the r^  = 0.60.
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2.2.8.7 Statistical definition of a rhythm
Rhythmic expression in a time course experiment was statistically defined as follows: 
One-way ANOVA analysis (section 22.1.5) needed to show a significant effect of 
time on the data set, and the cosine fit (section 2.2.7.4) needed to show significance 
for the fit.
2.2.8.8 Normalisation of the dataset
A way to normalise the data of participants is to normalise all data points to the 
average value of this particular participant. The average amount was calculated and 
defined as 1 or as 100%. All data points were then calculated as a % of this average 
value (Equation 2.7). To highlight the rhythmieity in the expression profiles the first 
value of the dataset was defined as 1. All other values of the dataset were then 
expressed in relation to this first value.
^average value^ 
y measurement j
xlOO% o f the average value -
Equation 2.6: Normalisation with the average value.
2.2.8.9 De-trending of time courses
The average value of the first 12 h and the second 12 h of the time course were 
calculated. The resulting two points were connected by a line. The value of this line at 
the different analysed time points was then subtracted from the measured value.
2.2.8.10 Calculation of amplitudes
The difference between the average of the three highest points and the three lowest 
points in the leptin and melatonin profiles were used to calculated the amplitude.
2.3 Cell lines and tissues
2.3.1 IMWAT cells
The IMWAT cell line was used before and after differentiation into adipocytes as a 
model to investigate the rhythmieity of clock and CCGs expression. This cell line 
expresses markers of WAT PPARy and aP2 but no markers of BAT (Morganstein et
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al, 2008). These cells have an intact insulin signalling pathway and express pro- 
inflammatory cytokines. The cells are derived from pre-adipocytes rather than 
fibroblasts (section 1.3.6.2).
2.3.2 Tissue from wild-type and Per3'^ ~ mice
Murine tissues of liver, kidney, heart, gonads and adipose tissue used for western 
blots were obtained from male wild-type and Per3'^ ' mice. Tissues were collected by 
Dr. Daan van der Veen and Dr. Simon Archer, (University of Surrey) in intervals of 
4 h over a 24 h period (ZT 0, 4, 8, 12, 16 and 20) and had an approximate weight of 
500 mg. The choice of the ZT time points used was based on an earlier study which 
detected clock proteins (Lee et a l, 2001).
Male wild-type C57B1/6J mice were housed under a 12 h light / 12 h dark cycle 
(approximately 250 lux during the day). Lights were switched on at ZT 0 and 
switched off at ZT 12. They were fed mouse diet (B&K Universal Ltd.) ad libitum. At 
the time of culling (cervical dislocation after 3 min in increasing CO2) the average age 
of the mice was 71+3.9 days (mean ± SEM). Tissues were removed and snap frozen 
in liquid nitrogen. The tissue samples were stored at -80°C until analysis. Samples 
were only thawed for usage. Tissue from male Per3 knockout mice with a disrupted 
PerS gene (PerS’^ ') were obtained in the same way as described for the wild-type 
mice.
2.3.3 Other cell lines
Un-pulsed 3T3-L1 pre-adipocytes, fibroblasts. Hep G2 and HUH-7 hepatocytes and 
RD muscle cell lines were used as positive controls (kindly provided by Dr. Kate 
Plant, University of Surrey). Characterisation of the cell lines can be found in the 
Appendix B.
2.4 Detection of gene expression
2.4.1 Preparation of RNAse free MilliQ water
Diethylpyrocarbonate (DEPC) (Sigma) (1 ml) was added to 1 1 of fresh MilliQ water. 
After mixing the solution and incubation overnight at room temperature, this mixture 
was autoclaved to remove any residual DEPC.
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2.4.2 RNA extraction
All solutions and plasticware used were DNase / RNase free and plasticware was 
autoclaved prior to use. The cell content of a well on a 6-well plate was dissolved in 
1 ml TRIzol reagent and added to a 1.5 ml RNase free Eppendorf tube. Chloroform 
(200 pi) was added to the cell lysate. Both components were at room temperature. To 
extract the RNA out of the TRIzol phase into the chloroform phase the mixture was 
shaken vigorously by hand for 15 s. After incubation time of 3 min at room 
temperature the reaction tube was centrifuged (12000 g, 15 min, 4°C). The colourless 
upper aqueous phase, which contained the RNA, was transferred to a new 1.5 ml 
RNase free Eppendorf tube. By adding 500 pi of isopropyl alcohol the RNA was 
precipitated out of the chloroform phase. After incubation for 10 min at room 
temperature, the ribonucleic acid (RNA) was collected at the bottom of the reaction 
tube by a centrifugation step (12000 g, 10 min, 4°C) and the supernatant was 
discarded.
To wash the RNA pellet 1 ml of ice-cold 75% ethanol was added. After vortexing and 
another centrifugation step (7500 g, 5 min, 4°C), the supernatant was removed and the 
RNA pellet was dried at room temperature for 5 to 10 min. The RNA pellet was 
re-dissolved in 20 pi of RNase-free water by repeatedly passing the liquid through a 
pipette. After incubation for 10 min at 57°C and spinning the samples down, two 
aliquots of 10 pi each were prepared. The RNA containing solution was stored at 
-80°C.
2.4.3 RNA quantification and quality control
RNA concentration and purity was determined using a NanoDrop spectrophotometer 
(Thermo Scientific) and gel electrophoresis after the DNAse treatment (2.4.4.1). Five 
hundred ng were applied onto a 1% agarose gel to control the quality of the RNA.
2.4.4 copy DNA synthesis
2.4.4.1 DNAse treatment
To remove all traces of DNA before amplification of the RNA, 2 units DNasel 
(Promega) were added to 1 pg RNA in solution. The digestion reaction was carried
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out at 37°C for 40 min and was stopped by adding 2 pi stop solution (Promega) and 
incubation at 65°C for 10 min.
2.4.4.2 Copy DNA synthesis
To reverse transcribe the total RNA, 100 ng DNase treated RNA was added to 1 pg of 
random primers (Promega) and 1.5 pi nuclease free water. To open up the secondary 
structure of the RNA this mixture was incubated at 70°C for 10 min.
A reverse transcriptase mixture containing 3.75 nmol MgCli (Promega), 7.5 nmol 
PGR nucleotide mix (Promega), 15 units RNasin inhibitor (Promega) and 150 units 
M-MLV reverse transcriptase (Promega) was added. The complete mixture was 
incubated at 25°C (annealing) for 5 min, then at 42°C for 60 min (extension) and at 
70°C for 15 min to inactivate the reverse transcriptase.
As a control, samples without reverse transcriptase were run for each sample. These 
are the controls to ascertain if the DNase treatment worked. If these controls give a 
signal in the qtPCR it means that DNA from the cells was taken over into the qtPCR 
step. This would mean that the DNase treatment and the copy DNA (cDNA) synthesis 
would need to be repeated.
2.4.4.3 Semi-quantitative reverse-transcriptase PCR
2.4.4.3.1 Primers and probes
Some of the primer sets and probes were previously designed by Dr. Daniella Otway. 
Some of the primer probe sets were designed by me, with the program Primer Express 
3.0 (Perkin Elmer). The primer sets for eukaryotic genes were designed within a 
single exon to allow use of genomic DNA to generate the standard curve. Sequences 
of primer probe sets can be found in Appendix A.
2.4.43.2 Genomic DNA standard calculation
To be able to define the amount of cDNA in the samples, their values were compared 
to a standard curve of known amounts of murine single genomic DNA strands using 
murine genomic DNA (Promega). Standards with 25005848, 2500585, 250058,
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25006, 2500, 2500 and 0 single strands of standard genomic mouse DNA per pi were 
prepared and used in duplicate for the calibration curve. The dilutions for the standard 
curve were made at the same time for all samples of the experiment. The complete 
calculation can be found in the Appendix F.
2.4.4.3.3 Semi-quantitative real time PCR
The cDNA synthesised in section 2.4.4.2 was used to set up the master mixes for the 
qtPCR. Per reaction 10 pmol of reverse and forward primer (Appendix A), 5 pmol of 
fluorescent probe (Appendix A) and 12.5 pi of Absolute™ QPCR ROX Mix 
(Abgene) were needed. The reaction volume of 20 pi and all dilutions were made up 
with TE-Buffer (Invitrogen). Five pi of the cDNA solution were added to each 
reaction.
The amount of genomic DNA single strands was added to the reaction master mix 
instead of sample cDNA to obtain the standard curve. To ensure the components for 
the qtPCR were uncontaminated, water was added to the reaction mix instead of 
DNA, as an extra control. To get more reliable data, the reaction was carried out in 
duplicate. The semi-quantitative qtPCR was carried out on a 7500 Real time PCR 
systems machine (Applied Biosystems). The program for the qtPCR included an 
initial phase of 20 min at 50°C, and a 15 min activation phase for the ROX Mix 
(Abgene) at 95°C. Exponential amplification of the DNA was carried out at 60°C for 
1 min after a 15 s activation phase at 95°C. This cycle was repeated 45 times.
Quality controls and water controls were included in the protocol. The baseline is the 
noise level in early cycles, typically measured between cycle 3 and 15, where there is 
no detectable increase in fluorescence due to amplification products. The baseline was 
set to 0.02 Ct (threshold cycle).
2.4.4.4 Housekeeping genes for normalisation / relative quantification
The standard curve was created by the 7500 Real time PCR software, as well as 
determination of the cDNA content in the samples. Standard curves were not used if 
they did not reach 99% of the optimal. All data were normalised against the
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housekeeping genes Gapdh (glyceraldehyde-3-phosphate dehydrogenase) and SI8. 
They are commonly used as genes to normalise and have constant expression levels.
2.5 C ell cu lture
All cell culture work was carried out in a type 2 laminar flow cabinet. Sterile 
techniques and materials were used. Media was pre-warmed to 37°C / 33°C in a water 
bath, and cells were stored in an incubator at 37°C / 33°C and 5% / 10% CO2 in the 
atmosphere.
2.5.1 Gelatine coating
Porcine gelatine (0.01%) (Sigma) in Milli Q water was prepared and autoclaved. The 
gelatine solution was applied on all cell culture surfaces where IMWAT cells should 
grow. The solution was allowed to incubate for 20 min at room temperature. 
Afterwards it was removed and allowed to dry at room temperature (15 to 20 min). 
The coated pates should not get completely dry. Twenty pi solution were used to coat 
one well of a 96 well plate (2 ml for a T25 flask, and 5 ml for a T75 flask).
2.5.2 Cell maintenance
The medium was changed every second day, and split when 90% confluence was 
reached (section 2.5.2.2). Cells were washed with phosphate buffered saline (PBS) 
before treatment with trypsin / EDTA and between media.
2.5.2.1 Beginning a new cell culture
To start a new culture a 1.5 ml cryo-vial was thawed for approx. 1 min at the 37°C 
water bath. When thawed the cell suspension was transferred into a 50 ml Falcon tube 
and 10 ml of growing medium was added drop wise to the cell suspension. After 
centrifugation at 400 g for 10 min, the supernatant was disposed off to remove cryo- 
protectans. The pellet was re-suspended in 10 ml growing medium and transferred to 
aT25 flask.
2.5.2.2 Splitting a cell culture
The cells were split at 90% confluence. After discarding the growth medium 
(IMWAT: 0.5 mM IFy, 10% Fetal bovine serum (FBS), 1% Anti-Anti in advanced
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DMEM:F12 (Dulbecco’s modified eagles medium, Invitrogen, 3.151 ml/1 D-glucose, 
non-essential amino acids (NEAA), 1 mM sodium pyruvate) 3T3-L1 preadipocytes: 
10% FBS, 1 mM sodium pyruvate in DMEM with D-glucose and L-glutamine, 1% 
Anti-Anti), the cells were washed once with 10 ml PBS. To detach the cells from the 
flask, 1 ml trypsin / ethylenediaminetetraacetic acid (trypsin / EDTA) (Fisher) was 
applied to a 25 cm  ^flask (3 ml to a T75 flask) and incubated for 3 min. The trypsin 
was neutralised by adding 10 ml of medium. The detached cells were transferred into 
a 10 ml tube. The resulting pellet was re-suspended in 1 ml of growth medium after 
centrifugation for 10 min at 400 g and room temperature. One third of this solution 
was transferred to a fresh T75 flask, resulting In a 1:3 split.
2.5.3 Preparation of cryo-stocks of IMWAT cells
The cells of a 90% confluent T75 flask were harvested as described above. The cells 
were re-suspended in 7.5 ml of freezing medium (0.5 mM INFy, 10% FBS and 10% 
dimethyl sulfoxide (DMSG), 1% Anti-Anti). Aliquots of 1.5 ml were transferred to a 
Cool Cell (BioCision), and slowly frozen to -80°C. The cryo-vials were transferred 
into the liquid nitrogen cell bank after 24 h.
2.5.4 Differentiation of IMW AT-Pre-adipocytes into mature adipocytes
All media for the IMWAT cell line are based on advanced DMEM:F12 (Invitrogen). 
Cells were cultivated in growth medium with INFy (0.5 mM INFy 10% FBS) at 33°C 
until the cells reached confluence (day 0 in Figure 2.2). The medium was then 
exchanged to growth medium without INFy (10% FBS, 1% Anti-Anti) for 24 h in a 
37°C incubator (day 1). The differentiation was initiated by adding quick 
differentiation medium (25 nM Dexmethasone (DEX), 500 pM 3-isobutyl-1- 
methylxanthine (IBMX), 2 pM rosiglitazone, 10% FBS, 1% Anti-Anti). The cells 
were cultivated for 4 days in this medium (day 5). At day 5 the medium was 
exchanged with differentiation medium (10 mM human transferin, 170 nM insulin, 
1 nM cortisol, 1 nM triiodthyronine (T3), 10% FBS, 1% Anti-Anti). Differentiation 
was achieved at day 8. The adipocytes were confluent for 8 days in total. The 
procedure is presented in Figure 2.2. The cells for experiments in Chapter 4 were 
grown by Dr. Ariel Poliandri from Imperial College London.
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Figure 2.2: Differentiation, serum pulse and harvesting as performed on the IMWAT cells for the 
analysis o f clock and metabolic gene expression. The serum pulse was performed with 50% horse 
serum in F12 advanced DMEM for the duration o f 2 h.
2.5.4.1 O-red-oil stain
The O-red-oil stain is used to stain the TG in the vacuoles of mature adipocytes. 
A saturated stock solution of 0.3% was made up by adding 0.3 g oil-red-0 (Sigma) to 
100 ml isopropanol. The working solution contained 60% of this stock solution and 
40% distilled water. The working solution was filtered sterile through a 0.45 micron 
filter after 20 min of incubation at room temperature. The medium was removed and
2.4 ml 10% formalin (37% formaldehyde, 13% methanol, 50% water) was added and 
discarded immediately. The same amount of 10% formalin solution was added again 
and allowed to incubate for 1 h at room temperature. Samples did not need to be 
analysed immediately, but could be stored protected from light and airtight for no 
more than 2 days. The formalin solution was removed and the cells were washed 
twice with 60% ethanol and twice with distilled water. The morphology was captured 
at this point using a digital camera (coolPIX990, Nikon) attached to the microscope 
(TMS-F, Nikon). Oil-red-0 working solution (1 ml) was added per well. The staining 
solution was removed after an incubation of 10 min at room temperature. The cells 
were washed with distilled water, and 1 ml of distilled water remained in the dish. The 
stained fatty acids were photographed the same way as described above.
2.6 Q uantification  o f  lipolysis
All cells used were passage 19. The lipolysis in differentiated IMWAT cells was 
quantified using a spectroscopic assay provided in a kit (Zen-bio). Samples were 
analysed in triplicate to confirm reproducibility and to minimise errors created by 
different amounts of cells in the wells. The controls (assay buffer, IBMX, ISO),
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ascorbic acid and 0.1% DMSO) were diluted in assay buffer as described in the assay 
protocol. Adrenaline was diluted in assay buffer (Appendix I) stabilised with 400 pM 
ascorbic acid.
The serum free medium (DMEM) was removed from the cells which were then twice 
washed gently with 200 pi wash buffer. Adrenaline / ascorbic acid solution was 
applied (150pl) and incubated. Control solutions (IBMX, ISO) were applied and a 
buffer control was included. Samples were transferred into reaction tubes after the 
incubation and stored at -80°C for at least 2 h.
Glycerol standards were prepared one hour prior to the study or the time point of the 
treatment. The content of the glycerol standard tube was spun down briefly. Wash 
buffer (400pl) was pipetted into the 1 mM glycerol standard tube provided and mixed 
by vortexing. This resulted in a 200 pi stock solution. Wash buffer (250 pi) was added 
into 6 tubes. By adding 250 pi of the stock, or the last prepared dilution to the 
subsequent tube, a serial dilution led to 200, 100, 50, 25, 12.5, 6.25 and 3.125 pM 
standards. Wash buffer was included as zero value for the standard curve.
The glycerol reagent A was hydrated by adding 11 ml of deionised water at room 
temperature and gently mixed. The solution was pipetted up and down with a 
serological pipette to dissolve all powder. Rehydrated glycerol reagent A could be 
stored for 7 days protected from light at 4°C. One batch of glycerol reagent A should 
be used for the whole assay.
Conditioned media (100 pi) was taken out at the different time points and transferred 
to a 96 well plate. One hundred pi of each standard were applied to the new plate. 
Reconstituted glycerol reagent A (100 pi) was added to each used well in the second 
96 well plate. The solution was mixed by gently pipetting up and down. Bubbles 
needed to be removed and the plate was then incubated at room temperature for 
15 min. The optical density of each well was then measured at 540 nm.
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2.6.1 Dose response curve
The IMWAT pre-adipocytes were differentiated as described in section 2.5.4 and 
Figure 2.2. The cells were washed once with 100 pi wash buffer (Zen-bio) after 
differentiation and incubated with 150 pi of the appropriate stimulus at 37°C.
Cells were treated with different concentrations of adrenaline (400 -  0.01 pM). 
Ascorbic acid (400pM) was applied to protect adrenaline against de-amination by 
monoaminaseoxidase (Goldstein et al, 1959) and the lipolysis was measured by 
measuring the glycerol output. One and two hour incubations with the different 
concentrations of adrenaline were analysed.
The ISO positive control from the Zen-bio lipolysis kit was used. The stock solution 
of 100 mM was diluted in assay buffer. ISO solutions (150 pi) of the concentrations
I mM, 100 nM, 10 nM, 1 nM, 100 pM and 10 pM were incubated for one or two 
hours at 37°C. The ISO solutions were stored at -80°C after treatment and before 
quantification. The incubation media of the dose response curves were stored at -80°C 
after incubation to be consistent with the later experimental conditions.
2.6.2 Serum pulse aud time course experimeut
Molecular clocks in individual cells (Nagoshi et al, 2004, Welsh et al, 2004) can be 
synchronised across a cell culture by exposure to of high serum concentrations 
(Balsalobre et al, 1998). IMWAT cells were seeded in 96 well plates and 
differentiated as described in section 2.5.4 (Figure 2.2). On day 9 when the cells were 
differentiated the medium was replaced by serum free DMEM (Invitrogen). The cells 
were maintained in this serum free medium for 48 h. Afterwards the medium was 
exchanged for serum pulse medium (50% horse serum, in advanced DMEM:F12). 
After 2 h, the medium was exchanged for serum free DMEM medium (Invitrogen), in 
which cells were maintained until treatment.
The cells were treated with a solution of ISO in assay buffer (Zen-bio) every 2 h from
II h after the serum pulse. Samples were harvested every other hour and stored at 
-80°C. The treatment solution was prepared before the experiment, aliquoted and 
stored at -80°C until RNA extraction or glycerol detection. Single aliquots were
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thawed one hour before the treatments. The whole protocol is shown in Figure 2.3. 
Differentiation of the pre-adipocytes into mature adipocytes was controlled 
microscopically and by oil-red-0 staining before the serum pulse (48 h) and at the end 
of the experiment (84 h). The synchronisation of the endogenous clocks was 
controlled by RNA extraction followed by quantification of clock gene expression at 
56, 72 and 80 h.
The cells used in chapter 4 were differentiated (section 2.5.4) and starved as described 
above by Dr. Ariel Poliandri from Imperial College. He also synchronised the 
molecular clocks of the cells in culture by applying a serum pulse. Cells were frozen 
to -80°C in Trizol (Invitrogen) reagent after the serum pulse. The cells were delivered 
on dry ice to the University of Surrey.
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Figure 2.3: Lipolysis experiment. Treatment = dashed lines, sample harvest = solid line. Serum pulse, 
50% horse serum in advanced DMEM.
2 .7  D etection  o f  proteins
2.7.1 General protein handling
Protein solutions were treated as gently as possible. Through addition of 20% glycerol 
(v/v) to the protein solution the samples were able to be stored for a few months at 
-80°C. Protein containing solutions were always kept on ice to minimise degradation 
when not stored at -80°C. Extraction buffers always contained a broad spectrum 
protease inhibitor (Pierce) and the solutions were frozen in aliquots of 25 pi. Each 
sample was defrosted only once.
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2.7.2 Dilution of lyophilised antibodies and control peptides
Primary antibodies against the PER proteins were delivered lyophilized. They were 
dissolved in 50% glycerol in ultrapure water (GIBCO). The final concentration was 
1 pg/ml.
2.7.3 Protein extraction
2.7.3.1 Protein extraction from adipose tissue
The extraction of proteins from adipose tissue turned out to be more time consuming 
than extraction from any other tested tissue because of the content of fatty acids. After 
spinning (700 g, 3 min, 4°C) the layer of fatty acids was soaked up with a pipette 
before proceeding with the usual protocol.
2.7.3.2 TRIzol
TRIzol reagent (Invitrogen) (1 ml) was used to lyse a lump of tissue (approximately 
0.5 mg). The lump of tissue was added to 400 pi TRIzol reagent (Invitrogen) and 
incubated and depending on the experiment mechanically homogenised by grinding 
for 5 min at room temperature. Another 600 pi TRIzol reagent was then added to the 
homogenate. If adipose tissue was extracted an extra centrifugation was conducted to 
be able to remove the FFA from the other cell contents (12000 g, 10 min, 4°C). The 
solution was spun to separate the phases (12000 g, 10 min, 4°C). The pink 
intermediate phase was transferred to a new tube. Chloroform (200 pi) was added and 
the mixture was shaken vigorously for 15 s. The mixture was spun (12000 g, 15 min, 
4°C) after an incubation (3 min) at room temperature. The upper organic phase was 
removed. Ethanol (300 pi) was added and mixed by inversion. The mixture was spun 
(12000 g, 5 min, 4°C) after incubation of 2-3 min at room temperature.
The supernatant was kept and transferred to a new tube. ISO (800 pi) was added 
mixed and incubated for 10 min. After centrifugation (12000 g, 10 min, 4°C) the 
supernatant was discarded and the pellet was washed 3 times with wash solution 
(0.3 M guanidine / HCl) by adding 1.5 ml wash solution, incubated for 20 min at 
room temperature, and centrifiigated (7500 g, 5 min, 4°C). The pellet was dissolved 
after the final wash by vortexing in 1.5 ml ethanol. This step was followed by
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incubation at room temperature for 20 min and centrifugation (7500 g, 5 min, 4°C). 
The ethanol supernatant was removed and the pellet was allowed to try at 50°C. PBS 
(200pl) with 1% sodium dodecyl sulphate (SDS) were added and left at 50°C 
overnight. The pellet was dissolved by pipetting up and down on the next day.
2.7.3.3 Protein extraction TBS and SDS
The extraction with SDS containing tris-phosphate buffered saline (TBS) 
(20 mM TRIS-Base, 137 mM NaCl, pH 7.6 with HCl) involved homogenisation of 
approximately 0.5 mg tissue with 200 pi buffer (1% (w/v) SDS in PBS) using a 
micropistille. The sample was centrifuged (13200 g, 5 min, 4°C) and the supernatant 
was directly used.
2.7.3.4 Protein extraction with TBS SDS and sonification
The tissue was extracted in TBS buffer (as described in 2.7.3.3). The tissue was 
sonicated twice for about 20 s at amplitude of 70% of the maximum (Sonics). 
Between and after the sonification steps the samples were kept on ice. To get rid of 
the insoluble parts of the tissue a centrifugation step was performed (700 g, 10 min, 
4°C), and the supernatant was used.
2.7.3.5 Protein extraction with homemade and T-Per tissue lysis buffer
One ml of either homemade lysis buffer (150 mM NaCl, 5 mM EDTA, 20 mM TRIS- 
Base, 0.5% Triton X-100, adjusted to pH 7.8 with HCl) or T-Per tissue lysis buffer 
(Pierce) was used to extract protein from the 0.5 mg tissue by either sonification or 
mechanical grinding. The proteins were separated from the insoluble cellular debris 
by spinning the samples (700 g, 10 min, 4°C), and the supernatant was used.
2.7.3.6 Protein extraction with glycerol containing extraction buffer
The homemade glycerol containing extraction buffer (3.4 mM SDS, 86.46 mM 
glycerol, 76.22 mM TRIS-HCl) was used to extract proteins from all described 
tissues. The cells from cell culture were either harvested just before the extraction, or 
earlier and stored at -20°C until analysis. The proteins were either extracted by 
mechanical grinding or by sonification.
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2.7.4 Determination of protein concentration
Protein content was measured with the BCA protein Assay kit (Thermo Scientific). It 
was carried out as a micro plate procedure with a working range from 
20 - 2000 pg/ml. A standard curve with bovine serum albumin (BSA) concentrations 
of 0, 0.025, 0.125, 0.25, 0.5, 0.75, 1, 1.5 and 2 pg/ml was used. Every sample was 
assayed in duplicate. After incubation for 30 min at 37°C the plate was read using an 
ELISA-Reader at wavelength of 560 nm (Victor3, 1420 Multilabel Counter, Perkin 
Elmer).
2.7.5 Dot blots
The polyvinylidene fluoride (PVDF) membranes were placed on a heating blot of 
about 90°C to stop liquid spreading and the protein solutions were pipetted (about 
10 pi) directly onto the membrane without gel separation. As temperature also 
denatures the proteins, epitopes which are hidden in the natural structure are also 
reachable by the antibodies. The amount of liquid applied should thus be the same for 
all samples, to gain similar radii of the spots. Protein detection was performed as 
described in sections 2.7.8.
2.7.6 Separation of proteins by molecular weight
Precast polyacrylamide gel electrophoresis (PAGE, 10% polyacrylamide) gels were 
used (Biorad). After mixing with 2 x loading dye (31.25 mM TRIS-Base, 2.73 M 
glycerol, 138 mM SDS, 1.4 M P-mercaptoethanol, 59 pM bromphenol blue, pH 6.8) 
the proteins were heated up to 95°C (except for the detections of REV-ERBa which 
were heated to 70°C) for 10 min to denature them. Usually 30 pg protein in 15 pi 
solution was loaded per lane. The same amount of liquid was loaded onto each lane. 
The gels were run in a Mini-PROTEAN Tetra Cell tank (Biorad) filled with running 
buffer (25 mM TRIS-Base, 192 mM glycine, 3.5 mM SDS). The run was started with 
80 V, to allow all the proteins to enter the collection gel at the same time. Later, when 
the proteins entered the separation gel, the voltage was raised to 120 V. The gel was 
run until the target molecular weight band of the ladder reached the middle of the gel. 
The used ladders can be found in Appendix I. They ranged from 10 to 250 kDa.
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2.7.7 Transfer of proteins from the gel onto a membrane
The transfer of proteins from the gel onto the membrane was carried out by two 
different methods, semi dry and wet blotting. For all blots PVDF membranes 
(Millipore) were used. These were activated by incubation for 20 s in methanol, 2 min 
in water, and at least 15 min in transfer buffer (semi dry: 47 mM TRIS-Base, 39 mM 
glycine, 1.2 mM SDS, wet blot: 25 mM TRIS-Base, 192 mM glycine, 20% methanol).
2.7.7.1 Semi dry blot
Six filter papers exactly the same size as the membrane were needed. Three of these 
were then placed on the positive electrode of the blotter (SDB Power Supply I I , Kem- 
En-Tec), followed by the membrane, gel and the final three pieces of filter paper. 
Different amounts of voltage and blotting time were tried: 40 V for 90 min, which is 
0.75 V/cm^ and 70 V for 240 min which is 1.13 V/cm^. The buffer used contained no 
SDS to avoid the appearance of air bubbles which would affect transfer of proteins in 
their area. To avoid air bubbles, both piles consisting of filter papers, membrane and 
gel were rolled over with a serological pipette.
2.7.7.2 Wet blot
Four filter papers a bit bigger than the size of the membrane were needed. The 
membrane was transferred onto the gel avoiding air bubbles between the membrane 
and the gel. Membrane and gel were surrounded by two filter papers and one sponge 
on each side. This ‘sandwich’ was placed into the transfer tank, with the membrane 
facing the anode. The first trials were carried out at 300 mA for 60 min. However, the 
protocol was improved by enhancing the blotting time to 90 min (Mini Trans-Blot 
Electrophoresis Transfer Cell, Biorad). All wet blotting procedures were carried out in 
the cold room at 4°C. The piles consisting of filter papers, membrane and gel were 
rolled with a serological pipette to avoid air bubbles.
2.7.8 Visualisation of proteins on the membrane
2.7.8.1 Staining of proteins in the gel
Gel staining was carried out using GelCode Blue Safe Protein Stain (Thermo 
Scientific). The gel was rinsed two times with ultra pure water, incubated with the
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staining solution for between 5 min and 12 h. The stained gel was washed two times 
with ultra pure water and photographed using a digital camera (Canon).
2.7.5.2 Ponceau stain of proteins of the membrane
To verify the transfer of proteins, membranes were incubated for about 5 min with 
0.2% Ponceau S solution (0.1% (w/w) Ponceau S (Sigma) in 5% acetic acid). To 
achieve sharp staining the membrane was washed several times afterwards with ultra 
pure water and finally washed with TBS with Tween20 (TBST: 20 mM TRIS-Base, 
137 mM NaCl at pH 7.6 and 0.05 - 0.2% Tween20 (v/v)) to remove the stain before 
detection with antibodies.
2.7.8.3 Detection of proteins by antibodies
The membrane was transferred to blocking buffer (5% skimmed milk powder in 
TBST (0.05% - 0.2% Tween20)) for 1 h at room temperature to block unspecific 
binding sites on the membrane. The first antibody diluted in TBS (1:200 -  1:5000) 
with or without Tween20 was incubated overnight at 4°C, if not mentioned otherwise. 
Incubation with the antibodies, as well as the washes was carried out in 50 ml Falcon 
tubes. The membranes were washed three times for 10 min in TBS or TBST (0.05 - 
0.2% Tween20), followed by incubation with a horseradish peroxidase-conjugated 
(anti-rabbit or anti-goat) secondary antibody (1:5000 -  1:10000) for 1 h at room 
temperature.
After incubation with the secondary antibody, another three washes with TBST wash 
buffer (20 mM TRIS-base, 137 mM NaCl, 0.05 - 0.2% Tween20 (v/v), pH 7.6) 
occurred in the dark room, the membrane was incubated for 1 min in luminol- 
enhanced chemiluminescence (ECL) western blotting detection reagents (GE 
Healthcare). Reagent A (3 ml) was mixed with 3 ml of reagent B. Excess buffer was 
removed from the membrane by dipping the side of the membrane on a tissue, and 
incubated for 1 min in the mixture of ECL reagents A and B. Excess ECL reagent was 
removed and the membrane was then placed between two pieces of plastic film and 
taped into a cassette. Under red light illumination an X-ray film (Amersham 
Hyperfilm ECL (GE Healthcare)) was placed on top, and the cassette closed. After 5 s 
to 20 h under red light, the film was placed in developer (Kodak) for approximately
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3 min, washed briefly in water, and then placed in fixer (Kodak) for approximately 
3 min. After rinsing in water, the film was left to dry on a rack.
2.7.9 Pre-adsorption
The relevant immunising peptide was added to the diluted primary antibody solution 
at least 1 h before the solution was incubated with the membrane. The excess of 
protein to antibodies was at least 40 times in molarity, and the incubation time was at 
least one hour at room temperature.
2.7.10 Quantification of western blot signals
The quantification of the western blot results were carried out by our co-workers at 
Imperial College London. Protein amounts were measured by a computer program 
(Image!). The same area was always measured for each band of the same protein and 
the same detected protein. The value of the protein of interest was then divided by the 
value for a normalisation protein which was detected on the same western blot.
2.8 Statistics
Information about the statistical analysis such one and two way ANOVA, cosinor 
analysis, correlation and linear regression analysis can be found in the relevant 
sections describing data analysis.
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Chapter 3: Analysis of plasma melatonin, 
cortisol and leptin rhythms in lean 
overweight and type 2 diabetic
participants
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3.1 Introduction
Endogenous clocks can be found in nearly every cell of the body. The system of 
endogenous clocks in the body is arranged in a hierarchical manner (section 1.2.1.3). 
The master clock which resides within the SCN of the hypothalamus acts to maintain 
correct phasing in other brain areas and most peripheral tissues (Dibner et a l, 2010). 
The SCN are directly connected with RGC and get synchronised to the light dark 
cycle of the 24 h day. Neuronal projections from the SCN project the temporal 
information to the pineal gland which releases melatonin in a diurnal fashion (sections
1.2.1.1 and 1.2.3.1). The endogenous phase of the SCN is best assessed by the 
melatonin rhythm in humans. The physiological function of melatonin in humans has 
not been clearly defined (section 1.2.3.1). Some humans are even able to live without 
producing any melatonin. The rhythm of plasma melatonin was shown to be 
influenced by peripheral autonomic neuropathy (O'Brien et a l, 1986).
The rhythm of plasma cortisol which is also driven by the SCN can be used as 
alternative phase marker of the SCN. The release of cortisol from the adrenal glands is 
controlled by the SCN nuclei via the HPA-axis (section 1.2.3.2).
A growing amount of evidence links circadian and metabolic physiology. Disruption 
of the circadian system was linked to multiple metabolic diseases including T2DM 
(Green et al, 2008, Bass and Takahashi, 2010) and section 1.5.2.1 describes links 
between higher incidences of obesity and T2DM. Tissue specific disruption of the 
clock in murine liver or pancreas has been shown to lead to an adverse whole body 
glucose regulation (section 1.5.2.1, Lamia et a l, 2009, Marcheva et a l, 2010, Sadacca 
et al, 2011).
There is also increasing evidence for circadian regulation of adipose function (section
1.5.2, Bray and Young, 2007, Zvonic, 2007, Maury et a l, 2010, Gimble et a l, 2011). 
Robust daily rhythms of WAT gene expression have been found in mice, rats and 
humans (Zvonic et al, 2006, Sukumaran et a l, 2010) and 20% of murine WAT 
transcripts exhibit 24 h variation (Ptitsyn et a l, 2006, Zvonic et al, 2006, Otway et 
al, 2011). Adipose tissue is a key metabolic tissue and directly linked to glucose 
regulation (section 1.3.4). It is therefore assumed to play a major role in the
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development of T2DM (Cusi, 2010). Function(s) of the clock in WAT are poorly 
understood, however, may include temporal control over the secretion of adipose 
hormones, termed adipokines. Attenuated rhythms of adipokines have been shown to 
in obese humans (Matkovic et a l, 1997, Saad et a l, 1998, Calvani et a l, 2004). 
Abnormal rhythmic adipokine secretion may therefore contribute to obesity or might 
be a consequence of it (section 1.5).
The daily rhythms of leptin are thought to be generated by an interaction between 
circadian rhythms, feeding and time awake (section 1.3.4.1, Shea et a l, 2005). There 
is inconsistency in the literature about leptin rhythms in obese and humans with 
T2DM. Some studies have described blunted amplitudes in obese and T2DM while 
other studies do not see a difference (Sinha et al, 1996b, Saad et a l, 1998, Yildiz et 
al, 2004). These differences could be due to differences in the design of the studies. 
In addition, most of the studies did not include stringent control of circadian phase of 
their participants which may confound interpretation of their data. This study presents 
leptin 24 h time course data for the first time expressed relative to internal circadian 
time as assessed by DLMO.
3.2 Hypothesis
Daily leptin rhythms are different in lean, OW non - diabetic and T2DM men, 
following strict circadian control and normalisation of the data to the phase of the 
melatonin rhythm. It is assumed that the metabolic state also influences the temporal 
relationship between leptin mRNA and plasma leptin.
3.3 Objectives
o Analyse plasma melatonin and leptin concentrations over a 24 h period from 
lean healthy, OW and insulin sensitive and participants diagnosed with T2DM.
• Normalise the leptin data with the individual circadian phase using DLMO as 
an internal circadian phase marker.
® Compare plasma melatonin and leptin rhythms between the study groups.
• Compare amplitude and phase of the plasma leptin rhythm with the leptin 
mRNA measured in the subcutaneous adipose tissue biopsies.
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3.4 M ethods
3.4.1 Participants
Three groups of male participants aged between 40 and 65 years were recruited. 
A lean healthy control group, a group of OW insulin - sensitive participants and a 
group of participants diagnosed with T2DM. Insulin resistance was defined by the 
criteria of the EGIR. These criteria and other parameters about the groups can be 
found in section 2.2.1. as well as detailed inclusion and exclusion criteria (section
2.2.3.).
3.4.2 Pre-screen
During the pre-screen a fasting blood sample was taken to analyse HbAlc, insulin, 
TG, glucose, iron and cholesterol (section 2.2.3.1). Height, weight, waist 
circumference, blood pressure were measured at the pre-screen day (section 2.2.2).
3.4.3 Pre-study protocol
The participants were asked to keep a daily activity routine. They needed to spend 8 h 
in bed, try to sleep at 22:30 h and get up at 6:30 h. They were not allowed to deviate 
from those times by more than 15 min (section 2.2.4.1). Set periods were given to 
consume meals (7:00 h - 9:00 h, 12:00 h - 14:00 h, 17:30 h - 19:30 h) and food was 
provided for the three days prior the study (section 2.2.4.2).
3.4.4 Laboratory study
Participants received 16 equal caloric Fortisip feedings per day (section 2.2.5.1). The 
study was conducted in a light / dark cycle (section 2.2.5.2) and participants were kept 
in a semi-recumbent position throughout the laboratory study (except if they needed 
to go to the lavatory) (section 2.2.5.3). Blood samples were taken every hour over a 
time course of 25 h (section 2.2.5.4). Four small open biopsies were taken from the 
upper buttock depot 6 h apart from each other (section 2.2.5.4).
3.4.5 Analysis of melatonin, cortisol and leptin
All three blood hormones were quantified by RIA (section 2.2.6). Profile features 
such as the DLMO were calculated from the data (section 2.2.7).
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3.5 Results
3.5.1 Participant demographics
Table 3.1 shows the results of the pre-screen data. The pre-screen procedure was 
carried out by Dr. Daniella Otway (University of Surrey). The three groups were 
matched for age and height. The waist circumference, BMI and the body weight were 
not statically different between the OW and the T2DM group, but significantly 
different between these both groups and the lean group (p < 0.05 vs. T2DM and OW). 
Fasting glucose, glycosylated haemoglobin and insulin concentration were 
significantly higher in the T2DM group (p < 0.05 vs. lean and OW) than in both other 
groups. The HOMA-IR value was significantly different between lean, OW and the 
T2DM (p < 0.05 vs. lean and OW) group. Blood iron concentration, systolic and 
diastolic blood pressure did not show significant differences between the groups. The 
questionnaires showed no significant difference, except of the BDI, where the 
participants in the T2DM group scored significantly (p < 0.05 vs. lean) higher than the 
participants of the lean group.
The majority of participants in the group diagnosed with T2DM were taking 
medication. Table 3.2 shows these medications in detail. Two participants in the 
T2DM group did not take any medication; they were diet and exercise controlled. 
Two participants were either treated with statins only or with statins and metformin. 
One participant was treated with metformin only. Participants in both the other groups 
(lean and OW) did not take any medication. The time in years since the participants 
were diagnosed with diabetes is also shown in Table 3.2.
3.5.2 Melatonin profiles
The age and the complete plasma melatonin profile measured by RIA of each 
individual subject can be found in Figures 3.1 - 3.3. Rhythmic diurnal plasma 
melatonin expression profiles could be found in all participants of the lean healthy as 
well as the OW group. The profiles of two participants in the group diagnosed with 
T2DM did not show increased melatonin at night. The highest melatonin 
concentrations in the lean healthy group reached 80 pg/ml and in the T2DM group 
55 pg/ml. The highest melatonin concentrations in the OW group reached 200 pg/ml.
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The full 24 h time course of the group mean plasma melatonin concentrations is 
shown in Figure 3.4a. Statistical analysis revealed highly significant effects for group, 
time and interaction (p < 0.0001). The results of the repeated measurement two-way 
ANOVA were for group (F(2, 542) = 28.11), time (F(24, 542) = 8.65) and interaction 
(F(48, 542) = 2.75) for the whole profile. This analysis included the two participants of 
the T2DM group which did not show increased melatonin plasma concentrations 
during the night. Statistical analysis of the data sets without these two participants 
revealed the same levels of significance (p < 0.0001) in the repeated measurement 
two-way ANOVA for group (F(2, 492) = 21.64), time (F(24, 492) = 7.62) and interaction 
(F(48, 492) = 2.15). In both analyses the Bonferroni post-hoc test showed no significant 
difference (p > 0.05) between the T2DM group and the lean group. The OW group 
was significantly different from the T2DM group (p < 0.01) and the lean group 
(p < 0.05). A detailed ovemew of the statistical findings can be found in Table 3.3.
To highlight the difference between the groups during peak melatonin production the 
time between 23:00 h and 06:00 h was plotted separately (Figure 3.4b). This graph 
includes the two T2DM participants which did not show increased melatonin levels at 
night. Statistical analysis of the repeated measurement two-way ANOVA revealed a 
significant effect of group (F(2, 172) = 28.40, p < 0.0001) and time (F(7  ^ 172) = 2.28, 
p < 0.05). A significant interaction was not observed (F(i4  ^172) = 0.06, p = 0.8611). A 
significant difference between the lean and the OW group (p < 0.05, Bonferroni) and 
the OW group and the T2DM group (p <0.05) was found in both analyses, regardless 
of whether the two participants which did not show increased melatonin 
concentrations were included or not.
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Table 3.1: Pre-screen participant data (lean, OW, T2DM).
Variable
n
Lean
8
OW
10
T2DM
7
Age [years] 53.8 + 2.1 50.8 ±2.9 57.1 ±1.6
Waist circumference [cm] 88.9* + 2.3 105.9 ±1.4 113.5+±3.2
Height [cm] 173.3 ±9.7 176.6 ± 6.9 174.3 ±3.3
Weight [kg] 69.7* ± 8.6 93.8 ±9.1 95.3+±6.2
BMI [kg/m^] 23.2*+ 0.5 30.1 ±0.8 32.0+ ±0.9
Fasting glucose [mM] 4.2 + 0.2 4.8 ± 0.3 6.7+* ± 0.5
Fasting insulin [pM] 28.1+5.9 40.6 ± 6.8 102.1+* ±27.8
Iron [g/dl] 17 + 1.3 16.5 ±1.1 16.8 ±0.4
HbAlc [%] 5.3 ±0.1 5.4 ± 0.2 6.9+* ± 0.3
Systolic [mmHg] 131.4 ±12.8 135±11 145.7 ±3.8
Diastolic [mmHg] 86.4 ±13.5 86.3 ± 10.7 85.6 ±4.3
HO 59 ± 6.5 57.4± 8.8 59.7 ± 4.2
PSQI score 3.4 ±1.5 4.4 ±1.8 3.7 ± 0.7
BDI 2 ±1.6 3.8 ±2.8 8.3+±2.6
Epworth score 3 ±2.3 4.4 ±2.1 5.6 ± 1.5
HOMA-IR 0.5 ±0.1 0.8 ±0.1 2.0 +* ± 0.6
Measurements and results o f the analysis o f the fasted blood sample. Mean ± SEM is presented, *p 
<.05 vs. OW group, <.05 vs. lean group. One-way ANOVA for effect o f group on each variable. 
Tukey post-hoc test was used.
Table 3.2: Medication in the group o f participants diagnosed with T2DM and for how long they had 
been diagnosed with T2DM.
Group Number of 
participants
Medication Time
since
diagnosis
[years]
Diet and
2 • Aspirin 75 mg/day; Pravastatin 10 mg/day 
Did not take those 12 days before study
4
exercise • statins, ramipril both not used before the study 6
Metformin
only
1 • Metformin Hydrochloride 2000 mg/day 22
Statins only 2 • Simvastatin 40 mg/day 5,2
Metformin 
and statins
2 • Metformin Hydrochloride 1000 mg/day 
Simvastatin 20 mg/day
Ramipril 10 mg/day
• Metformin Hydrochloride 2000 mg/day 
Simvastatin 40 mg/day
Ventolin and Beclazone used until Nov 2008
10
2
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Figure 3.1: Full 24 h melatonin profiles of the lean healthy group. Melatonin concentrations [pg/ml] 
were detected by RIA in plasma which was collected hourly over a period of 25 h. Values below the 
detection limit have been set to the value of the assay detection limit. The time between DLMO and the 
DLMOff (25% method) is indicated by grey shading. The dark phase is indicated by the dark bars 
below the x-axes. Each sample was analysed in duplicate the average of two valid measurements are 
plotted. The age and ID number o f each individual participant is indicated in the graphs.
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Figure 3.2: Full 24 h melatonin profiles of the OW group. Melatonin concentrations [pg/ml] were 
detected by RIA in plasma which was collected hourly over a period of 25 h. Values below the 
detection limit have been set to the value of the assay detection limit. The time between the DLMO and 
the DLMOff (25% method) is indicated by grey shading. The dark phase is indicated by the dark bars 
below the x-axes. Each sample was analysed in duplicate the average o f two valid measurements are 
plotted. The age and ID number of each individual participant is indicated in the graphs.
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Figure 3.3: Full 24 h melatonin profiles of the group of participants diagnosed with T2DM. Melatonin 
concentrations [pg/ml] were detected by RIA in plasma which was collected hourly over a period of 25 
h. Values below the detection limit have been set to the value of the assay detection limit. The time 
between the DLMO and the DLMOff (25% method) is indicated by grey shading. The dark phase is 
indicated by the dark bars below the x-axes. Each sample was analysed in duplicate the average o f two 
valid measurements are plotted. The age and ID number of each individual participant as well as the 
medication is indicated in the graphs.
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Figure 3.4: Group means o f plasma melatonin time courses. Average group values (lean healthy, OW 
and T2DM) and error bars are shown (SEM). a whole profile b just dark phase. The dark phase is 
indicated by the dark bars below the x-axes. For the analysis the following n numbers apply; Lean 
healthy (n = 8), OW (n = 10), T2DM (n = 5). Lean: diamonds and solid line; OW: squares and dashed 
line; T2DM: triangles and dotted line; ** p <  0.01 vs. T2DM group,  ^p < 0.05 vs. lean healthy group.
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Table 3.3: Statistical analysis o f group means o f plasma melatonin concentrations.
Whole
Group Time point [h] and significance 
T2DM vs. lean ns
T2DM vs. OW 2:00**; 3:00 - 6:00***; 07:00**
Two participants of profile
T2DM group lean vs. OW 02:00*; 3:00 - 6:00***; 07:00**
which do not show — :----------------- -^---- :--------------------------------------------------
melatonin peak T2DM vs.lean ns
included dark T2DM vs. OW 2:00 - 7:00*
period Lean vs. OW 02:00 *
Whole
T2DM vs. lean ns 
T2DM vs. OW 3:00 - 6:00**Two participants of profile
T2DM group Lean vs. OW 3:00 - 6:00***; 07:00**
which do not show ---------------------------- ----------------------------------------------------
melatonin peak T2DM vs.lean ns
excluded dark T2DM vs. OW 2:00-5:00*  
period Lean vs. OW 2:00*
The analysis was conducted with and without the two participants o f the T2DM group which did not 
show a peak in melatonin production at night. The whole 24h profile as well as just the dark phase was 
analysed. *p < 0,05, **p < 0,01, ***p < 0.001, ns = not significant.
Comparisons of the DLMO and DLMOff, mid melatonin (from sleep diaries) and 
melatonin duration of all groups are shown in Figure 3.5. The DLMO is shown in 
Figure 3.5a. A significant difference between the groups was not found the one-way 
ANOVA analysis (F(2, 20) = 0.40, p = 0.675). The lean group showed on average the 
most delayed DLMO of the three groups. The DLMOff (Figure 3.5b) was on average, 
but not statically (F(2, 20)= 2.38, p = 0.1176, one-way ANOVA) later in participants of  
the OW group compared to the T2DM or the lean group. The melatonin duration was 
calculated as the time between DLMO and DLMOff (Figure 3.5c). The participants of 
the OW group produced melatonin on average longer but not statistically 
(F(2, 20) = 1.79, p = 0.1929) than the participants o f the other groups. The mid 
melatonin time point is shown in Figure 3.5d. The difference in the timing o f the 
midpoint o f melatonin between the groups was not significant
(F(2, 20) = 1.5, p = 0.2562, one-way ANOVA). The participants of the T2DM group, 
however, showed on average the earliest mid melatonin point.
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Figure 3.5: Features o f the melatonin rhythm, a The DLMO was calculated by the 25% method, by 
using 5 points o f the baseline and the 3 highest points o f the profile (F(2, 20) = 0.40, p = 0.675, one-way 
ANOVA) b DLMOff, the DLM Off was calculated by using the same formula (F(2, 20) = 2.38, p = 
0.1176, one-way ANOVA) c Duration o f melatonin (time between DLMO and DLMOff) (F(2, 20) = 
1.79, p = 0.1929, one-way ANOVA) d Mid melatonin, calculated as the midpoint between DLMO and 
DLM Off (F(2, 20) = 1.5, p = 0.2562, one-way ANOVA). A significant difference between the groups 
was not observed in any o f the analysed features. Lean healthy (n = 8), OW (n = 10) and T2DM (n = 5) 
have been included in the analysis. Just T2DM participants showing a melatonin rhythm have been 
included.
The phase angle between endogenous circadian phase (DLMO) and environmental 
phase (sleep time) was investigated. Sleep diaries provided the sleep time in the week 
before the study. A significant difference in the phase angle between the groups was 
not observed (F(2,20)= 0.1952, p = 0.8242, one-way ANOVA, Figure 3.6a). This is not 
surprising as we asked all participants to stick to the same sleep wake cycle in the 
week prior the study. Participants in the T2DM group showed on average the highest 
melatonin values. The variation is the highest in the T2DM group as well. The group 
means of the habitual sleep time before the study mentioned in the pre-screen 
questionnaire were also compared (Figure 3.6b). A significant difference was not 
observed between the groups (F(2, 19) = 2.596, p = 0.1008, one-way ANOVA). The 
habitual sleep time of the T2DM group was closest to the enforced sleep time of 
22:30 h in the week before the study.
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Figure 3.6: Group means o f the phase angle between DLMO and habituai sleep time, and habitual 
sleep time before the study period, a The phase angle between external and internal time was calculated 
by subtraction o f  the time when the participants tried to sleep in the week before the study from the 
melatonin onset DLMO. The phase angle difference is shown in min and a significant difference 
between the groups was not observed. (P(2, 2o)= 0.1952, p = 0.8242, one-way ANOVA b Habitual sleep 
time as assessed in the pre-screen questionnaire (F(2, 19) = 2.596, p = 0.1008, one-way ANOVA). A 
significant difference was not observed. Lean (n = 8), OW (n = 10) and T2DM (n = 5). Only T2DM 
participants who showed a clear increase in the melatonin concentration at night were included in the 
analysis.
The increase in melatonin at night did not correlate significantly with age (r^  = 
0.07195, p = 0.1948, two-tailed correlation analysis. Figure 3.7a,), BMI (r^= 0.02726, 
p = 0.4302, 3.7b), glucose (r^= 0.006163, p = 0.7092, 3.7c), insulin (r^= 0.006554, p 
= 0.7005, 3.7d), iron (r  ^= 0.01068, p = 0.6229, 3.lé), HbAlc (r^  = 0.07669, p = 
0.1802, 3.7f), body weight (r^= 0.04487, p -0.3094, 3.7g) and systolic blood pressure 
(r^  = 0.08220, p = 0.1647, 3.7i). Correlation between the increase in melatonin at night 
with the diastolic blood pressure was found to be significant (r  ^= 0.2068, p = 0.0224, 
3.7h). This correlation was not significant in the lean and T2DM group but only in the 
OW group (r^= 0.5768, p = 0.0108).
Correlation between the time that the participants of the T2DM group have been 
diagnosed with T2DM and their nocturnal melatonin amplitude was not significant 
(r^  = 0.2043, p = 0.3086, two-tailed correlation analysis. Figure 3.8).
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Figure 3.7: Comparison o f the plasma melatonin amplitude with pre-screen measurements. Lean 
healthy (n = 8), OW (n = 10) and T2DM (n = 5). Two-tailed, correlation analysis a age r^ = 0.07195, p 
= 0.1948 b BMI r^= 0.02726, p = 0.4302; c glucose r^= 0.006163, p = 0.7092; d insulin r^= 0.006564, 
p = 0.7005; e iron r  ^= 0.01065, p = 0.6229; f  H bA lc r^ = 0.07669, p = 0.1802; g body weight r^ = 
0.04487, p = 0.3094; h diastolic r^ = 0.2068, p = 0.0224; i systolic blood pressure r  ^= 0.08220, p = 
0.1647.
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Figure 3.8: Comparison o f the plasma melatonin amplitude with the duration o f diabetes in the T2DM 
participants, (n = 7). r^= 0.2043, p = 0.3086, two-tailed correlation analysis, (n = 7).
3.5.3 Cortisol
As previously discussed two of the T2DM participants did not show a diurnal rhythm 
in plasma melatonin. The plasma cortisol concentration was analysed in order to 
investigate if the missing increase in nocturnal melatonin is due to a defect or missing 
SCN clock or to improper melatonin secretion by the pineal gland. The plasma 
cortisol rhythm is partly controlled by the SCN via the HPA-axis (section 1.2.3.2). 
The SCN need to possess a endogenous clock to be able to measure rhythmicity in the 
plasma concentration of cortisol. Plasma cortisol was measured by Dr. Benita 
Middleton (University of Surrey) in samples from the T2DM group.
The full cortisol profiles can be found in Figure 3.9. The two participants who failed 
to show an increase in the plasma melatonin concentrations in the dark phase showed 
a rhythm in cortisol (section 2.2.7.7). Significant cosinor fits could be applied to the 
cortisol profiles of these two participants (p < 0.05). The cortisol rhythm of one 
participant did not significantly fit a cosine curve (p(fit)= 0.3238), and is therefore not 
plotted (Figure 3.9). Acute cortisol responses were observed at the times of the 
biopsies in about half of the participants.
The features of the significant cosine fits are presented in Table 3.4. The highlighted 
values belong to the participants without a melatonin rhythm. The value of these 
curve fits did not differ from the fits of the participants showing a nocturnal increase 
in melatonin.
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Figure 3.9: Cortisol profiles o f the group of T2DM. Cortisol concentrations have been measured by 
Dr. Benita Middelton by RIA. The time o f the adipose tissue biopsies is indicated by the vertical bars at 
11:00 h, 17:00 h, 23:00 h and 05:00 h. The dark phase is indicated by the dark bars below the x-axes. 
Shown cosinor fits are significant p(f,t) < 0.05. Medication and the p-value of the individual fits are 
shown on the graphs. It is also indicated if there was no nocturnal rise in plasma melatonin. Each blood 
sample was analysed in duplicate, the average of two valid measurements are plotted.
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Table 3.4: Features of the cortisol cosinor fits.
ID Average Cortisol concentration 
Number [nmol/1]
Acrophase
[hh:min]
Amplitude
[nmol/1]
109 169 1E22 57
112 236 0934 91
131 142 0736 107
134 131 1036 ' 9 0 ^
136 234 10:10 116
149 187 07:49 140
Mean ± SEM 194 ± 16 9:25 ± 33 109 ±13
The highlighted values belong to participants without melatonin peak. Errors in SEM.
3.5.4 Leptin
3.5.4.1 Plasma leptin
Full leptin profiles are presented in Figures 3.10 - 3.12. The y-axis indicates the 
values for the values of leptin [ng/ml]. A cosinor curve was fitted to the data and the 
time without Fortisip is indicated in grey. All cosinor fits were highly significant 
(P(fit) < 0.0001). The peak in the plasma concentration of leptin appears around 
midnight, whilst the leptin concentration is the lowest at around 10:00 h.
Two-way ANOVA on the group means of the whole leptin profiles revealed a 
significant effect of group (F(2, 496)= 156.6, p < 0.0001) in the repeated measures two- 
way ANOVA and no significant effects of time or interaction (Figure 3.13a). 
Significant (p < 0.05, Bonfeii'oni) differences between the lean and T2DM group 
between 14:00 h and 5:00 h as well as at 7:00 h were observed. Figure 3.13b shows a 
significant effect of group for the increase in leptin at night time 
(F(2, 496) = 5.8 1 7, p < 0.0094).
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Figure 3.10: Leptin profiles of the lean healthy group. Leptin concentrations were measured by RIA. 
The time when the participants did not receive an hourly fortisip feed is indicated in grey shading. The 
dark phase is indicated by the dark bars below the x-axes. The plasma leptin values have been fitted 
with a cosinor curve. The p values of all cosinor fits were highly significant (p(f,t) < 0.0001). Each 
sample was analysed in duplicate, the average of two valid measurements are plotted. The ID o f the 
individual participant is shown.
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Figure 3.11; Leptin profiles of the OW group. Leptin concentrations were measured by RIA. The time 
when the participants did not receive an hourly Fortisip feed is indicated in grey shading. The dark 
phase is indicated by the dark bars below the x-axes. The leptin values have been fitted with a cosinor 
curve. The p values o f all cosinor fits were highly significant (p^ n,) < 0.0001). Each sample was 
analysed in duplicate, the average of two valid measurements are plotted. The ID o f the individual 
participant is shown.
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Figure 3.12: Leptin profiles of the T2DM group. Leptin concentrations were measured by RIA. The 
time when the participants did not receive an hourly fortisip feed is indicated in grey shading. The dark 
phase is indicated by the dark bars below the x-axes. The leptin values have been fitted with a cosinor 
curve. The p values of all cosinor fits were highly significant (p(f,t) < 0.0001). Each sample was 
analysed in duplicate, the average of two valid measurements are plotted. The ID o f the individual 
participant is shown.
The DLMO was used to determine the phasing of the leptin profile curves relative to a 
marker of endogenous circadian phase. T2DM participants without a melatonin 
rhythm were not included in any of the analysis below. Figure 3.14a shows the raw 
leptin data of all three participant groups plotted as a percentage of the mean. In 
Figure 3.14b the same data set is shown, but each leptin profile was shifted depending
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on the individual DLMO value, before the group means were calculated. The DLMO 
of each profile was set at 360°. There was no significant differences between the 
phases of the three groups and between DLMO shifted and not shifted data. The 
features of the fitted cosinor wave can be found in Table 3.5.
The amplitude of plasma leptin of each participant has been correlated with different 
markers of metabolism (Figure 3.15). Correlation between the plasma leptin 
amplitude and BMI was highly significant if all participants are taken into account 
(r^  = 0.5288, p < 0.0001, two-tailed correlation analysis. Figure 3.15a). This 
correlation was only significant in the OW group when the groups were correlated 
separately (r^  = 0.5055, p = 0.0212). Correlation between plasma glucose and the 
plasma leptin amplitude was significant (r^  = 0.1834, p = 0.0327, Figure 3.15b) as 
well as the correlation between the plasma leptin amplitude and plasma insulin which 
was also found to be highly significant (r^  = 0.6615, p < 0.0001, Figure 3.15c). 
Correlation between plasma insulin concentration, and the plasma peak leptin was the 
weakest of the correlations, because of the 3 outliers (all 3 outliers were in the T2DM 
group). Correlation of the separate participant groups with plasma glucose did not 
reveal any statistical significance. Correlation between the plasma leptin amplitude 
and insulin was found to be significant in the lean (r^  = 0.5481, p = 0.0375,) and the 
T2DM group (r^  = 0.6605, p = 0.0263), but not in the OW group. An overview of all 
the statistical findings is presented in Table 3.6. The average melatonin value was 
correlated with the plasma leptin amplitude value. A statistically positive correlation 
between the increases in melatonin and leptin could not be found (data not shown).
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Figure 3.13; Group means of plasma leptin. Means ± SEM. Lean (n = 8), OW (n = 10), T2DM (n = 7) 
a the dark phase is indicated by the dark bars below the x-axes. Group (F(2, 4%) = 156.6, p < 0.0001), 
time (F(24. 496)= 126, p =  0.3098, interaction (F(4g 4%) = 0.2329, p = l) .p* < 0.05, p** < 0.01 , p*** < 
0.001 lean group vs. T2DM group. Lean: red diamonds line, OW: blue squares and line, T2DM: black 
triangles and line, b Comparison o f the leptin amplitudes between the study groups. Group (Fn 4%i = 
5.817, p<  0.0094); p** < 0.01 lean vs. T2DM group (Bonferroni post-hoc test).
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Figure 3.14: Group means o f the leptin profiles, raw data and normalized to DLMO. a Raw data 
normalised to the average plasma leptin concentration b Normalised to the average plasma leptin 
concentration and to participants individual DLMO (360°C). The resulting x-values were binned 
around half past the hour, and mean ± SEM are plotted. The DLMO corrected values have been fitted 
With cosine curves. Lean: red diamonds line, OW: blue squares and line, T2DM: black triangles and 
line.
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Table 3.5: Cosine curve fitted to each individual group leptin profile.
Group n Not DLMO 
corrected
DLMO
corrected
acrophase [hh:mm ± min]
lean healthy 8 00:04 ±15 00:06 ± 22
OW 10 00:16 ±16 00:34 ±28
T2DM 7 00:31 ±26 00:49 ± 38
There was no significant (p > 0.05; one-way ANOVA) effect o f group on either the acrophase (peak 
time) or amplitude o f the rhythms. The acrophase o f the leptin rhythm was also corrected to the 
DLMO.
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Figure 3.15: Correlation o f  the plasma leptin amplitude with different markers o f metabolism. Two- 
tailed correlations; lean healthy (n = 8), OW (n = 10) and T2DM (n = 7). a. BMI r  ^= 0.5288, p < 
0.0001; b plasma glucose r^ = 0.1834, p = 0.0327; c. plasma insulin r^= 0.6615, p < 0.0001.
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Table 3.6: Statistical findings o f the correlations between the amplitude in leptin and pre-screen 
results.
Leptin amplitude in [nmol/1] 
n
lean
8
OW
10
T2DM
7
BMI [kg/m''] p = 0.0669, p = 0.0212, p = 0.0995,
r^  = 0.7304 r^  = 0.5055 r^= 0.4490
Glucose [mmol/l] p = 0.5591, p = 0.3807, p = 0.9818,
r^= 0.05990 1^=0.09711 r^= 0.0001147
Insulin [pmol/1] p = 0.0375, p = 0.1727, p = 0.0.0263,
1-^=0.5481 r^= 0.2189 r^= 0.6605
Two-tailed correlation analysis.
3.5.4.2 Leptin mRNA
Four biopsies from subcutaneous adipose tissue were taken during the study duration. 
The amount of leptin mRNA of the biopsies was determined by qtPCR by Dr. 
Daniella Otway. The mRNA values were normalised to the house keeping gene 
Gapdh. The means of this quantification in the different groups are shown in Figure 
3.16. A significant effect of time (F(s, 88) = 1.5, p = 0.22) or interaction (F(6, gg) = 
0.04239, p = 0.9997) was not found in the repeated measures two-way ANOVA 0. A 
significant effect of group, however was observed (F(2,gg) = 6.201, p= 0.003).
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Figure 3.16: Group means (± SEM) leptin mRNA. Lean: diamonds and solid line; OW: squares and 
dashed line; T2DM: triangles and dotted line. Normalised to Gapdh. Lean (n = 8), OW (n = 10) and 
T2DM (n = 7).
The leptin mRNA correlated significantly (r^  = 0.2466, p = 0.0116, two-tailed 
correlation analysis) with the amplitude in leptin. This correlation was only found to 
be significant in the OW group when the groups were analysed separately (r  ^ = 
0.7378, p = 0.0015).
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Figure 3.17: Correlation between leptin mRNA and the leptin amplitude. Normalised to Gapdh. Lean 
(n = 8), OW (n = 10) and T2DM (n = 7) r  ^= 0.2466, p = 0.0116 two-tailed correlation analysis.
3.6 Discussion
To investigate if obesity or T2DM influences the daily rhythm in plasma 
concentrations of leptin, three groups of male participants between 40 and 65 years of 
age were recruited. The three groups were: an obese and insulin sensitive group, 
participants with diagnosed T2DM and a lean healthy control group. Blood was taken 
every hour for the duration of 25 h study period as well as four sWAT biopsies from 
the upper buttock region taken at 6 hourly intervals. The blood was used to analyse 
melatonin, cortisol and leptin concentrations and the WAT tissue biopsies was used to 
analyse the expression profiles of clock genes and CCGs.
3.6.1 Participants
The three groups were matched for age. The BMI was matched between the OW and 
the T2DM group, but was significantly lower in the lean control group. This was 
expected as obesity is one of the risk factors to develop T2DM (Koopman et a l, 
2009). Body weight which is part of the BMI calculation and the waist circumference 
showed no significant difference between the OW and the T2DM group. Fasting 
glucose and insulin levels were significantly increased in the T2DM group compared 
to both other groups. This was expected as hyperglycaemia and hyperinsulinaemia are 
part of the pathophysiology of T2DM and a signal for insulin-resistance (Reaven et 
al, 1967, Guilherme et al, 2008). The percentage of glycosylated haemoglobin was
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significantly higher in the participants in the T2DM group compared to the other 
groups. Glycosylated haemoglobin is a marker of the glucose concentration in the 
blood during the last months (Cefalu et a l, 1994). Glycosylated haemoglobin is not a 
long term marker for the diabetic status (Rahbar, 1980). Although we know how long 
the participants have been diagnosed with T2DM for, we do not know how much time 
elapsed before they sought medical advice. Most of our participants in the T2DM 
group were well controlled for their diabetes. The HOMAR-IR values were also 
significantly elevated in the T2DM group compared to the other both groups. The 
HOMA-IR value describes the insulin-resistance (Esteghamati et a l, 2010, Qu et al, 
2011). Together with the increased glucose and insulin concentrations in the blood, 
this shows that the participants in the T2DM group were insulin-insensitive. 
Hypertension is one of the risk factors for the development of T2DM (Groop et a l, 
1993), however, neither the systolic nor the diastolic blood pressure showed 
significant differences between the groups. This finding could in part be due to the 
fact that the blood pressure readings were taken in a potentially stressful situation.
The questionnaires about diurnal preference (HO score), PSQI and sleepiness 
(Epworth score) did not show significant differences between the groups. The BDI 
showed that the participants in the T2DM group were significantly more depressed 
than the participants in the lean control group. The highest depression scores were 
found in the diet and exercise controlled T2DM patients who showed a moderate level 
of anxiety. The other participants in the T2DM group showed a minimum level of 
anxiety. Two participants in the OW group also showed mild anxiety. It has been 
reported that diabetes increases the risk of depression (Leedom et a l, 1991). There is 
also a lot of evidence linking circadian rhythms and depression (Kronfeld-Schor and 
Einat, 2012). Depression itself shows daily and seasonal patterns, mutations in clock 
genes have been connected with depression, sleep disorders have be associated with 
depression, sleep deprivation works as an antidepressant, bright light exposure helps 
to fight depression and antidepressant drugs effect sleep and circadian rhythms 
(Kronfeld-Schor and Einat, 2012). An effect of depression on the results can therefore 
not be excluded.
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3.6.2 Melatonin profiles
The melatonin plasma profiles were measured by RIA. A nocturnal rise in the 
melatonin plasma concentrations could be detected in all participants of the lean and 
OW group. Two participants of the T2DM group failed to show a nocturnal increase 
in plasma melatonin. It is known that the melatonin amplitude decreases with 
increasing age (Iguchi et al, 1982, Skene and Swaab, 2003), and is positively 
correlated with body weight (Arendt et a l, 1982). The two participants in the T2DM 
group which do not show an increase in nocturnal melatonin, however, were not the 
oldest of their group. One of the participants who were not showing a nocturnal 
increase in melatonin had a BMI of 35 kg/m^ and was therefore the heaviest 
participant in the study. One of them did not take any medication at all, the other one 
took metformin and statins. Metformin is able to influence peripheral oscillators, but 
because it cannot cross the BBB barrier it is not able to affect the SCN clock (Um et 
al, 2007) (section 1.4.3.3). It could also be the case that those participants do not 
produce any melatonin at all. Neuropathy could be another reason for the reduced 
melatonin amplitude. Reduced amplitude rhythms were reported previously in T2DM 
with autonomic neuropathy (O'Brien et al, 1986, Tutuncu et al, 2005) and 
retinopathy (Hikichi et a l, 2011).
The group means of the plasma melatonin concentrations were compared. The OW 
insulin-sensitive group showed significantly the highest nocturnal plasma melatonin 
compared to the other both groups. The statistical significance does not change if the 
two participants from the T2DM group which failed to show a nocturnal increase in 
melatonin were excluded. It has been reported that plasma melatonin concentrations 
are positively correlated with body weight in insulin-sensitive individuals (Arendt et 
al, 1982). The correlation between melatonin and BMI was not analysed in that 
study. In the current study body weight was not significantly different between the 
OW and the T2DM group.
The participants in the OW group were found to be insulin-sensitive whilst the 
participants in the T2DM group were insulin-resistant. This was shown by their 
HOMA-IR values and the hyperglycaemia and hyperinsulineamia in the fasting blood 
sample. Recent studies have linked decreased nocturnal melatonin secretion with 
insulin-resistance. Animals without melatonin signalling because their pineal gland
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was removed showed insulin-resistance (Nogueira et al, 2011). The same is true for 
animals without a functional receptor (Contreras-Alcantara et al., 2010). Increased 
levels of plasma melatonin with decreased levels of insulin have also been found in 
animal models of type 1 diabetes mellitus (TIDM) as well as T2DM (Peschke et al, 
2010, Peschke et al, 2011).
The participants of the study needed to keep a strict wake / sleep cycle in the week 
prior to the study similar to the wake / sleep cycle during the laboratory study. 
Therefore it was not surprising to see that the DLMO was found to be not 
significantly different between the groups (as well as DLMOff, melatonin duration 
and mid melatonin). The timing of the nocturnal increase of plasma melatonin is 
known to be the most reliable phase marker of the SCN clock in humans. This implies 
that obesity and T2DM do not alter the phasing of the SCN clock, under controlled 
laboratory conditions. The DLMO needed to be assessed as its name indicates in dim 
light conditions. The study, however, was not conducted under dim light conditions. 
However, all participants in our study experienced the same lighting environment and 
their DLMO was calculated in the same way.
The phase angle between the timing of the enforced sleep / wake cycle and the 
entrained phase assessed by the DLMO did not show a significant difference between 
the groups. The habitual sleep time before the study (as assessed in the recruitment 
questionnaire) of the T2DM group was the closest to the enforced time of the pre­
study period. This might be the reason why the participants of the T2DM group 
showed on average the shortest phase angles.
The melatonin peak concentrations showed a significant correlation with the diastolic 
blood pressure in the overweight group. This supports the findings by other groups 
which reported decreased blood pressure readings at night time when plasma 
melatonin concentrations are high (Simko and Pechanova, 2009, Yildiz and Akdemir, 
2009). A correlation between systolic blood pressure and melatonin concentration 
could not be found. A correlation between the peak melatonin concentration and the 
age of the participants was also not observed. It has been shown previously that 
plasma melatonin concentrations in humans decrease with age (Iguchi et a l, 1982) 
The amount of melatonin produced during each 24 h day shows large variations 
between individuals. This could be one reason why we did not see a significant
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correlation between age and the peak melatonin concentration. The correlation 
between body weight and plasma melatonin was mentioned in a paper in 1982 
(Arendt et a l, 1982), but to my knowledge has not been mentioned since. We could 
not find a positive correlation between BMI or body weight with the peak melatonin 
concentration.
There was no correlation between the duration that participants of the T2DM group 
have been diagnosed with T2DM and their melatonin peak values. This is limited by 
the fact that we did not know how long the participants have had symptoms of T2DM 
before they consulted their general practitioner. The destruction of neurons in 
autonomic neuropathy as described above, is a gradual process, and progresses at 
different paces in different individuals. This may also mean that the decrease in 
melatonin secretion is a gradually process. A deereased amplitude of melatonin could 
also be due to less synehronisation in the SCN and therefore a less strong output 
signal to the pineal gland.
3.6.3 Cortisol profiles
The cortisol rhythms in the T2DM group were analysed primarily to investigate 
whether the absence of a nocturnal melatonin rhythm in some participants was due to 
an alteration in the master SCN circadian clock or its output pathways. The cortisol 
plasma rhythm like the melatonin rhythm is concentration controlled by the SCN 
clock. The two participants which failed to show a nocturnal increase in plasma 
melatonin had rhythmicity in the plasma cortisol. The expression profiles of these 
participants did not differ in average cortisol concentration, phase or amplitude fi"om 
the profiles of the other participants in the T2DM group. The absence of a nocturnal 
increase in melatonin is therefore most likely due to an impaired pineal output, rather 
than an impaired SCN clock. This impaired pineal output could be caused by 
autonomic neuropathy.
Some of the participants showed peaks in the cortisol profile which could be related to 
biopsy stress. The blood samples were not always taken at the same time before or 
after a biopsy was taken. It eould therefore be possible that we were not able to 
measure all responses. It could also be that those peaks in the expression are part of 
the diurnal rhythmicity of cortisol.
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In one particular case there was no peak in the cortisol profile at the first biopsy at 
11:00 h in the morning. One could speculate that at the time when the first biopsy was 
taken the participant did not know how they would cope with it. This participant had 
peaks in the cortisol assay at 17:00 h, 23:00 h and 5:00 h when the other biopsies were 
taken.
3.6.4 Leptin
Leptin is an adipokine and is secreted by mature adipocytes only (Wagner et al, 
2007). It exhibits a 24 h variation in the plasma concentrations in humans (Sinha et 
al, 1996a). Plasma leptin rhythms are influenced by feeding, wake time and by an 
endogenous circadian component (Shea et al., 2005). The clock in adipocytes could 
be part of the circadian regulation of leptin seeretion (Otway et a l, 2009). A rhythmic 
expression of leptin could be detected in all participants, even in those which did not 
show rhythmicity in melatonin production. This might be due to the fact that the 
concentration of leptin in plasma is influenced by many factors such as food 
restriction and overfeeding (Chin-Chance et al, 2000, Elimam and Marcus, 2002) as 
well as sleep restriction (Taheri et a l, 2004). The participants in our study were fed 
hourly, to prevent post-prandial increases in leptin. It has been suggested that 
increased concentrations of melatonin cause a down regulation of leptin (Kus et a l, 
2004) and that melatonin increases leptin levels in the presence of insulin, resulting in 
decreased appetite during the night (Alonso-Vale et a l, 2005). Plasma leptin 
concentrations were statistically lower in lean controls compared to obese insulin- 
sensitive and obese diabetic participants. The correlation between BMI and plasma 
leptin concentrations is known (Kolaczynski et a l, 1996). There was no significant 
difference in the BMI between the OW and the T2DM group. Reasons for this 
difference could be leptin resistance. The results show that rhythmicity in plasma 
melatonin is not essential for the rhythmic appearance of leptin in plasma. It can be 
further speculated that autonomic neuropathy does not influence the timing signal 
from the SCN to the secretory adipocytes.
The timing of the leptin concentrations was reported to be influenced by obesity and 
T2DM (Sinha et al, 1996a). The current findings do not support these findings. 
Robust rhythms of plasma leptin were detected when the data was expressed relative 
to the 24 h mean of each group. Neither the shape nor the phasing of the leptin rhythm
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over the 24 h day was affected. The different findings could be explained by lack of 
circadian control in the Sinha et al, study (Sinha et ah, 1996a).
There was an overall significant effect of group on the leptin mRNA from 
subcutaneous adipose tissue. A rhythmicity in the leptin mRNA could not be detected. 
It has been shown that epididymal WAT shows robust leptin rhythms, but that there 
are less roboust rhythms in sWAT (Zeman et a l, 2009). Therefore it can be assumed 
that the rhythmic expression of leptin mRNA is controlled differently in different 
adipose tissue depots. A tighter significant correlation was found between 24 h plasma 
leptin concentrations and BMI than between plasma leptin and leptin mRNA.
3.6.5 Medication
Metformin suppresses hepatic gluconeogenesis (Kirpichnikov et a l , 2002), increases 
insulin sensivity (Ou et al, 2006), and enhances peripheral glucose uptake and 
increases glucose oxidation. It has been suggested that metformin may have a role in 
regulating clock genes and circadian rhythms (Um et al., 2007). One of our two 
participants of the T2DM group which did not show an increase in nocturnal 
melatonin takes metformin. The hypothesis that metformin supports circadian 
rhythms (Um et a l, 2007) could not be supported or rejected because of small the 
numbers in participants.
3.6.6 Summary
In summary the data showed elevated nocturnal plasma melatonin concentrations in 
insulin-sensitive obese men, but not in insulin-insensitive participants with T2DM, in 
well controlled T2DM patients and under well controlled study conditions. The timing 
of the plasma leptin rhythm was not influenced by the metabolic state under 
controlled conditions. Our data strongly suggests that obesity and T2DM per se do not 
alter diurnal rhythms of plasma leptin. The same is true for leptin mRNA expression 
in sWAT. The current findings therefore support a functional link between obesity 
and insulin sensivity and melatonin production. Our data do not support the 
hypothesis that obesity or T2DM influence the plasma concentration of leptin nor the 
phasing of its expression.
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The power calculation was based on the study by Ando et al (2005) which compares 
clock gene mRNA expression between lean and obese -  diabetic mice. The study was 
not powered to analyse humoral factors. The Ando et al (2005) study was conducted 
in C57BL/6J inbread mice whilst our study which was conducted in humans. Those 
factors are reasons why most of my results are not representative. Especially 
representative statements about the T2DM group could not be made, because of the 
heterogeneity of this group.
1 0 2
Chapter 4: Characterisation of a circadian 
clock within conditionally immortalised
mouse adipocytes
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4.1 Introduction
Endogenous clocks have been identified in most tissues of the mammalian body 
(Schibler et a l, 2003). In comparison to other tissues such as the liver and the 
kidneys, little is known about the rhythmic expression of clock genes and clock 
proteins in WAT. Endogenous clocks were identified in most eells of adipose tissue. 
Such as fibroblasts, macrophages, vascular endothelial cells, leucocytes, pre­
adipocytes and human adipose-derived stem cells (Johnston et al, 2009, Gimble et 
al, 2011). The strongest evidence for an endogenous clock in adipocytes comes from 
the rhythmic plasma concentrations of adipokines (Hotamisligil, 1999, Shulman, 
2000, Kalsbeek et a l, 2001, Gavrila et al, 2003, van der Bom et a l, 2003). 
Adipokines are only secreted by mature adipocytes (Kalsbeek et al, 2001).
The 3T3-L1 pre-adipocyte cell line which can be differentiated into mature adipocytes 
is used widely to investigate adipogenesis and adipocyte biology. Our laboratory has 
investigated clock gene and clock-related gene expression in pre-adipocyte and 
mature 3T3-L1 cells (Otway et al, 2009). Rhythmic expression of clock genes in 
these cells has provided evidence for the presence of a endogenous clock mechanism 
in these cells. Some of the clock genes {Perl, Cryl, Bmall) and all of the investigated 
clock-related genes (Srebpl, Pparct, Ppary) failed to show rhythmic mRNA 
expression. Nonexistent rhythms in gene expression in 3T3-L1 cells might be 
explained by the fact that an isolated cell system is used, as rhythms could be created 
or influenced by humoral or neuronal inputs to adipocytes. These inputs could either 
be created by other cells in adipose tissue or by other organs.
The 3T3-L1 cell line is well established and widely used in the research into 
adipocyte biology. However, the biology of these adipocytes might not be 
representative. These cells are derived from embryonic fibroblasts rather than from 
multi-potent mesodermal stem cells (Farmer, 2006). They are aneuploid (Green and 
Kehinde, 1975) which could influence their metabolism and alter their responses to 
treatments.
The IMWAT cell line is derived from pre-adipocytes. They behave like primary pre­
adipocytes and were gained by taking a biopsy from the inguinal fat pad of the 
H-2k^-tsA58 mouse (IMMORTO™ mouse) (Morganstein et a l, 2008). The
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IMMORTO™ mouse expresses a mutated temperature sensitive SV40 large T-antigen 
under the control of a major histocompatibility complex class II promoter (Jat et al, 
1991). The IMWAT cell line expresses markers of white fat such as PPARy but no 
markers of BAT. The insulin signalling pathway is intact and the cells express 
cytokines (Morganstein et al, 2008). We therefore predict that the IMWAT cell line 
will be more suitable to use as an in vitro cell model to investigate the endogenous 
clock of adipocytes.
The major physiologieal duty of adipocytes is to store and release FF A. The need of 
the body for energy shows rhythmicity over the 24 h period. The release of FFA into 
the blood stream by adipocytes should therefore also show rhythmicity over the 24 h 
time course. In a final experiment it was investigated if the endogenous adipocyte 
clock gates the release of FFA in IMWAT adipocytes (section 4.6).
Lipolysis can be induced by hormones such as adrenaline, glucagon, growth hormone 
and testosterone. The sympathetic nervous system is able to stimulate lipolysis, 
mainly by noradrenaline. The main lypolitic pathway involves activation of 
p-adrenoceptors. Adipocytes express pi. Pa and adrenoceptors (Carmen and Victor 
2006). Adrenaline and ISO both activate p-adrenoceptors (Robidoux et al. 2004).
The aim of this experiment was to verify and examine the endogenous clock 
mechanism in pre-adipocytes and adipocytes of the IMWAT cell, and to investigate 
an output of this endogenous clock namely lipolysis in mature IMWAT cells.
4.2 H ypothesis
The expression profiles of clock gene and metabolic gene mRNA varies between pre­
adipocytes and differentiated adipocytes. Synchronised IMWAT cells display 
circadian rhythmicity that varies between the differentiated and undifferentiated state. 
Acute stimulation of lipolysis by ISO is gated by the endogenous clock in IMWAT 
adipocytes.
4.3 O bjectives
Objective 1: Provide evidence for an endogenous clock in IMWAT pre-adipocytes 
and mature IMWAT adipocytes
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• Quantify the expression of clock gene mRNA {Perl, Per2, Per3, Cryl, 
Rev-erba, Bmall, Ddp)
• Quantify clock-related metabolic genes mRNA {Ppary, Ppara, Srebpl, Fas, 
RORd)
• Quantify adipokine mRNA {adiponectin, leptin)
Objective 2: Compare the expression of clock genes in pre-adipocytes with the 
expression in adipocytes
® Analyse phasing of the gene expression 
® Compare expression levels in pre-adipocytes and adipocytes
Objective 3: Analyse lipolysis after an acute stimulus over a time course of 24 h
® Differentiate IMWAT preadipocytes into adipocytes
o Run dose response curves to establish the half maximal effective concentration 
(ECso) to trigger lipolysis in IMWAT adipocytes as well as to identify the 
optimal incubation time.
® Run a time course experiment over 36 h to find out if acute stimulation with 
ISO influences lipolysis activity.
4.4 Methods
For molecular analysis, IMWAT pre-adipocytes cells were grown, differentiated and 
serum pulsed. This as well as the western blots of differentiated IMWAT cells was 
carried out by Dr. Ariel Poliandri at Imperial College London. The cell content of a 
well on a 6-well plate was dissolved in 1 ml TRIzol reagent and a cell scraper before 
freezing to -80°C. The cell lysates were transferred to the University of Surrey on dry 
ice. RNAse free MilliQ water (section 2.4.1) and sterile one way plasticware was used 
for all working steps.
4.4.1 RNA extraction and quantification
The RNA was extracted using the TRIzol protocol. It includes a chloroform extraction 
followed by precipitation with isopropanol to purify the RNA. The protocol is detailed 
in section 2.4.2. RNA containing solutions were stored at -80°C. The quantity of RNA
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was determined by measuring the absorbance at 260 / 280 run. The quality of the 
RNA was investigated by electrophoresis (section 2.4.3).
4.4.2 cDNA synthesis
Traces of DNA were removed (section 2.4.4.1) and random primers were used to 
transcribe the extracted RNA into cDNA (section 2.4.4.2).
4.4.3 Semi-quantitative reverse-transcriptase PCR
Primer probe sets have been designed within a single exon to allow the use of 
genomic DNA as a standard. Known standards of genomic DNA were used to 
quantify the synthesised cDNA. The calculation for these standards can be found in 
Appendix F. The protocol for the semi-quantitative qtPCR can be found in section 
2.4.4.B. Assay buffer and DNase treatment controls were included. Standard curves 
needed to be at least 99% of the optimal to be used and all data were normalised with 
the housekeeping genes Gapdh and S18 (section 2.4.4.4). A cosinor wave was fitted to 
the results. Details can be found in section 2.2.T.4.
4.4.4 Cell culture for lipolysis
All cell culture work was carried out in a type 2 laminar flow cabinet and sterile 
techniques and materials were used (section 2.5). Reagents for medium preparation 
are listed in Appendix I. Flasks and plates used to cultivate IMWAT cells needed to 
be coated with 0.01% gelatine (section 2.5.1). Cells were stored in a liquid nitrogen 
cell bank. For each experiment a fresh cryo-vial was used (section 2.5.3). To ensure 
the same passage was used in each experiment. Cells were split at 90% confluence. 
The medium was exchanged every second day.
IMWAT pre-adipocytes were grown to confluence in medium containing IFy at 33°C. 
The medium was exchanged at this point with a medium containing no IFy and the 
culture was transferred to an incubator at 37°C. The medium was exchanged again 
after 24 h and replaced with a medium initiating the differentiation. The medium was 
exchanged after 4 days with a medium to finalise the differentiation (section 2.5.4). 
Differentiation was proven by morphological changes of the cells and staining of the 
lipid droplet with red-oil-0 (section 2.5.4.1).
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4.4.5 Quantification o f lipolysis
Lipolysis was quantified using a spectroscopic assay provided in a kit (section (2.6). 
The released glycerol reacts with a quinoneimine dye to produce 
N-ethytl-N-(3-sulfopropyl)m-anisidine which shows an absorbance maximum at 
540 nm.
4.4.6 Dose response curve
Different concentrations of adrenaline (400 - 0.01 pM) protected from oxidation with 
400 pM ascorbic acid were used to treat the differentiated cells (section 2.6.1). 
Different concentrations of ISO were also used to treat the cells (1 mM -  
10 pM).
4.4.7 Time course experiment
Cells were grown and differentiated as described in section 2.5. The serum pulse and 
the time course experiment was conducted as described in section 2.6.2.
4.5 Results
4.5.1 mRNA extraction from IMWAT cells
Whole mRNA was extracted from the cells grown in one well of a 6 well plate. The 
concentrations of the samples used were between 118.7 and 958.6 ng/pl with an 
average amount of 280 ng/pl. Samples (368 out of 416) were able to be used for the 
analysis. A representative gel of total mRNA extraction is shown in Figure 4.1. The 
subunits of the ribosomes (28S big subunit and 18S small subunit) were visible in 
most of the extractions. The quality of these was sufficient to be used in the analysis. 
The RNA extraction of sample 11.2 in Figure 4.1 failed and could not be used for 
analysis.
4.5.2 Normalisation of the data
As differences in expression could be created by differences in the mRNA extraction 
and cDNA synthesis, clock gene data were normalised to the expression of the 
housekeeping genes Gapdh and SI8.
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Figure 4.1: Total RNA extractions of IMWAT cells with TRIzol. Separated on a 1% agarose gel, 
visualised with ethidium bromide. The ribosomal RNA subunits are the most common RNA species in 
a cell, for this reason they could be visualised. The RNA was of good quality, the subunits o f the 
ribosomes were visible in clear bands.
4.5.2.1 Expression profiles of housekeeping genes
Genes whieh are expressed in a non rhythmie manner ean be used to normalise the 
data for effects of the RNA extraction efficiency and RNA quality. The big subunit of 
the mammalian ribosome (SI8) as well as the citric cycle enzyme {Gapdh) are widely 
used for this purpose. The expression profiles for Gapdh and SI8 in IMWAT cells 
after a serum pulse are shown in Figure 4.2 a and b. Four samples per time point were 
measured in duplicate and analysed (n = 4). The expression profiles did not show 
rhythmicity (shown by a non significant eosinor fit). A significant fit could not be 
applied to pre-adipoeytes and adipocytes of both SI8 and Gapdh (Table 4.1).
4.5.2.2 Decision of housekeeping gene for normalisation
The clock gene expression data were normalised to both housekeeping genes SI 8 and 
Gaphdh (Figure 4.3). Most expression profiles showed a peak in the measurement 1 h 
after the serum pulse. The profiles of Per2, Dbp, Rev-erba and Perl do not show 
much difference between the normalisation with the two different housekeeping 
genes. The profiles of Cryl and Email seem to be spikier in the normalisation with 
Gapdh. These are completely subjective thoughts. Both genes were shown to be valid 
to be used in normalisation, and thus the decision to use SI8 was a subjective one. 
Zovnie et al compared normalisation of some clock genes to different housekeeping 
genes are likewise they could not find significant differences (Zvonic et a l, 2006).
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Figure 4.2: Relative mRNA expression o f the housekeeping genes S18 and Gapdh in IMWAT pre­
adipocytes and adipocytes following a serum pulse, a S I8 b Gapdh. First measurement was normalised 
to 1. Gene expression was measured in duplicate by qtPCR. Data shows mean ± SEM, n = 4 per time 
point, x-axis: time in hours after serum pulse, y-axis: relative mRNA expression. Pre-adipocytes: 
squares and dashed line, adipocytes: circles and solid lines.
Table 4.1: Cosinor analysis o f the housekeeping gene time courses.
variable Cosinor fit P (fit)
pre-adipocytes 0.07
adipocytes 0.06
Gapdh
pre-adipocytes
adipocytes
0.18
0.67
1 1 0
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Figure 4.3: Relative mRNA expression o f the clock genes, normalised with Gaphdh and S18. Data 
show mean ± SEM, n = 4. Pre-adipocytes; squares and dashed line, adipocytes: circles and solid line.
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4.5.3 Detection of mRNA levels of clock genes and metabolic genes in 
IMWAT cells
The clock and metabolic mRNA expression between pre-adipocytes and mature 
adipocytes was analysed. All analysed clock genes except Cryl and all analysed 
metabolic genes showed a significant difference between pre-adipocytes and 
adipocytes (Table 4.2, two-way ANOVA). The mRNA was on average down 
regulated in Per2, Cryl, Rev-erha, Per3 and FAS (fatty acid synthase) in adipocytes 
compared to pre-adipocytes (Figure 4.4). The expression of all other analysed genes 
was unregulated in adipocytes. These mRNA expressions over the time course are 
presented in Figures 4.5 and 4.6. All analysed genes except Cryl in the group of clock 
genes showed a significant effect of the differentiation state (p < 0.05, Table 4.3). An 
interaction between the time and the differentiation state was found in all analysed 
genes except Cryl, PPARydcoA RORa (p < 0.05, Table 4.4).
Pre-adipocytes and adipocytes were de-trended and analysed separately for 
rhythmicity (Figures 4.5 and 4.6). A cosine fit was applied to profiles showing a 
significant effect of time (two-way ANOVA) and a significant value for the cosine fit 
itself. In the detected clock genes the adipocytes detected with Perl and Bmall as 
well as pre-adipocytes and adipocytes detected with Per3 failed to show rhythmic 
expression (Figure 4.5). The profile of the pre-adipocytes detected with FAS was the 
only one in the group of the metabolic genes showing rhythmic expression (Figure 
4.6). The statistical features of the cosine fits are presented in Tables 4.2 and 4.3.
Clock genes part of the negative regulatory arm, Per2 and Cryl, were in a similar 
phase (peak at about 24 h, and nadir at about 12 and 36 h) and in approximate 
antiphase to the genes part of the positive regulatory arm Bmall (peak at about 36 h, 
and nadir at about 24 h). CCGs Dbp and Rev-erba were in the same phase as the 
members of the positive regulatory arm (peak at about 12 h and nadir at about 0 and 
24 h). Rhythmicity was not found in the expression of Perl, but the statistical analysis 
showed a significant effect of time and cell type in both normalisations, and a 
significant interaction of these factors in the normalisation of Perl to SI 8.
The difference in the phase between pre-adipocytes and adipocytes was also 
investigated. The cosine curves of genes which showed rhythmic mRNA expression
1 1 2
in pre-adipocytes as well as in adipocytes were analysed for their phase. The peak 
values of the profiles are shown in Table 4.4. The differenee in phase varied between 
2 h 36 min {Dhp) and 7 h 2 min (Rev-erba), with an average of 4 h 21 min ± 
1 h 14 min (SEM). A statistical difference eould not be found between the genes 
(Figure 4.7). The expression always appeared earlier in adipoeytes than in the pre- 
adipoeytes. The dampening of the fitted eosine waves was also analysed. A pattern in 
the damping factors could not be detected (Table 4.5).
4.5.4 Analysis of adipokine mRNA in adipocytes
The gene expression of leptin and adiponectin rose gradually throughout the 
observation period (Figure 4.8). The data were de-trended to be able to access 
rhythmicity. The expression of the adipokines in IMWAT cells did not show 
rhythmicity, neither one-way ANOVA of the time course nor eosinor fits reached 
statistical significance (Table 4.6).
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Figure 4.4: Percent difference in the average relative gene expression between pre-adipocytes and 
adipocytes in all analysed genes. Positive values show a higher expression in adipocytes than in pre­
adipocytes.
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Figure 4.5: Time courses o f clock gene expression normalised to S18. Data shown as mean ± SEM, 
n = 4. The expression levels in pre-adipocytes and adipocytes are compared in the middle and right 
column. The data were normalised to the percentage o f the maximum in the middle and left columns. 
The data were de-trended and significant cosinor fits applied. Pre-adipocytes: squares and dashed line, 
adipocytes: circles and solid line.
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Table 4.2; Two-way ANOVA and cosinor fitting statistics o f clock gene expression data.
Gene
two - way ANOVA 
Differentiation state 
(raw-data)
P  (diff) P  (interaction) P  (time)
one - way A.NOVA 
pre-adipocytes adipocytes 
P  (fit) f  P  (time) P  (fit) T
Perl 0.21 0.193
Per2 ** 0.362 **** 0.348
0.072 0.168 » *** 0.163 *** *** 0.204
Rev-erba 0.03 *** ** 0.145
Bmall ** *** 0.084 0.077 **** 0.326
Dbp **** 0.455 **** 0.495
Per3 *** ** *** 0.499 - *** no fit
****p < 0.0001, ***p < 0.001. **p < 0.01, *p< 0.05
Table 4.3: Two-way ANOVA and cosinor fitting statistics on metabolic gene expression data.
Gene
two - way ANOVA 
Differentiation state 
(raw-data)
P(diff) P(interaction)
one - way ANOVA
pre-adipocytes adipocytes
2 2 
P(time) P  (fit) f  P(time) P  (fit)
PPARy 0.059 0.377 0.314 - * 0.772
PPARa * ** 0.315 - * no fit
Strebpl ** **** - 0.608
Fas * * * 0.123 * 0.071
Rora ** 0.884 ** 0.788 - 0.752 0.736
****p < 0.0001, ***p < 0.001. **p < 0.01, *p < 0.05
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Table 4.4: Acrophase of the cosine waves fitted to the clock and metabolic gene expression profiles.
Gene
Differentiation
state
Acrophase
[h:min]
Approx. std error 
[min]
Perl pre-adipocytes 23:17 37
Perl pre-adipocytes 00:50 37
adipocytes 22:44 33
CAyy pre-adipocytes 05:35 58
adipocytes 02:58 55
Rev-erha pre-adipocytes 21:48 50
adipocytes 14:46 63
Bmall adipocytes 16:18 40
Dbp pre-adipocytes 22:04 28
adipocytes 17:32 41
Fas pre-adipocytes 07:55 74
C r y  1 D b p  P e r2  R e v -e rb  a
Figure 4.7: Phase difference in hours between adipocytes and preadipocytes. The peak gene expression 
always occurred earlier in adipocytes compared to pre-adipocytes. Data shown as value ± SEM. On 
average peak expression of mRNA of the adipocytes was about 4 h 21 min (± 1 h 14 min, SEM) earlier.
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Table 4.5: Damping factors o f the cosine waves fitted to the gene expression profiles.
Gene Differentiation state Damping Approx. std error
Bmall adipocytes 34 19
Cry; pre-adipocytes 69 106
adipocytes 92 131
Dhp pre-adipocytes 38 13
adipocytes 1.75e''' 3.68e^^
Fas pre-adipocytes 2.24e'*' 1.45e^ ^
Perl pre-adipocytes 22 8
Perl pre-adipocytes 45 22
adipocytes 43 23
Rev-erba pre-adipocytes 8.52e'* 1.35e^^
adipocytes 2.83e* 2710
Big numbers in the dampening factor means no dampening at all.
Table 4.6: Cosinor fitting statistics on adiponectin and leptin time course expression data.
Cosinor fit adipocytes
P (fit)
leptin 0.6966
adiponectin 0.7320
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Figure 4.8: Time course of the relative mRNA expression o f the adipokines leptin and adiponectin in 
IMWAT adipocytes. The left column shows the relative gene expression raw data. The right column 
shows the time course normalised to the percentage of the maximum and de-trended. One-way 
ANOVA revealed a significant effect o f time for both o f the investigated adipokines. Data shown as 
mean ± SEM, n = 4.
4.5.5 Clock protein western blots
Proteins are a key component of the current model of the molecular oscillator. It is 
therefore important to investigate whether the rhythmicity in the mRNA described in 
section 1.2.2, also occurs at the protein level. Western blots to detect rhythmicity in 
the protein amount of FAS and the REV-ERB a  protein were carried out by Dr Ariel 
Poliandri (Imperial College London).
Two independent experiments were conducted with 3 or 2 western blots, respectively. 
Figure 4.9 shows representative western blots of FAS and REV-ERBa. The intensity 
of the signal was weak around 18 h after the serum pulse in both analysed proteins. 
The ACTIN signal showed that the gel was loaded equally. The density of the bands 
was converted into values by our co-workers at Imperial College. The gained data
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were normalised with the activity of the ACTIN band to erase differences in the 
protein load. A significant cosinor wave could be fitted through the data (Figure 4.10).
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4.5.6 Comparison between protein and mRNA rhythm
The t?ev-erhamRNA expression as well as the REV-ERBa protein expression profile 
of IMWAT adipocytes showed rhythmicity. The phase difference between the mRNA 
and the protein in the detection of Rev-erba / REV-ERBa was 19 hours (Figure 
4.11a). The detection of Fas (Figure 4.11b) mRNA in adipocytes did not show
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rhythmicity. A comparison between the rhythmic FAS protein expression and Fas 
mRNA was therefore not possible.
5 0 - 5 0 -0) Q.
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G) Q .
—1------------1—
4 2  4 8 6  1 2  1 8  2 4  3 0  3 6  4 2  4 8
T im e a fter  seru m  p u lse  [h]
Figure 4.11: Comparison between the phase of mRNA and protein expression o f a Rev-erba and b 
Fas. The phase peaks are indicated by dashed lines. Data shown as mean ± SEM. mRNA; triangles and 
dashed line; protein: circles and solid line.
4.6 A nalysis o f  lipolysis over a tim e course
4.6.1 Differentiation of IMWAT pre-adipoeytes
The differentiation process from IMWAT pre-adipocytes to mature adipocytes was 
investigated over the differentiation period of 10 days. The shape of the cells changed 
from long slim fibroblast like cells (Figure 4.12 day 4) to spherical round cells (Figure 
4.12, day 5). The number of TG vacuoles increased from day 5 of the differentiation 
onwards (Figure 4.12, day 5 — 9). The identity of the vacuoles as TG storage sites was 
verified by staining with oil-red-0 (Figure 4.12, second row). Many cells possessed 
the characteristic large TG droplets of mature adipocytes (Figure 4.12, days 8 and 9).
4.6.2 Dose response curve
4.6.2.1 Adrenaline and ascorbie acid
Adrenaline stabilised by ascorbic acid was used to induce lipolysis in the mature 
IMWAT adipocytes. Adrenaline was protected against oxidation by ascorbic acid. 
Adrenaline was used because it is able to induce lipolysis under physiological 
conditions. Incubation of the cells with adrenaline did not induce lipolysis.
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Quick d iffe ren tia tion  m edium D iffe ren tia tion  m edium
Figure 4.12: Differentiation of IMWAT pre-adipocytes to adipocytes over a time course o f 9 days. 
First row: morphology. Second row: triglyceride accumulation stained with oil-red-0 (red).
4.6.2.2 Isoproterenol
ISO shares most of its atomic structure as well as the active site with adrenaline. ISO 
does not get oxidised. Dose response curves between the concentrations of 10 pM and 
I mM were constructed with incubation times of one and two hours (Figure 4.13).
The amount of glycerol released by the adipocytes and detected increased with the 
longer incubation time. The calculated EC50 value for an one h incubation was 
23 pM (Figure 4.13 a) and for a two h incubation was 6 8 pM (Figure 4.13 b). For the 
one h incubation 17 wells of cells were treated and for the two h incubation 8  wells 
were treated in different experiments.
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Figure 4.13: Dose response curves with isoproterenol with incubation times of a 1 h and b 2 h. All 
cells used were passage 19.
122
4.6.3 Time course experiment
The first 24 h time course was conducted using 50 nM ISO and an incubation time of 
1 h. Samples were taken every two h. Glycerol changes of about 4 pM were evident, 
but a statistically significant rhythm could not be detected (Figure 4.14a). Additional 
cells were grown in the wells of a 6 well plate to analyse the expression levels of the 
clock genes Dbp, Perl and Bmall at 8, 24 and 32 h after the serum pulse (Figure 
4.14b). The trend in the appearance of the analysed clock genes was the same as 
found earlier for those times after the serum pulse and shown the highest 
concentrations of Dbp and Perl 24 h after the serum pulse and the smallest amounts 
of Bmall at this time. The changes in the amounts of clock gene mRNA present were 
on average 16.2% smaller compared to the serum pulse conducted at Imperial College 
(Table 4.7). The cells were kept in a serum free medium for 48 h before the serum 
pulse at Imperial College and in the time course experiments conducted.
The influence of the cultivation in serum free medium on the health and lipolysis of 
the cells was investigated. The cells decreased the amount of released glycerol and 
therefore FFA by half after the cultivation period in serum free medium (Figure 
4.14c). The cells were treated with ISO concentrations from 1 pM - 10 pM, and the 1 
pM treatment showed the best results. The lipolysis of these cells was investigated at 
3, 6, 11, 27 and 32 h after the serum pulse (Figure 4.14d). The amount of glycerol 
detected increased in the first three measurements from nearly no glycerol at 3 h after 
the serum pulse up to 8.4 pM. The amounts measured 27 and 32 h after the serum 
pulse showed decreased lipolysis. The serum pulse was not confirmed by mRNA 
quantification for those cells. A final time course experiment was conducted 
measuring the lipolysis after treatment with 1 pM ISO in serum pulsed and in serum 
free medium cultivated cells every 4 h after the serum pulse. The amounts of glycerol 
detected varied within 3 pM over the time course of 32 h (Figure 4.14e). The amount 
of glycerol released increased in the time between 4 and 8 h after the serum pulse, 
showed a dip at 12 h and increased afterwards and stayed at about the same amount 
until 32 h where a decreased amount of glycerol was measured. The serum pulse was 
shown to have worked. This was analysed by mRNA extraction followed by 
quantification of the clock gene Dbp. The trend was the same as shown previously in 
an earlier lipolysis experiment (Figure 4.14b), as well as earlier in the qtPCR results
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of the serum pulse pre-adipoeyte and adipocyte IMWAT cells (section 4.5.3). The 
cosinor wave fitted onto the glycerol values did not reach statistically significance 
(F = 2.85, p = 0.2762, cosinor fit). The amplitude in the gene expression between the 
investigated time points is smaller in the time course which was not kept in serum free 
medium for 48 h before the serum pulse. The expression of Bmall is 10% smaller at 
24 h, the expression of Dbp is 27% reduced at 8 h and 16% reduced at 32 h and the 
expression of Per2 is reduced by 20% at 8 h and 8% at 32 h.
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Figure 4.14: Lipolysis time course experiments. ISO was incubated for I h in all experiments. All cells 
used were passage 19. Mean ± SEM are shown. Dhp: square and solid line, Bmall: circles and dashed 
line, Per2: triangles and dotted line, a 50nM ISO, n=6. Cells were not cultivated in serum free medium 
before serum pulse, b mRNA extraction of a, n=4 Bmall: cycles dashed line; Dpb: squares and solid 
line; Per2: triangles and dotted line c Detection o f lipolysis before and after cultivation in serum free 
medium, I pM ISO was used, n = 3 d detection o f glycerol after a serum pulse e Detection o f glycerol 
over a time course, I pM ISO, n = 8. f  Dbp mRNA extraction of the time course shown in e, n = 3.
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4.7 Discussion
There is currently no published literature available about mRNA expression in 
IMWAT cells because the cell line was only established recently (Morganstein et al, 
2008). However, mRNA profiles of the clock genes have been carried out by other 
laboratories in other models. Adipose-derived stem cells (Wu et a l, 2007), human 
adipose tissue from subcutaneous and visceral depots (Gomez-Santos et a l, 2009, 
Gomez-Abelian et a l, 2010), mouse peripheral adipose tissue (Ando et a l, 2005), 
different adipose tissues of the mouse (Zvonic et a l, 2006) and murine 3T3-L1 cells 
(Otway et a l, 2009) have been analysed. All these studies have found more or less 
distinctive changes in the expression profiles of adipocytes compared to the controls. 
These changes have involved the amplitude or the phasing of the genes.
4.7.1 Differences in gene expression between pre-adipocytes and 
adipocytes
When pre-adipocytes differentiate into mature adipocytes they develop new functions 
which they need as mature adipocytes and loose other functions which they do not 
need to possess any longer. This change is also visible in gene expression. The 
receptors PPARa (Brun et al., 1996), PPARy (Chawla et al., 1994) and RORa (Austin 
et al., 1998) have been shown previously to be up-regulated in mature adipocytes. It 
has been shown that insulin and glucose are able to increase Strepbl mRNA 
expression in adipocytes (Kim et ah, 1998, Hasty et al., 2000). High insulin and high 
plasma glucose levels are known to support adipogenesis. The FAS protein plays a 
central role in the synthesis of FF As from acetyl-CoA. The majority of the de novo 
synthesis of FFA in which FAS plays a major role is conducted in the cytosol of 
hepatocytes. Other cells besides hepatocytes were also found to express FAS 
(Kusakabe et ah, 2000). It has been shown that 3T3-L1 pre-adipocytes are not able to 
differentiate without functional FAS. Furthermore an increase in adipocytes compared 
to pre-adipocytes was reported in the differentiation of 3T3-L1 adipocytes (Moustaid 
and Sul, 1991). In the current study the expression of Rev-erba was slightly reduced 
in the adipocytes compared to pre-adipocytes. This finding is in contrast to the 
literature (Laitinen et al., 2005). Bmall was increased in adipocytes compared to pre­
adipocytes, which has been described in the literature previously (Shimba et al., 
2005). It has been shown that PER2 directly and specifically represses PPARy a
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receptor important in the differentiation process (Grimaldi et a l, 2010). The 
expression levels of Perl a core clock gene was down regulated in adipocytes 
compared to pre-adipocytes. Perl and Dbp have shown reduced expression in 
adipocytes compared to pre-adipocytes in human subcutaneous adipose tissue (Wu et 
a/., 2007).
Rhythmicity in gene expression was detected in the Peri and Fas pre-adipocytes but 
not in the adipocytes. On the other hand rhythmicity has been only found in the Bmall 
adipocytes but not in the pre-adipocytes. Rhythmic mRNA expression was detected in 
murine WAT samples previously (Ando et a l, 2005, Zvonic et a l, 2006, Bray and 
Young, 2007) for Perl, Cryl and Bmall. Perl failed to show a rhythmic profile in 
another study with human and murine mesenchymal stem cells (Huang et al, 2009).
Since rhythmic expression could be detected in Bmall adipocytes but not in Bmall 
pre-adipocytes in my experiments, the hypothesis that adipocytes are less sensitive to 
the serum shock therefore cannot be supported (Ando et al., 2005, Kohsaka et al., 
2007, Otway et al., 2009).
A rhythm would not be detectable, if the molecular clock of the cells become 
desynchronised to each other. Our synchronisation protocol was validated by the 
rhythms detected in the other genes. Perl and Bmall are both core clock genes and 
the core clock oscillator would be influenced by their malfunction. The fact that the 
Cryl gene, a direct partner of Perl in the molecular oscillator, was expressed in a 
rhythmic manner and the observed rhythmic expression of CCGs like Rev-erba and 
Dbp in both pre-adipocytes and adipocytes suggest a functional core clock loop.
The FAS rhythm detected in the pre-adipocytes but not in the adipocytes could mean 
that the influence of the endogenous clock of the pre-adipocytes is strong enough to 
create rhythmic expression, whereas the clock in adipocytes is not. This would 
support the hypothesis that enhanced TG content influences the clock mechanism 
(Ando et al., 2005, Kohsaka et al., 2007, Otway et al., 2009).
Analysis of the phase of gene expression in which the detections in pre-adipocytes as 
well as adipocytes showed a significant rhythm revealed an advance in phase in the 
adipocytes compared to the pre-adipocytes. The serum shock used to synchronise the
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cells was the same for both cell types. The synchronisation of endogenous clocks in 
the cells with a serum shock works on the basis that substances in the serum pulse 
medium are able to bind to the promoter and therefore trigger the expression of clock 
genes (Balsalobre et a l, 1998). The results show that the highest level of gene 
expression was reached about 4 h earlier in adipocytes than in pre-adipocytes. This 
means that the ligand reaches the promoter earlier in adipocytes, or that the expression 
is faster in adipocytes than in pre-adipocytes. This could be due to the availability of 
co-factors or suppressor proteins. It seems that the response of adipocytes was not just 
shifted compared to the pre-adipocytes but also that different metabolic pathways 
were influenced with different impact. Even a small change in the phase of gene 
expression could mean a change in the amount of gene present at a certain time 
influencing downstream functions.
The SCN synchronises the clocks of peripheral tissues (Zylka et al, 1998b, Field et 
al, 2000, Lee et al, 2001) (section 1.2.2.1). The rhythmic output signals of the 
molecular oscillators are synchronised to each other by serum pulse. Analysis of the 
cosinor fit showed that the rhythmicity was not lost any quicker in adipocytes 
compared to pre-adipocytes. This suggests that the clock mechanism is not less stable 
in adipocytes compared to pre-adipocytes.
The molecular oscillator is able to work properly without Per3 (Zheng et a l, 2001). 
The detection of Per3 was found not to be rhythmic. Rhythmic expression of Per3 has 
been detected in leucocytes from human blood (Archer et a l, 2008).
The reason rhythmic expression could not be detected in any of the CCGs and Per3 
could at least partly be due to humoral and neuronal inputs from the SCN and other 
organs that are missing in a cell culture model. These endogenous signals could 
stabilise, or enhance rhythmic expression. Rhythmicity can also be produced by post- 
translational modification of the mRNA or degradation in a rhythmic manner.
4.7.2 Adipokines
Rhythmic plasma leptin and adiponectin levels have been reported in humans as well 
as in rodents (Sinha et a l, 1996b, Kalsbeek et a l, 2001, Gavrila et al., 2003, Spiegel 
et al, 2004, Shea et al, 2005). The leptin but not the adiponectin concentration in the
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culture medium of 3T3-L1 adipocytes was found to be rhythmic (Otway et a l, 2009). 
Neither, the mRNA expression of leptin nor adiponectin was found to be rhythmic in 
the same study. Many endogenous factors such as feeding and wake time influence 
the rhythmic plasma concentrations of leptin (Shea et al, 2005). It is therefore 
possible that the signal of the endogenous clock alone is not sufficient, or it could be 
that rhythmicity is introduced to the system after mRNA transcription (section 4.6.3). 
The detected leptin mRNA and plasma profiles were found to rise during the 24 h 
detection period. This might denote that the cells were still differentiating because 
pre-adipocytes do not express leptin or adiponectin.
4.7.3 Correlation between mRNA and leptin protein
Our co-workers at Imperial College London managed to quantify REV-ERBa and 
FAS in a 52 h time course of IMWAT cell extractions. The cosinor fits of both 
proteins showed statistical significance, but only Rev-erba mRNA in adipocytes 
showed a significant cosine fit. The phases of the mRNA and protein could therefore 
only be analysed for Rev-erba. The mRNA peak was 19 h before the peak in protein 
concentration. The time of 19 h for transcription of mRNA into protein would make it 
impossible for the cell to react to an actual event. Lee and co-workers (2001) found a 
phase difference between mRNA and protein of about 6 h for PERI and PER2. On the 
other hand, some mRNA molecules are processed and modified intensively before 
they get translated into proteins. The experiment should be repeated by conducting the 
serum pulse at the same time on the cells used for the protein and mRNA detection to 
confirm the present findings.
It was (Reddy et a l, 2006) who shown that rhythmic mRNA expression and protein 
abundance do not necessarily match up. Rhythmicity at the protein level could be 
introduced by controlled translation or by degeneration or silencing of the mRNA. 
The liver proteome has provided evidence that protein rhythms do not necessary 
reflect temporal mRNA expression (Reddy et a l, 2006).
4.7.4 Lipolysis
Differentiation was controlled by investigation of the morphical changes of the cells. 
Only mature adipocytes are able to perform lipolysis; therefore the cells should be
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differentiated to show a signal in a lipolysis assay. Molecular markers can be used to 
detect the differentiation state such as GLUT-4 (Bimbaum 1989), PPARy (Gumell, 
2005) and leptin (Klok et al, 2007).
Diurnal variations in the sensivity to adrenaline-induced lipolysis have been shown in 
experiments on epididymal fat explants from rats (Suzuki et al, 1983). Adipose 
lipolysis has been reported to decrease in the afternoon in healthy as well as in TIDM 
and increases at night (Frayn et a l, 1996, Hagstrom-Toft et al, 1997). The release of 
FFA from adipocytes started earlier in the evening in TIDM patients than in the 
control group.
Adrenaline is a physiological trigger of lipolysis, but it gets oxidised and therefore 
inactivated very quickly. Attempts to protect adrenaline from oxidation by addition of 
ascorbic acid failed. ISO, an artificial homologue of adrenaline, was thus used to 
trigger lipolysis.
The amount of glycerol detected after the incubation period was dependent on the 
amount of cells and their differentiation state in my experiments. How well cells have 
been synchronised to each other influences the possibility to detect a rhythm. This 
was shown in my experiment by the fact that the amplitudes of the time course kept in 
serum free medium for 48 h (4.9 pM) before the serum pulse were higher than in cells 
which were not kept in serum free medium.
The first time course was conducted using a 50 nM ISO solution to trigger lipolysis. 
This ISO concentration resulted from the dose response experiments where the cells 
were not cultivated in serum free medium for 48 h before the time course. The second 
time course experiment was conducted with different concentrations of ISO, as it was 
not clear how the cells would cope with 48 h without serum. The results showed that 
the amount of glycerol released by the cells was reduced after 48 h in serum free 
medium. The solution with 1 pM ISO showed the best results. The fact that changes 
in glycerol concentration were detected and the fact that 1 pM ISO is just at the upper 
end of the dose response curve validates its future use.
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The differences in the amount of glycerol detected over the time course are in the pM 
range. The low glycerol standards with 12.5 pM, 6.25 pM and 3.125 pM are easy to 
distinguish in the assay.
Lipolysis was reduced during the time the cells spent in serum free medium. This was 
understandable as during a starvation period the release of glycerol does not help the 
cell to survive. The two measurements 3 and 6 h after the serum pulse did not show 
increased lipolysis in the second, but quite high values in the third time course 
experiment. It has been shown in the literature that DEX promotes lipolysis by 
increasing HSL mRNA levels (Slavin et a l, 1994) and removal of G;. The serum 
pulse was conducted with 50% horse serum in medium. DEX is a synthetic 
glucocorticoid an under natural conditions not present in horse serum, but it cannot be 
excluded that glucocorticoids in the horse serum have the same effects. DEX also 
impairs insulin signalling via insulin-like receptor substrate (IRS-1). There are also 
other studies which showed that acute incubation of adipocytes with serum can be 
lipolytic (Curtis-Prior, 1973, Rumberger et a l, 2004).
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Chapter 5: Clock protein quantification
in murine tissue
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5.1 Introduction
The best characterised model of the molecular clock mechanism consists of a 
transcriptional-translational feedback loop (section 1.2.2). The proteins directly 
involved in this mechanism are called clock proteins (section 1.2.2). Translation of 
mRNA into proteins at the ribosomes is highly regulated, and mRNA can be modified 
to delay or prevent translation completely. These processes are, at least partly, 
controlled by the endogenous clock (Reddy et al, 2006). The detection of rhythmicity 
in clock proteins in extractions from adipocyte cell lines will help to prove the 
existence of a functional clock mechanism in adipocytes.
Different antibodies have been used in the literature to detect core clock genes in 
extractions from different cells and tissues (Field et al, 2000, Chilov et a l, 2001, Lee 
et al, 2001, Liu et al, 2005, Bendovâ and Sumovâ, 2006, Garcia-Femândez et a l, 
2007, Maronde et a l, 2007). The molecular weight of the clock proteins changes 
between antibodies used and tissue or cell type analysed. There are even differences 
in the molecular weights detected between the nuclear and the cytosolic fraction of a 
cell (Table 5.1). The molecular weight of the protein detection is not mentioned in all 
cases. Post-transcriptional modifications, tissue specific isoforms and tissue specific 
differences might be the reason for the detections of proteins of different molecular 
weights.
To my knowledge the abundance of clock proteins has not been investigated in WAT 
or adipocytes. The ability to detect clock proteins in adipose tissue would help to 
bring new insights on the influence of obesity and T2DM on adipocyte biology.
As core clock proteins were detected in protein extractions of murine liver and kidney 
tissue (Lee et al, 2001), those tissues were used to establish the western blot method 
with the different antibodies. Immunising peptides and tissue from knock-out mice 
will be used to support the finding of a specific antibody reaction.
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Table 5.1: Detection of clock proteins in different tissues and cell compartments.
Reference Antibody used (and 
so u r c e )
Detected in Size
Maronde et al, BMALl Hamster liver Not mentioned
2007
Field et al,
PERI (Santa Cruz) 
mPERl (Hastings et a/.. Mouse SCN and cortical double band -140
2000 1999) tissue kDa
Lee et al, 2001
mPER21 -A (aDiagnostics) 
mPER31-A (aDiagnostics) 
mPERl (homemade) Mouse liver
-135 kDa 
-120 kDa 
Not mentioned
Chilov et al.
mPER2 (homemade) 
BMALl (homemade) 
mPERl-N (Affinity HEK 293 cells (N) 55 kDa
2001 BioReagents) Only in transfected HEK 140, 75 kDa
mPERl-C (Affinity
293 cells
Rat-1 fibroblasts (N) 
Swiss3T3; N2A cells (N) 
Nuclear brain 
Nuclear Liver 
Nuclear kidney 
Nuclear spleen 
Whole brain 
Rat-1
140 kDa 
45 kDa
Double band 48 kDa 
-45-48 and 55 kDa 
-45-48 and 55 kDa 
140 kDa 
-110 kDa 
200 kDa
BioReagents) Swiss 3T3; N2A cells -150 kDa
Bendovâ and PERl-N, PER2-N
(C) PERI over 
expression 
Whole brain
Hearts, liver
Double band 140 
kDa
55-60 kDa
Sumovâ, 2006 (Santa Cruz) Lung (N) Double band 60 and
Liu et al, 2005 mPERl (Hastings et al., 1999)
Lung (C) 
Whole brain
70 kDa 
60 kDa
Not mentioned
Garcîa- N-PERl (N-20, Santa Cmz) Mouse retina 75, 110 kDa
Fernândez et Mouse brain 140, 110, 75 kDa
a/., 2007
Koyanagi et al. mPLRl 1-A (aDiagnostics) HEPG2 (N) Not mentioned
2006
Liu et al, 2007 mPERll-A(aDiagnost',c3 Mouse brain Not mentioned
Nishii et al. I^ER21-A («Diagnostics) Rati cells Not mentioned
2006
Nuesslein- mPER21-A («Diagnostics) Hamster brain -120 kDa
Hildesheim et 
6/7, 2000
Highlighted antibodies were used in this thesis. N = nuclear, C= cytosolic.
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5.2 Hypothesis
The work described in this chapter was designed to test the following hypothesises 1.) 
The expression profiles of the proteins involved in the core loop of the cellular clocks 
are detectable via the western blot method in murine adipose tissue. 2.) Tissues of 
different metabolic states show a difference in the amount of protein expression. 3.) 
The amount of clock proteins oscillates in a diurnal manner.
5.3 Objectives
Objective 1: Establish a western blot protocol to detect core clock proteins in 
extractions from murine tissues.
And primarily in WAT and adipocytes:
Objective 2: Quantify protein and analyse differences in phasing between protein 
extractions from lean and obese mice together with mice showing symptoms of 
metabolic syndrome.
Objective 3: Investigate differences in the phasing between gene and protein 
expression.
Objective 2 could not be met because Objective 1 could not be completed successful. 
Objective 3 could only be met for REV-ERBa by the use of protein data from 
Imperial Collage London.
5.4 Methods
Protein solutions were always kept on ice to reduce degeneration and extraction 
buffers were always supplemented with a broad spectrum protease inhibitor. Protein 
solutions stored at -80°C always contained 20% of glycerol and samples were only 
thawed once before they were used.
5.4.1 Tissues and cell lines used
Mouse tissues from male wild-type (C57B1/6J) and male Per3'^ ' mice were used 
(section 2.3.2). Unpulsed 3T3-L1 pre-adipocytes, fibroblasts, hepatocytes (Hep G2 
and HUH-7) and muscle cells (RD) were used as positive controls (section 2.3.3).
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5.4.2 Protein extraction
Different methods were used to extract proteins; these included TRIzol, Tris-buffered 
saline with SDS, homemade extraction buffer, T-Per, glycerol containing extraction 
buffer, sonification and mechanical grinding (section 2.7.3). Extraction with T-Per 
buffer and sonification was used for the presented western hlots.
5.4.3 Total protein quantification
Proteins in solutions were quantified by comparison with a known standard curve of 
BSA (section 2.7.4).
5.4.4 Separation by molecular weight and transfer of proteins to a 
membrane
Proteins can either be applied directly onto the membrane as in a dot blot 
(section 2.7.5) or after separation by molecular weight in a polyacrylamide gel 
electrophoresis (section 2.7.6). Proteins in a polyacrylamide gel can be visualised by 
staining (section 2.7.8.1). Proteins can be transferred from a polyacrylamide gel onto 
a membrane by different methods. Semi dry blot (section 2.7.7.1) and wet blot 
(section 2.1.12) were tested with the result to use the wet blot method.
5.4.5 Protein visualisation
An aqueous solution of Ponceau S was used to stain proteins unspecific on a 
membrane (section 2.7.8.2). Antibodies were used to visualise specific proteins on 
membranes. Primary antibodies need to be specific for the protein of interest. Primary 
antibodies are bound by secondary antibodies which are specific against antibodies of 
the species in which the primary antibody was raised. Secondary antibodies are tagged 
with a protein or enzyme which allows them to be detected.
5.4.6 Pre-adsorption
Primary antibodies should be specific for the protein that they have been raised 
against. Specific antibodies should bind to the immunising peptide. This means all 
specific antibodies should bind to this immunising peptide, and not be able to bind to
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other epitopes on the membrane. The specific band is not visible on a membrane 
incubated with these antibodies, but all the unspecific bands should be visible.
5.5 R esults
5.5.1 Comparison of protein extraction methods
The extraction with TRIzol and mechanical grinding with a micropestel to open up the 
cell membrane yielded about 70 pg protein per -50 mg of murine liver tissue. More 
direct extraction methods with mechanical grinding yielded protein amounts around 
150 pg per -50 mg of tissue. Mechanical grinding was then replaced by sonication 
which increased the yielded amount of protein to about 200 pg/ -50 mg tissue. The 
pattern of proteins, as viewed on a stained gel or stained on a membrane did not 
visibly differ between the mechanical grinding and sonication (data not shown). An 
obvious visual difference could also not be detected in the protein pattern on a 
polyacrylamide gel or on the membrane between the extractions with the commercial 
T-Per buffer (25 mM bicine pH 7.6) and homemade extraction buffer (20 mM Tris 
Base pH 8) (data not shown).
5.5.2 Transfer of proteins onto a membrane
Staining of the gel with Code blue safe (Thermos Scientific) showed that the first 
attempts to transfer proteins with the semi dry blotting machine (40 V for 90 min) 
were not successful and proteins of all molecular weights were left in the gel. 
Therefore the voltage and blotting time (70 V for 240 min) was increased. This 
change did not yield a complete transfer of the proteins from the gel onto the 
membrane. Proteins were still left in the gel, especially at high molecular weights 
(data not shown). To achieve a complete transfer of proteins, a wet blotting system 
was used. Nearly all proteins were transferred to the membrane (120 V, 60 min) on 
the first attempt. Some of the proteins with molecular weight over 100 kDa were left 
in the gel (revealed with GelCode Blue SafeProtein stain, data not shown). Because 
protein transfer time is proportionally linked to protein size the transfer time was 
increased. After extending the transfer time to 90 min proteins of all molecular 
weights were successfully transferred to the membrane. All future western blots were 
thus transferred by wet blot.
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5.5.3 Optimisation of antibody concentrations
Dot blot experiments were conducted to find the most efficient concentrations of the 
antibodies. The antibody against murine mPERl showed usable signal with a dilution 
of 1:2000 for kidney and liver. The antibody against mPER2 showed a usable result at 
a dilution of 1:2000 for both kidney and liver. A dilution of 1:2000 was found for the 
antibody against mPER3 in kidney, and 1:1000 for liver tissue (Figure 5.1).
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Figure 5.1: Dot blots with PERI, 2 and 3 antibodies, a. PERI (PERU-A) b. PER2 (PER2I-A) c. 
PER3 (PER31-A). Murine liver and kidney tissue was extracted with T-Per. The dilutions o f the 
antibodies ranged from 1:500 up to 1:2000. The membranes were stained with Ponceau S. Each matrix 
contains the proteins of a single extraction from murine liver and kidney tissue. The amounts o f protein 
loaded are 2.5; 5; 10 and 20 pg protein (y-axis). The different ZT times 0, 4, 8, 12, 16 and 20 are 
shown on the x-axis o f each blot.
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5.5.4 PERIODl
The full length murine PERI protein consists of 1291 amino acids and the molecular 
weight of the protein is 136 kDa (Tei et a l, 1997). In order to find out how the PERI 
antibody performs on a western blot, different conditions have been investigated. 
Murine liver extractions (ZT 4, ZT 16) were separated on a gel. The separated 
proteins were then transferred onto a membrane. The membrane was cut into two 
halves and treated in different ways (Figure 5.2 1). Membrane 5.2 la was treated with 
0.2% Tween20 in the TEST wash buffer, and failed to show any signal. The other half 
was treated with 0.05% Tween20 in the TEST and showed lots of unspecific binding 
(Figure 5.2 lb). A dominant signal was detected at about 45 kDa (Figure 5.2 lb). On 
the basis of the protocol used in the half of the western blot in Figure 5.2 lb, different 
conditions in antibody concentration, blocking time and washing steps were tested 
(Figure 5.2 2). The band at around 45 kDa was detected in Figure 5.2 2a as well as in 
the detections with increased blocking time and reduced primary antibody 
concentration (Figure 5.2 2b and 2c). The band at 45 kDa could not be detected with a 
reduced concentration of the secondary antibody (Figure 5.2 2d), or with twice the 
amount of washes (Figure 5.2 2e). Figure 5.2 3 shows incubations with different 
primary antibody concentrations. The 1:2500 dilution lead to the strongest signal, with 
a band around 45 kDa.
The extraction of proteins with homemade and T-Per buffer is compared in Figure 
5.3a. Lots of signal bands and more protein were detected in the lanes of ZT 0 
compared to the ZT 12 lanes (Figure 5.3a). The band at around 45 kDa was detected 
as well as other bands as a strong band in the ZT 0 lanes and as a weak band in the 
ZT 12 lanes. This band at around 45 kDa had been detected before (Figure 5.2a and 
b). There was also a very weak signal at around 140 kDa in lanes of ZT 0 
(Figure 5.3a).
Figure 5.3b show a pre-adsorption experiment. Figure 5.3bl shows the not 
pre-adsorbed western blot. The primary antibody was pre-adsorbed in (Figure 5.3b2). 
The secondary antibody was incubated with the immunising peptide of the primary 
antibody (Figure 5.3b3). All three detections show many signals of different 
molecular weight. A specific band was not pre-adsorbed. The pre-adsorption profiles 
extracted with T-Per or homemade buffer did not look different visually.
138
2 1 0 k D a  —  2 1 0 k D a — I
110 kD a —  ^  110 kD a
80 k D a —  *  M  80 k D a — |
47  k D a —  #  47  kD a
ZT  4 4 4 16 16 4 4 4 16 16 ZT  4 16 4 16 4 16 4 16 4 16
M9 5 10 15 5 10 5 10 15 5 10
2 1 0 k D a  —
110 kD a — ,
80 kD a —  •
47  kD a —  9,*. «W,
ZT  4 16 4 16 4  16
D ilu tion  1°ab 1 :2 5 0 0  1 :5000  1 :7500
Figure 5.2: Detection of murine PERI at ZT 4 and ZT 16. Deteetion in murine liver, extracted with 
TBS and TEST. Detection with ECL. PERI 1-A was used, la  Blocking 4% milk (0.2% TEST), 1 h 
incubation with PERI 1-A 1:5000, 2° ab (1:5000), exposure time 10 min. lb  like la  expect 0.05% 
TEST. Only lb  showed a band. Exposure time 10 min. 2 Different treatments: a l°ab (1:5000) in 
TEST (.05%) 1 h, 2°ab (1:10000) in TEST (.05%) 1 h, 3 times washes for 10 min TEST 0.05%. b 
similar to a but blocking overnight, c similar to a except l°ab 1:10000. d like a except 2°ab 1:40000. e 
like a but twice as many washes, a and b showed the best result. Exposure time 5 min. 3 treatments 
with different concentrations of primary antibody 1:2500; 1:5000; 1:7500. Secondary antibody 
(1:100000 in TEST (0.05%), three times 5 min wash. 1:2500 shows the best results. Exposure time 20 
min.
5.5.5 PERIOD2
The full length PER2 protein consists of about -130 kDa and is predicted to run at 
136 kDa (Shearman et al, 1997). In order to detect the PER2 protein with the mouse 
antibody a concentration of 1:2000 in blocking buffer (5% milk powder in TEST), as 
recommended by the supplier, was used. The methods of mechanical grinding and 
sonication to open the cell membranes were compared. The pattern of the detected 
proteins was different between the methods (Figure 5.4a). The ground ZT 4 lane 
showed a strong signal at about 43 kDa, whilst the sonicated ZT 4 lane showed a 
weaker signal. The differenee was even more visible in the ZT 16 lanes. The ground
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extraction showed two strong signals at around 23 kDa and 34 kDa. These signals 
were completely absent in the sonifieation extraction. Extraction with different buffers 
did not alter protein deteeted by the PER2 antibody (Figure 5.4b). There was no 
difference in the pattern gained by tissue whieh was extracted with homemade or T- 
Per buffer. To ensure we did not miss the time point where the PER2 protein was 
expressed in the cells, a gel with the cell extract of unsynchronised 3T3 cells was run 
(Figure 5.4e). In the lane of the 3T3 cell extract, the PER2 antibody bound to many 
proteins of different sizes compared to the lanes loaded with liver extract (ZT 16) or 
adipose tissue extract (ZT 16) (Figure 5.4c). In the lane of the adipose extract a strong 
band was visible at about 37 kDa.
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Figure 5.3: Optimisation o f PERI detection in extractions with homemade and T-Per buffer. PERI 1-A 
was used as primary antibody. Murine liver extracts from the time points ZT 0 and ZT 12 were used, a 
Blocking 4% milk in TEST (0.05%) incubation 1 h. 1, homemade buffer, 2, T-Per buffer. l°ab PERI 1- 
A a ran tibody  (ab) 1:2000, 2°ab 1:10000, washing 3 times 10 min TEST 0.05%. A weak band is 
visible at 140 kDa at ZT 0. Exposure time 5 min. b l preadsorption l°ab 1:2500, 2°ab 1:5000, washing 
3 times 10 min TEST 0.05%, 1:2500 control peptide PER-11-P 1:2500 bl pure 1° and 2°ab was used. 
b2 the specific antibodies in the l°ab were pre-adsorbed. b3 the specific antibodies in the 2°ab were 
pre-adsorbed with the immunising peptide, b l Two strong bands were visible at ZT 0 but not at ZT 12. 
The identity o f these bands was guaranteed by blockage of the bands in the other two thirds o f the 
membrane. There was also no cross reaction between the 2°ab and the PERIOD 1 protein. Exposure 
time 10 min.
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Figure 5.4: Detection of PER2. The PER21-A antibody was used. Blocking 4% milk in TEST (0.05%) 
1 h, l°ab 1:2500 incubation over night, detection with ECL, 2°ab 1:5000 in TEST (0.05%) 1 h, washes 
TEST (0.05%). Murine liver extracts ZT 0, 12 and 16. a Sonication and grinding were compared. 
Extractions with T-Per buffer, three times 5 min wash. Exposure time 10 min. There were differences 
in the protein pattern visible, but also between the replicates within one time point, b Comparison 
between the extraction with homemade and T-Per buffer. Three times 10 min washes. Exposure time 
10 min. c Detection of PER2 in unpulsed 3T3-L1 cells as well as in extracts from liver and adipose 
tissue. Three times 5 min washes. In the lane of the 3T3 cell extract a lot of bands were detected. There 
was a difference in the molecular weights of the bands detected in the liver / adipose tissue. Exposure 
time 5 min.
Time courses of murine liver extracts were used to detect PER2. The samples were 
4 h apart from eaeh other and there were 6 samples to cover 24 h. Figure 5.5a shows 
the detection of PER2. The specific PER2 antibodies were pre-adsorbed (Figure 5.5b). 
The strongest signal was detected around 37 kDa in all samples except ZT 8. The 
antibody, however, detected proteins of more than one moleeular weight in the 
western blot and more than one specific band was pre-adsorbed.
5.5.6 PERIODS
Different antibodies against the human as well as against the murine PER3 protein 
have been used. Some of the antibodies were available commereially (PER-31A and 
PER-32A, aDiagnostics), as well as the monoclonal antibodies (2, 5 and 8, 
abdserotec). The “in-house” antibodies (1889 and 1890, kindly provided by Dr. 
Malcolm von Schantz, University of Surrey) have also been tested. The full length 
PER3 protein has an estimated molecular weight of 120 kDa (Zylka et a l, 1998a). 
The “in-house” antibodies 1889 and 1890 were raised against a protein with the
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sequence (H)MVVQEMKKYFPC(OH). The monoclonal antibodies were custom
made by AbD serotec using the AgX antigen expression service. These are
monoclonal antibodies from the HuCAL antibody library (Frisch et a l, 2003, Sun et 
al, 2003).
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Figure 5.5: PER2 detection and pre-adsorption o f a liver time course. Extractions from liver and the 
antibody PER21-A were used. Blocking 1 h 5% milk in TEST (0.1%), l°ab 1:2000 in blocking buffer 
incubation overnight at 4°C and 1 h at RT, three times 5 min washes with TEST (0.1%), 2°ab 1 5000 
Detection with ECL. Exposure time 30min. a Normal detection b Pre-adsorption. All bands were 
preadsorbed. A specific band for PERI0D2 could not be found. Exposure time 15 min.
5.5.6.1 PERIODS monoclonal antibodies
Three monoclonal antibodies have been tested. The monoclonal antibody number 2
was used to try to detect PER3 in protein extracts from cell lines and a time course of
murine liver extracts. Proteins of different sizes were detected by this antibody
(Figure 5.6a). A strong band was visible in most of the human cell line extracts at
around 60 kDa. The murine fibroblast cell line extraction shows a signal at about
75 kDa. The PER3 protein consists of 1113 amino acids and should therefore run at
about 120 kDa. No band was visible at this molecular weight. The monoclonal
antibody number 5 was tested on extractions from murine wild-type liver extracts and
PerS mice liver extracts. More PER3 protein was detected by the antibody at ZT 16
compared to ZT 4. A specific signal was not obtained (Figure 5.6b). The monoclonal
antibody number 8 did not detect a strong band, neither in the human cell line extracts
nor in the murine tissue extractions (Figure 5.6c). A change of the protocol (twice the
amounts of washes, 0.2% Tween in the TBST) failed to affect the result (result not 
shown).
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Figure 5.6: Detections with monoclonal PER3 antibodies. Blocking 5% milk in TBST for 1 h. l°ab 
5 pg /ml, incubation overnight at 4°C and 1 h at room temperature. 2°ab 1:3000, incubation 1 h at room 
temperature. Three times 5 min washes. Detection with ECL. a Monoclonal antibody #2, exposure time 
2 min. A specific band was not detected either in the cell extractions or in the time course of the liver 
extractions, b Monoclonal antibody #5, exposure time 120 min, 0.2% Tween 20 in the TBST. A 
specific band could not be detected which was absent in the Per3-/- detections, c Monoclonal antibody 
#8, exposure time 15 min, 0.1% Tween 20 in the TBST. A specific band could not be detected.
5.5.6.2 ‘In-house’ polyclonal PERIODS antibodies
The commercial available antibodies (PER-31A, PER32A) were compared with the 
“in-house” polyclonal antibodies (1889 and 1890) in the detection of kidney extracts 
from ZT 0 and ZT 4. Both “in-house” made antibodies detected more than a single 
band. The commercial available antibody against murine PER3 failed to detect 
anything (Figure 5.7a). Besides weaker bands, the number 1889 antibody showed a 
signal at around 60 kDa, 50 kDa and 35 kDa (Figure 5.7b) and the number 1890 
antibody at around 42 kDa and 80 kDa (Figure 5.7c). The antibody 1890 also showed 
a weak signal at the molecular weight of about 140 kDa which could be caused by 
PER3. The antibody against human PER3 also showed a very thin band around 
140 kDa the same 80 kDa signal as the 1890 antibody and two strong signals at 
molecular weights of about 55 kDa and 42 kDa (Figure 5.7d).
Immunising peptides were available for the ‘in house’ polyclonal PER3 antibodies. 
Figure 5.8 shows a pre-adsorption time course experiments with the polyclonal PER3 
antibodies 1889 (Figure 5.8a) and 1890 (Figure 6.8b). The pre-adsorbed halves
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showed stronger background signal and more unspecific bands. The normal detected 
half showed a wide range of bands.
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Figure 5.7: Comparison of polyclonal and monoclonal PER3 antibodies. Blocking 4% milk in TBST 
(0.1%) 1 h at room temperature, three times 5 min washes, 2°ab 1:5000 incubation for 1 h. Murine 
kidney extractions with T-per ZT 0 and ZT 4. 30 pg loaded. Detected with ECL. Exposure time 10 
min. a PER31-A did not show a signal at all b 1889 c 1890 d PER32-A showed 3 bands and a shadow 
at around 140 kDa. 1989 and 1890 showed more than one band, but not at the same molecular weight.
5.5.63 Commercial polyclonal PERIODS antibodies
The commercially available PER3 antibody (PER31-A), which is designed against the 
murine PER3 protein, was tested on murine liver extracts. In both buffer systems the 
amount of detected protein at ZT 0 was larger than in the lanes for ZT 12 (Figure 
5.9a). The full length mouse PER3 molecule has a molecular weight of about 
120 kDa. The band with the highest molecular weight that was visible was around 70 
kDa. A 120 kDa band was not detected. The PER3 antibody PER-31-A was tested on 
wild-type and Per3'^ ' knock out tissue protein extracts (Figure 5.9b). The PER31-A 
antibody, detected three bands (37, 42 and 100 kDa). The band at 100 kDa was very 
weak and only visible on the original X-ray film. These bands were visible in both the 
wild-type as well as in the knock out protein extractions at ZT 4 and ZT 16. The 
PER32-A antibody, which was designed against the human PER3 protein, showed 
stronger signals in the wild-type extract than in the Per3" knockout extractions at 
about 110 kDa at both ZT 16 and ZT 4 (Figure 5.9c).
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Figure 5.8: Time courses and pre-adsorption of the polyclonal PER3 antibodies 1889 and 1890. 
Blocking 4% in TBST (0.1%) 1 h, l°ab (1:2500) overnight and 2°ab (1:5000) 1 h at room temperature, 
both in blocking buffer. Three times 5 min washes. Murine liver tissue ZT 0; 4; 8; 12; 16; 20, extracted 
with T-Per. Detection with ECL. Exposure time 10 min. a 1889 b 1890. In both blots a specific single 
band was not pre-adsorbed.
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Figure 5.9: Detection of PER3 with polyclonal antibodies. Murine liver tissue extractions ZT 0, 4, 12 
and 16, extracted with T-Per and or HM extraction buffer. The primary antibody was incubated 
overnight. 2°ab 1 h at room temperature. Three times washes 5 min each. Detected with ECL. a 
PER31-A raised against the murine PER3 protein. Blocking 5% milk powder in TBST (.2%), l°ab 
1:2000 in blocking buffer. Exposure time 10 min. b PER31-A raised against the murine PER10D3 
protein. Blocking 5% milk powder in TBST (.1%), Tab 1:1000 in blocking buffer. Exposure time 15 
min. c PER32-A raised against the human PER3 protein. Blocking 5% milk powder in TBST (.2%), 
l°ab 1:1000 in blocking buffer. Exposure time 3 min.
To verify these findings a time course of murine liver extracts from wild-type and 
Per3' ' knockout mice (Figure 5.10) was performed with the antibodies. The PER-32A 
antibody showed a single band at around 110 kDa in knockouts and wild-type 
extractions (Figure 5.10a). The detection with the PER-31A antibody resulted in many
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bands of different molecular weights (Figure 6.10b). The strongest band was visible at 
about 35 kDa. This band was like all the other bands visible in the extractions from 
the wild-type mice as well as in the extractions from the PerS' ' knockout mice.
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Figure 5.10: Time courses of PER3 in wild-type and PerS" knockouts. Murine liver extracts ZT 0, 4, 
8, 12, 16, 20. Blocking 5% milk in TBST (0.2%) 1 h, l°ab in blocking buffer incubation overnight and 
1 h at room temperature. 2°ab anti-rabbit (DAKO) 1:5000 in blocking buffer. Three washes 5 min each. 
Detection with ECL. a PER-32A detects human PER10D3 1:1000. Exposure time 90 min. Single 
signals at 110 kDa in PER10D3 wild-type mice and PerS'' knockout mice. The proteins used were 
extracted on the same day as the western blot was performed, b PER-31 A detected murine PER10D3 
1:500. Exposure time 90 min. Single signals at 110 kDa, in both PER10D3 wild-type mice and PerS' '^ 
knock outs. Proteins were frozen once. Exposure time 10 min. Many signals for all time points in 
PER10D3 wild-type mice and PerS' ' knock outs.
5.5.7 REV-ERBa
The molecular size of the REV-ERBa protein is 80 kDa (Pena-de-Ortiz and Jamieson, 
1997). We have been able to detect two bands at around 80 kDa, with about 15 kDa 
difference in their molecular weight.
5.5.7.1 REV-ERBa in human cell lines
The REV-ERBa antibody produced two bands in all analysed protein extracts from 
human cell lines. The murine fibroblast protein extraction detected by REV-ERBa 
caused a third band at around 60 kDa (Figure 5.11).
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Figure 5.11: Detection o f REV-ERBa in different cell lines. 20 pg total protein extraction was loaded 
per well. Blocking 5% milk in TBST,Tab REV-ERBa (1:1000) in TBST (0.2%). 2°ab anti-rabbit-HRP 
(1:5000) in TBST. Detection with ECL.
5.5.7.2 REV-ERBa time courses in murine liver extracts
After REV-ERBa was detected in human cell lines, murine liver extract time courses 
were tested. The ACTIN detection as loading control for the REV-ERBa detection 
was performed on the same membranes (Figure 5.12). The double band around 80 
kDa was detected at most of the time points. The signals-strength of the REV-ERBa 
and the ACTES! on the western blots needed to be analysed to show a rhythmic 
expression. It was not clear which band of the REV-ERBa double band represents 
REV-ERBa.
5.5.7.3 REV-EBRa time courses in murine kidney, gonads and heart extractions
The detected size of REV-ERBa in kidney extractions is about 65 kDa (Figure 5.13a) 
and therefore 15 kDa lower than the bands detected in the liver. The detected double 
band was similar to the liver extracts. The detection of REV-ERBa in the protein 
extraction from the heart did not result in a band (data not shown). The kidney time 
course failed to produce a signal at ZT 12, ZT 16 and ZT 20. The lighter band was 
visible in the first 3 time points (ZT 0, 4, 8) but not in any of the following ones 
(Figure 5.13a). The ACTIN loading control revealed more protein in the third well
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compared to the other wells. The time course of the adipose tissue extractions showed 
just 2 bands at the lower molecular weight (ZT 16, 20) (Figure 5.13b). The ACTfN 
loading control showed that less protein was loaded at ZT 4 and 8. The time course of 
the protein extraction from the gonads showed the band with lower molecular weight 
in all time points except ZT 0 (Figure 5.13c). The two bands were not separated fully 
at the time points ZT 16 and 20, which made it difficult to identify their size. The 
band at the time points ZT 8 and 12 looked thinner than all other detected light bands. 
The ACTIN loading control revealed higher protein amounts at the time points ZT 16 
and ZT 20.
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Figure 5.12: REV-ERBa detections in murine liver extract time courses. Blocking 5% milk in TBST 
(0.2%), l°ab REV-ERBa (1:1000) in blocking buffer. Three times 5 min washes with TBST. 2°ab anti­
rabbit HRP (DAKO) Detection with ECL. Loading control l°ab actin (1:3000) in blocking buffer over 
night and 1 h at room temperature, 2°ab anti-rabbit HRP (1:5000) in blocking buffer. 30 pg protein was 
loaded per lane. The proteins were never frozen, a 10 min exposure time b 90 min exposure time.
5.5.8 BM ALl
A band representing a protein of about 150 kDa was prominent in the kidney 
extractions (Figure 5.14a), and this band was visible in two of the adipose tissue 
extracts, although these also showed the strongest ACTIN signals (Figure 5.14b). The 
protein amount loaded was less in the first 4 adipose tissue samples than in the last 
two (Figure 5.14a). Proteins at different molecular sizes were detected in both 
experiments. A weaker band was visible in both extractions at about 80 kDa and at 
about 110 kDa in the kidney but not in the adipose tissue extraction. The ACTIN band 
was detected at its usual size at about 42 kDa.
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Figure 5.13: REV-ERBa time course detection in murine kidney, adipocytes and gonads. Blocking 5% 
milk in TBST (0.2%). l°ab BMAL 1 (1:1000) in blocking buffer incubation overnight. 2°ab anti-rabbit 
HRP (1:5000) in blocking buffer incubation for 1 h at room temperature. Three washes 
5 min each, a murine kidney b murine adipocytes c murine gonads.
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Figure 5.14: Detection of BMALl in murine adipocyte and kidney tissue extractions. Blocking 5% 
milk in TBST (0.2%). Blocking 5% milk in TBST (0.2%), l°ab BMALl (1:1000) in blocking buffer, 
2°ab anti-rabbit HRP (1:5000) in blocking buffer. Loading control l°ab actin, (1:3000) in blocking 
buffer 2°ab anti-mouse HRP (1:3333) in blocking buffer. Three washes 5 min each. Detection with 
ECL. Exposure time actin 10 sec. a murine kidney, exposure time 10 sec. b murine adipose tissue, 
exposure time 1 h.
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5.6 Discussion
Clock proteins play as well as clock gene mRNA a crucial role in the current model of 
the circadian oscillator (section 1.2.2). Rhythms in clock gene mRNA expression have 
been detected in most cells and tissues. Less in known about the expression profiles of 
clock proteins. Clock genes as well as clock proteins get degraded, stabilised and 
modified in the clock mechanism. Detection and quantification of the clock proteins 
would help to gain insight into the clock mechanism and the effect of the metabolic 
state on the molecular oscillator. Different extraction methods, different antibodies 
and different protocols were tested in order to detect and quantify clock proteins.
Most of the antibodies used in this study are commercially available, and the epitope 
or peptide sequences targeted by the antibodies is not known. We therefore cannot be 
sure if we failed to detect a certain isoform of the PER proteins because the antibodies 
were targeting sequences which were not present. None of the detected bands could 
be identified as specific. It seems from the current results that the commercially 
available antibodies were not as good as the HM antibodies which agrees with earlier 
reports (section 5.1).
The objective to analyse the difference in phasing between protein extractions from 
lean and obese mice together with mice showing symptoms of the metabolic 
syndrome could not be tackled because the detected signals could not be definitely 
identified as the targeted proteins. Due to the REV-ERBa protein results provided by 
Imperial College London it was at least possible to tackle objective 3 for Rev-erba 
and compare the phasing between mRNA and protein.
5.6.1 Pre-adsorption
Pre-adsorption is only able to show that the antibodies are specific for the incubating 
protein or peptide. It does not prove the specificity of the antibody for the protein in 
the tissue (Swaab et al., 1977, Willingham, 1999). It is not evidence for the identity of 
the protein because the immunising peptide might not be identical to the targeted 
protein or it might represent an isoform which does not share the same sequence with 
the targeted protein.
150
5.6.2 PERIOD proteins
The proteins were detected with different molecular weights (Table 5.1). The full 
length proteins over a 100 kDa, as predicted from their gene sequence, were found in 
just a few tissues and cell compartments (Garcfa-Femandez et al, 2007). These 
findings lead to the assumption that the PER proteins exist with different molecular 
weights caused by splicing and post-translational modifications. The detected heavy 
molecular weight isoforms of the PER proteins could not be restricted to a cell 
compartment. Sonication was used to extract the proteins for detection in this thesis. 
Sonication destroys the cell membrane as well as the nuclear membrane. Whole cell 
protein content was analysed in this study. Different molecular weights of the PER 
proteins have been found in different cell compartments (Hastings et al, 1999, Chilov 
et al, 2001, Lee et al, 2001, Akashi et al, 2002, Kamphuis et al, 2005). The stability 
of the PER proteins in the extraction buffer is dependent on the pH of the buffer, 
additives such as protease inhibitors and salts to maintain ionic strength as well as the 
storage temperature. The extraction buffers used in the literature by groups successful 
in detecting PER proteins were not essentially different from the buffers used in the 
current study. Mechanical grinding as well as hypertonic extraction buffers have been 
used to extract proteins in the literature. Another reason for the variability in the 
molecular weights reported for the PER proteins could be that some unspecific bands 
have been reported as specific. The protein isoforms could correspond to the reported 
splicing variants of Per genes (Hida et al, 2000, Taruscio et al, 2000, Chilov et al, 
2001, Lee et a l , 2001, Bendovâ and Sumovâ, 2006).
From some antibodies used in the different studies in the literature it is known if they 
targeted either the N or the C terminus of the PER protein. In the current study a 
pattern in the detection could not be found. Most of the antibodies used in this study 
are available commercially and it is not known what their target on the protein is. The 
‘in-house’ antibodies 1889 and 1890 were targeted against the C-terminal sequence 
(H)MVVQEMKKYFPC(OH).
All antibodies targeted against PER proteins failed to produce specific signals in the 
experiments described in this thesis. Different washing times, detergent 
concentrations in the wash buffer and blocking solution contents in the antibody 
solutions were tested in an attempt to optimise conditions. Even the monoclonal
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antibodies against the C-terminus of the PER3 protein failed to show single specific 
bands.
There is no molecular weight for the detection of PERI with the PERI 1-A antibody in 
the literature. A strong band was detected at about 47 kDa in our detections. 
Detections from -120 kDa up to -135 kDa have been reported in the literature for 
detection with the PER21-A antibody in mouse and hamster brain (Field et al, 2000, 
Nuesslein-Hildesheim et al, 2000). A single strong band was detected at about 
37 kDa besides lots of other bands. This band was preadsorbed by the immunising 
peptide. The mPER31-A antibody has been shown to detect a band at -120 kDa in 
murine SCN (Field et al, 2000). Bands of different molecular size were detected for 
PER3 in this study. The ‘in-house’ antibodies 1889 and 1890 failed to get pre­
adsorbed by its immunising peptide, suggesting that the detected band is likely 
unspecific.
The polyclonal commercial available antibodies against PER3 showed the same bands 
in the extractions from wild-type and Per3' '^ mice. The antibody PER-32A which 
targets against the murine PER3 protein detected a strong band at 110 kDa. The PER- 
31A antibody detected a weak band at 110 kDa and strong bands at 40 kDa and 
35 kDa in extracts from murine liver.
Distinct double lines were detected in the PER2 detection and in some of the PER3 
detections. These double lines could be due to post-translational modifications like 
phosphorylation. Double bands have been reported as different post-transcriptional 
modifications by (Lee et a l , 2001).
5.6.3 REV-ERBa
The detection of REV-ERBa resulted in a double band with about a 15 kDa 
difference in molecular weight. The same pattern was detected by Dr. Ariel Poliandri 
(Imperial College London). Just one band was detected in the extractions from 
IMWAT cells. The molecular weight of the detected REV-ERBa protein was equal to 
the molecular size calculated from the gene sequence. This antibody is the most 
promising one of all the antibodies tested. Rhythmicity could be detected in a time 
course of serum pulsed IMWAT adipocytes by our collaborators at Imperial College.
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5.6.4 BMALl
The detections of BMALl in this study resulted in more than one signal. Pre­
adsorption could not be conducted because the immunising peptide is not available 
and thus we cannot be sure if there was rhythmicity of BMALl. Because we are not 
able to identify the bands as BMALl we are not able to discuss the rhythmicity. The 
amount of protein showed elevated levels at the end of the dark period in hamster 
liver, which was significant when kept under a long photoperiod (16 h light / 8 h dark) 
(Maronde, et al., 2007). Rhythmicity in the BMALl protein abundance as well as 
phosphorylation was also detected in mouse liver extracts (Lee, et al., 2001). Lowest 
amount of BMALl occurred at ZT 9 the time predicted for the maximum of mPERl 
and mPER2. Phosphorylated BMALl protein was abundant at this time point.
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Chapter 6: DisCUSSioil
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Obesity and T2DM are increasing health problems, not just in the industrialised 
nations. An increasing amount of evidence, mainly from animal studies, supports the 
link between the circadian timing system, metabolism and therefore diseases 
including obesity and T2DM. However, there are still important gaps in our 
understanding how those metabolic states interact with the timing system of the 
human body. In particular, the influence on human AT which plays a central role in 
those diseases is poorly understood.
Experiments on cell cultures with immortalised adipocyte cell lines, or cells which are 
able to be differentiated into mature adipocytes are useful to investigate the function 
of the clock in adipocytes. The cell lines used to investigate the clock in adipocytes 
lack robust rhythms of clock gene expression (Otway et al, 2009). And tissue cultures 
are difficult to obtain (Gomez-Ambrosi et al, 2004, Gomez-Santos et al, 2009).
The central hypotheses addressed in this work were therefore:
® The rhythmicity in the plasma concentrations of melatonin and leptin is 
influenced by the metabolic state in humans.
© Pre-adipocytes and adipocytes of the IMWAT - cell line possess a circadian 
clock.
e The expression of clock genes and clock controlled genes is different between 
pre-adipocytes and adipocytes.
© Lipolysis in IMWAT-adipocytes is gated by the endogenous clock.
The first hypothesis was addressed by analysis of blood plasma samples, collected 
hourly over a period of 25 h in a well controlled laboratory study with lean, OW and 
T2DM participants. The concentrations of melatonin and leptin were measured by 
RIA. The results were compared between and within the groups (Chapter 3).
Cells of the IMWAT cell line were cultivated and differentiated into mature 
adipocytes. Following synchronisation of cellular rhythms with a serum pulse, clock 
and clock controlled metabolic genes were quantified by qtPCR. Differentiated 
IMWAT adipocyte cells were used to determine if the lipolysis is under circadian 
gating by the adipocyte clock (Chapter 4).
The overall conclusions drawn from this thesis and how this work helps to fill the 
gaps in the current understanding of adipocyte biology, obesity and T2DM will be
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outlined. Finally, limitations of this work and possible future research options to 
extend the knowledge will be discussed.
6.1 The link between circadian clocks and metabolism in humans
Our knowledge about the link between circadian clocks and the energy metabolism 
includes results from animal studies in which the administration of food influenced 
the circadian timing system and from obese (Kudo et al, 2004b, Cailotto et al, 2005, 
Mendoza et al, 2005) diabetic animals which show changes in the expression of clock 
genes (Ando et al, 2005). The link between the energy metabolism and the circadian 
system in humans is supported by findings in shift workers, who are more likely to 
develop obesity and T2DM (Knutsson, 2003). Endocrine rhythmicity of leptin, which 
was detected in both animals and humans, provides another link (Licinio, 1998, Saad 
et al, 1998, Kalsbeek et al, 2001). Research on the link between the clock 
mechanism in peripheral tissues and their role in obesity and diabetes is still in their 
infancy, in animals as well as in humans. The interest in WAT is growing, as it plays 
a crucial role in obesity and T2DM. The presence of a clock mechanism in adipose 
biology is indicated by rhythmicity of clock genes and genes linked to basic 
metabolism in murine WAT (Ptitsyn et al, 2006, Zvonic et al, 2006).
A big disadvantage of using animal models is that the findings can be influenced by 
the genetic background of the animals (Turek et al, 2005, Kennaway et al, 2007). 
Another general drawback of animal results is that they cannot always be easily 
applied to human obesity and diabetes. The most obvious difference is that mice are 
night active animals whilst the active phase of humans is during the day. Plasma 
melatonin is known as the most reliable marker of the endogenous phase in humans 
(Lewy and Sack, 1989), and is therefore used in many studies to assess the 
endogenous phase in participants from many human cohorts. Leptin concentrations 
were also measured in different human cohorts before (Lockley et al, 2000, Skene 
and Swaab, 2003). However, none of those studies controlled for as many factors as 
we did in our study. Factors such as sleep / wake and nutrition as well as the feeding 
time are able to influence leptin concentrations and phase of the secretion from the 
adipocytes (Fogteloo et al, 2004, Buijs et al, 2006). Those factors were therefore 
controlled for the week before the study and during our study.
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A decrease in nocturnal plasma melatonin concentration with increasing age is 
accepted in the field (Iguchi et al, 1982) and a correlation between BMI and the 
plasma concentration of melatonin was mentioned before in the literature once 
(Arendt et al, 1982) but was as far as I know not mentioned thereafter. A correlation 
between BMI and melatonin concentration could be found in this study for insulin 
sensitive subjects. The participants of the OW and T2DM group were matched for 
age; the difference in the nocturnal melatonin concentration should therefore be 
explainable by the features of the T2DM. The pineal gland receives inputs from 
sympathetic nerves originating from the superior cervical ganglion (Cardinali and 
Stem, 1994). It is known that sympathetic firing leads to an increase in the release of 
melatonin from the pineal gland (Klein et al, 1981). The increased melatonin 
concentrations in OW participants might be explained by hyperactivity of sympathetic 
nerves innervating the pineal gland. Consistent with this increased activity of 
sympathetic nerves in muscles were detected in patients with the metabolic syndrome 
(Grassi 2005).
T2DM is marked by high blood glucose. We do not know if the participants of the 
T2DM group suffer from neuropathy, but it’s very unlikely as subjects completed a 
General Health Questionnaire and had good diabetes control. However, neuropathy 
influencing the sympathetic nerves innervating the pineal gland could be an 
explanation of the reduced nocturnal melatonin secretion in the T2DM group (O'Brien 
gfaA,1986).
Insulin resistance is the main factor for the increased glucose blood concentrations. 
High plasma insulin concentrations are found in T2DM patients, before the p-cells 
stop producing and secreting it. The plasma insulin concentration in the participants of 
the T2DM group was significantly higher compared to both other groups. Insulin 
receptors were detected in many tissues of the CNS (e.g. olfactory bulb, hypothalamus 
and pituitary), and malfunction in the insulin signalling in the CNS was linked to 
neurodegenerative diseases (Frolich et al, 1998). A study by Garcia et al, (2008) 
showed increased synthesises of melatonin of insulin treated rat pineal glands. Those 
findings support the hypothesis that plasma insulin, at least in part influences the 
plasma melatonin concentration. Other studies showed that pancreatic p-cells express
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melatonin receptors (Peschke et al, 2000) and that melatonin is able to inhibit the 
release of insulin by those cells in the presence of glucose in a dose dependent manner 
(Peschke et al, 1997, Muhlbauer et al, 2011). It cannot be said if the reduced 
nocturnal melatonin concentration is effect or cause of the increased plasma insulin 
concentration. However, hyperinsulinemia was reported to be the primary initiator of 
CNS insulin resistance, and might be at least in part be responsible for leptin 
resistance (Isganaitis and Lustig, 2005). The participants of the T2DM group show the 
highest leptin concentrations of the three groups. This is in accordance with the 
finding by Buyukbese et al, (2004) who detected higher leptin levels in obese women 
with T2DM than in women without T2DM. The facts that leptin binding sites have 
been localised in the rat pineal gland (Dal Farra et al, 2000) and that leptin receptor 
mRNA was detected in bovine pineal glands (Chelikani et al, 2003) makes an 
influence of leptin in the secretion of melatonin likely. Leptin is transported across the 
BBB barrier, but this transport gets blocked by TG in the blood of OW participants, 
this is termed leptin resistance (Banks, 2006). The leptin concentrations were not 
significantly different between the OW and the T2DM, but increased in the T2DM 
group. The groups were matched for BMI. The amount of released leptin should 
therefore be equal if just the amount of adipose tissue is taken into account. All 
participants of our study got a functional SON clock, because all of them showed 
rhythmic changes in the concentrations of plasma melatonin or plasma cortisol.
A study reported obesity to blunt leptin rhythms (Saad et al, 1998). This could not be 
detected in our results. The BMI of the OW participants in the Saad et al, (1998) 
study was smaller than the BMI of the OW participants in our study. However, the 
reasons for the difference in the findings could be that the sleep / wake cycle was not 
controlled strictly and the fact that their participants received three full meals.
Our study showed that the phasing of the human plasma leptin rhythm is not 
influenced by the metabolic state. A phase difference in the changes in the plasma 
leptin concentration could not be detected after normalisation with the individual 
DLMO. Our study therefore suggests that T2DM does not influence the way the SON 
gets entrained. Differences in the timing of increases in plasma leptin were reported 
between lean, obese and obese T2DM participants in a study by Sinha et al, (1996a). 
Reasons for conflicting data from the studies could be due to the fact that the 
participants in the Sinha et a/., (1996a) study were not entrained to a regular sleep /
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wake cycle, they received three meals per day with different amounts of nutrients. 
Other factors for the different findings could be that their data was not corrected by 
the individual endogenous phase and their participants. Their participants showed 
higher values for the HbAlc in the lean and OW groups (lean 7.2%, OW 7.6%) 
compared to ours (lean 5.3% and OW 5.4%). Especially high HblAC values were 
measured in their T2DM group of participants (11.5%). This means that the diabetes 
of their T2DM participants was poorly controlled, whilst the participants in our 
T2DM group were highly controlled (6.9%).
Elevated, but not significantly higher, leptin mRNA levels were detected in the OW 
group whilst the higher plasma leptin concentration was measured in the T2DM 
group. This could imply that there is a difference in the way leptin mRNA gets 
translated into protein between the OW and the T2DM group. Rhythmicity was not 
detected in leptin mRNA in any of the analysed groups. However, rhythmicity was 
detected in the plasma leptin concentration in all three groups.
The increase of vWAT depots is known to be a better predictor for the metabolic 
syndrome than the increase of sWAT depots (Despres and Lemieux, 2006). The 
sWAT depot from the upper buttock region was chosen in our study because this 
depot is known to be metabolically active (Khan et al, 2002) and relatively 
accessible. There is also the possibility that different depots of adipose tissue have 
different proportions on the rhythm in plasma leptin (Perfetto et al, 2004). Different 
adipose tissue depots could also be influenced by the metabolic state in different ways 
and with different strength.
6.2 Function of clocks in adipose cells
Adipose tissue consists of many cell types, such as fibroblasts, immune cells, dentritic 
cells, pre-adipocytes and adipocytes. Most of those cell types were shown to possess 
their own circadian clock mechanism (reviewed in Johnston et al, 2009, Gimble et 
al, 2011). The cell composition of an adipose depot is not stable, as the amounts of 
the different cell types vary in response to the metabolic state. Chronic inflammation 
of adipose tissue characterised by influx of immune cells like macrophages is one
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aspect of obesity (Odegaard and Chawla, 2008). Rhythms measured in WAT are 
therefore difficult to assign to a single kind of cells.
Adipocytes play an active role in energy - metabolism in part by releasing adipokines. 
Adipokines like leptin are only secreted by mature adipocytes. The plasma 
concentrations of leptin show clear diurnal rhythmicity in humans and animals 
(Licinio, 1998, Saad et al, 1998, Kalsbeek et al, 2001) as well as in the culture 
medium of differentiated 3T3-L1 adipocytes (Otway et al, 2009). This finding 
implies that the release of leptin from adipocytes is at least partially controlled by the 
clock in adipocytes. However, the plasma leptin concentration is not just controlled by 
the clock in adipose tissue, but is also influenced by the sleep / wake cycle as well as 
by neuronal and humoral inputs by the SON (Kalsbeek et al, 2001, Fogteloo et al, 
2004, Shen et a l , 2007).
Adipocyte cell models provide the possibility to investigate the clock in adipocytes 
and their outputs without the influence of masking by humoral or neuronal signals 
from other parts of the body. However, the 3T3-L1 cell line which was used in 
previous studies to investigate adipogenesis and adipocyte biology failed to show 
rhythmicity in the expression of some clock genes (Otway et al, 2009) and may 
therefore not be an optimal cell model to investigate the link between the clock in 
adipocytes and energy metabolism. There are many factors which could be the reason 
for the abnormal patterns of clock gene expression in those cells; the aneuploid 
genome, the inclusion of an immortalising gene (Wolfe et a l , 2008) and the fact that 
those cells originate from fibroblasts (Green and Meuth, 1974). Cultures of primary 
cells and adipose-derived stem cells overcome those problems, but are difficult to 
handle and to obtain (Wu et al, 2007, Huang et al, 2009). The robust rhythms of 
multiple clock genes found in differentiated and un-differentiated IMWAT cells, 
possibly make this cell line a better model to investigate the clock in adipocytes. 
Differences in the phase angle of the entrainment were detected between pre­
adipocytes and adipocytes. This was also true for 3T3-L1 pre-adipocytes and 
adipocytes (Otway et al, 2009). Others have reported that the phase of the clock 
genes in adipose tissue is dependent upon anatomical location of the adipose biopsy 
(Zvonic et al, 2006, Bray and Young, 2007, Gomez-Santos et al, 2009). Those 
findings imply an influence of the metabolic state of the cell on the clock gene 
expression in adipocytes. My results show that the damping factor of the cosinor wave
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fitted onto the rhythmic concentration of clock gene mRNA is not higher in 
adipocytes than in pre-adipocytes. Therefore the synchronisation between the cells 
seems not to be influenced by the differentiation state. This could be interpreted in a 
way that the metabolic state does not weaken the molecular clock mechanism.
Rhythmicity in the leptin mRNA was not detected in IMWAT adipocytes, the same 
was described for 3T3-L1 adipocytes (Otway et al, 2009). Leptin mRNA was also 
found to be not rhythmic in the biopsies from human sWAT from our study. 
However, leptin mRNA was found to be rhythmically expressed in eWAT, but not in 
sWAT and vWAT in mice (Ando et al, 2005, Bray and Young, 2007). The 
expression of the clock genes was also found to show differences in the amplitude and 
the phase between eWAT and sWAT (Bray and Young, 2007).
6.3 Limitations, improvements and future work
Experiments with cell lines representing pre-adipocytes and adipocytes provided 
insight into the effects of increasing storage of FFAs on the clock in adipocytes 
(Otway et al, 2009). To be able to investigate the effect of obesity on the clock of 
adipocytes lean and obese adipocytes need to be compared. The lipid content of the 
cells could be investigated and quantified. Inflammation is a feature of obese 
adipocytes, and the influx of immune cells might influence the response of the 
adipocyte clock. The inflammation could be assessed (e.g. by the number of 
macrophages) and the influence of the inflammation status on circadian gating could 
be investigated. The complex process of inflammation could be investigated in cell 
culture by using a co-culture approach with cell culture inserts. In such an experiment, 
adipocytes and the macrophages would be maintained in separate compartments, but 
cultivated in the same medium. Cytokines from the macrophages would therefore 
have the opportunity to influence the adipocytes without physical cellular contact. As 
inflammation plays a major role in adipose tissue of obese and overweight 
participants the inflammation status should be assessed in all experiments and be 
considered in the data analysis. It would be interesting to compare adipocytes with 
obese adipocytes. It could also be investigated if there is a correlation between the 
phase angle of entrainment and the TG content of the cells.
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There are also limitations to the use of the IMWAT cell model in investigating the 
link between the clock and obesity and T2DM. The cells for this cell line originate 
from the inguinal depot of WAT in mice (Morganstein et al., 2008). Inguinal WAT is 
not as metabolically active as vWAT, and it is not known to play a crucial role in 
obesity and T2DM. Another limitation is that the tissue originates from mice; this 
means the results might not be similar to the results in humans.
It is known that insulin inhibits lipolysis (Kralisch et al, 2005) and the fasting insulin 
concentration was significantly higher in the T2DM group compared to both other 
groups in our study. It would be interesting for this reason to see how insulin 
influences lipolysis in obese adipocytes and if there is a temporal gating, or if it 
influences the way the system reacts to substances inducing lipolysis. This could be 
investigated by experiments treating adipocytes with a trigger of lipolysis as well as 
with insulin followed by quantification of the glycerol released. The release of 
adipokines could be investigated in differentiated IMWAT cells. Questions such as; 
does the amount of triglycerides in the cells influence the timing of the release of 
adipokines and how does the inflammation state influence this could be addressed.
Studies with human participants are necessary to gain insight into human physiology 
and to verify the mechanisms found in animal models and cell culture experiments. 
Serial adipose tissue biopsies are the only way to investigate adipose tissue biology at 
different time points with all neuronal and humoral inputs. Four time points over a 
time course of 24 h are not ideal to fit a cosinor wave to the data, and analyse for 
phase and rhythmicity. In vitro cultivation of adipose biopsies can provide more time 
points over a period of 24 h. However, it possesses the drawback that the neuronal and 
humoral influences from other parts of the body are missing. One aim needs therefore 
to be to increase the sampling frequency. There are ethical limitations to this 
approach, but maybe less invasive ways can be found to access adipose tissue in 
humans. Most information will be gained from those biopsies by array analysis for 
both genes (microarray) and proteins (proteomics). Those results can then be 
compared between different groups and different medications. The participant 
numbers in the group of T2DM participants in the herein described study was too 
small to be able to declare an effect of T2DM medication on the circadian system. 
However, metformin has been shown to influence AMPK and therefore to be able to 
influence the molecular oscillator (Um et al, 2007). Metformin was shown to increase
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AMPK activity in WAT of dh/db mice and in 3T3-L1 adipocytes (Caton et al, 2011). 
The influence of metformin on the temporal profiles of clock genes and adipokine 
secretion could be investigated in a cell model, as well as in animal model with or 
without luciferase tagged PER2 as reporter. Another study could focus on T2DM 
participants with different medications. The temporal link between mRNA and protein 
could also be analysed in all the experiments mentioned beforehand as the 
transcription from mRNA to protein could also be influenced by the metabolic state. 
The study described in this thesis was not conducted under a constant routine regime. 
Light and dark cycles could have masking effects. This masking effect could be 
excluded by conducting following studies under constant dim light conditions and 
with a constant routine. Food is known to be able to influence the timing system in 
mice. It would also be interesting to know how food, and the time when it is provided 
influences the circadian timing system in humans.
Animal models are needed to investigate input and output pathways of adipose tissue 
and the clock in adipocytes a complex organism. Neuronal ablation could be used to 
investigate the role of neuronal input pathways. Neuronal ablation studies in mutant 
mice showing phenotypes of obesity and diabetes could help to gain insight into their 
pathophysiology. The clock gene could be quantified, secretions of specific tissues 
could be detected, or general factors could be assessed. WAT or specific depots of 
WAT of mice with tissue-specific disruptions of the clock would help to gain insight 
in the role WAT and the different WAT depots in obesity and diabetes. Tissue- 
specific disruption of the clock was demonstrated for liver and the pancreatic p-cells 
in the islets of Langerhans islets (Lamia et al, 2008, Marcheva et al, 2010). By 
combining those mouse models with mouse models of obesity and diabetes the role of 
the WAT could be investigated further. An animal model is needed to investigate if 
the sympathetic nerves invading the pineal gland are hyperactive in OW and / or 
T2DM. The pineal gland in rats is relatively easy to access, so that an electrode could 
be inserted and the firing rate of the sympathetic nerves innervating the pineal gland 
could be detected. To investigate the response of the metabolism to hormones at 
different time points, constant or timed hormone infusions in an animal could be used.
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Appendix A: Primer and probe sets
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Primer
Name
Upper Primer 
(5’ to 3’ end)
Lower Primer 
(5’ to 3’ end)
TaqMan probe (5’ 
to 33
GenBank
Accession
Number
Region
amplified
Product
size
mPerl TCCCCCTGCC GCACCAAGG TCCCCTGCTACCT NM_011065 2916-2989 74
CCTACATC CCACCATTG TCCCTTCTCCCTT
AG
mPer2 GACGCACAC CTCCGCAGG TCCACCTCCCTGC NM _011066 484 -599 116
AAAGAACTG GCATACTTC AGACAAGAAGGC
ATAAGG A
mCryl AGGTTTCAG ATGCACTTTC AGCCACTGGAGAT NM_007771 1037-1119 83
(set 2) ACTCTCGTCA CTATCACATC GCCAGCAGACAC
GCAA TGATG
mBMAL-1 CTCAGCTGC TCCATAGATT CGCCTGCACTCGC NM_007489.3 1451 -1536 86
(set 2) CTCGTTGCA TCACCCGTAT ACATGGTTC
A TTCC
mRev-erba CCTGCCCGCT GGATGACGA TGCGCCACCCAGT NM_145434 684 -758 75
CTTTTGG TGATGCAGA CTCAGTGATGAT
AGAA
mDbp CACCGTGGA CATGGCCTG TGAACCTGATCCC NM _016974 981 -1051 71
GGTGCTAAT GAATGCTTG GCTGATCTCGC
GA A
mLeptin CTCCATCTGC CATCCAGGC AGAGCTGCTCCCT NM_008493 381-456 76
TGGCCTTCTC TCTCTGGCTT GCCTCAGACCAG
mAdipo- ACTGGCAAG GGCTCACCTT CTCTACTACTTCT NM_009605 562 -646 85
nectin TTCTACTGCA CACATCTTTC CTTACCACATCAC
ACATTC ATG GGT
mPPARy CCAACTTCG GTAAAGGGC CTCCGTGATGGAA NM_011146 167-242 76
GAATCAGCT TTGATGTCA GACCACTCGCA
CTGT AAGGA
mPPARa AGTCAGCTG ATGCGTGAA TCCCCCGGCAGTG NM_011144 685 -800 116
CCCCGTGAT CTCCGTAGT CCCTG
C GGTA
mSREBPl CGAAGTGGT TAGCTCTGCT CGCCGGCTCACCC NM _011480 1297-1382 86
GGAGACGCT GCCAAAAGA TCCCA
TAG CAA
18S CGGCTACCA GCTGGAATT TGCTGGCACCAGA X00686 451 -637 187
CATCCAAGG ACCGCGGCT CTTGCCCTC
AA
GAPDH CAAGGTCAT GGGCCATCC ACCACAGTCCATG NM 008084 527 -616 90
CCATGACAA ACAGTCTTCT CCATCACTGCCA
CTTTG G
RIP 140 GCAGCAGTA CTGGCCATG CTCTAAAAACGCA NM_173440 1554-1634 80
CTCTCGGGA GCTGCAAGT GAACGCACATCA
ACA GGTG
Per3 GCGCAGGCT CTCCCTGAG CCCTGGTAGTTCC NM _011067 2702 -2797 95
TAGCATTCC AGGCCATAT CAGCCAGACCC
CTTG
ROR a GCCGTCAGC CGGGTTTGA ACATCCAGCCCTC NM _013646 654 -729 75
AGCTTCTACC TCCCATTGAT CCCAGACCAG
T G
mPEPCK GATGTTCGG AAGGCGTTT AAGACAGCGCCA NM _011044 1757-1831 74
GCGGATTGA TCCTTAGGG AGCTCACGCC
ATGT
mFAS CAAGGAGGG CACAGGAGC CATGCATGACAGC NM_007987 794-881 87
CAAGATAGA AGCTGGACT ATCCAAGACACA
TGAGA TTCT GC
The mouse genome specific probes are marked with an m in front o f the gene name. Primers without a 
letter in front o f the name are cross species primer probe sets. The probes are tagged with FAM 5’, and 
TAMRA3’ as a quencher.
196
Primer
Name
Upper Primer 
(5’ to 3 ’ end)
Lower Primer 
(5’ to 3’ end)
TaqMan probe 
( 5 'to 33
GenBank
Accession
Number
Region
amplified
Product
size
hLeptin TCCTCACCA
GTATGCCTTC
CA
GTGAAGAAGA
TCCCGGAGGTT
CGTGATCCAA
ATATCCAACG
ACCTGGA
NM_000230 311-384 74
Human quantitative primer-probe sets: The 3 ’ modification is TAMRA3’, and 5’ is FAM5’.
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Appendix B: Cell liîies iised
198
Different cell lines used in the different experiments.
Internal name Scientific name Host Experiment
Adipocytes 3T3-L1 pre-adipocyte (ATCC-LGC) mouse westem-blot
Fibroblasts Fibroblasts human westem-blot
HepG2 Hep G2 human westem-blot
RD Muscle Muscle RD, rhabdomyosaroma mouse westem-blot
Pre-adipocytes IMWAT mouse IMWAT/
adipocytes Lipolysis
HUH-7 HUH-7 human westem-blot
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Appendix C: Quality control data
melatonin RIA
200
3000- 0.006-
2000 0.004-
«  1000- ë  0.002-
500100 200 300 400 100 200 300 400 500
concentration [pg/mi] concentration [pg/ml]
Standard curves o f the melatonin RIAs. 13 assays were conducted, a Raw data b 1/count.
Beginning of assay [pg/ml] End of assay [pg/ml]
Subjects
assayed
low medium high x-high low medium high x-high
ID 144/149 10.0 23 75 116 9 20 76
ID141/143 7.8 21 86 109 8 16 83 97
ID 126/129 8.2 24 107 123 7 22 120 131
ID 136/163 8.2 23 101 108 5 20 100 129
ID 160/166 11.2 128 126 8 22 89 115
ID 131/146 17 99 124 121 130
ID 132/134 10.7 17 82 98 11 18 88 92
ID 107/109 13.7 22 97 107 17 33 115 139
ID 124/127 6.2 24 117 120 16 95 111
ID 110/121 7.3 17 65 7 19 82 93
ID 130/169 6.1 19 103 150 7 24 109 149
ID 112/114 8.1 14 8 19 78
ID 100/102 22 82 91 17 25 76 93
Repeat 1 22 83 107 16 82 96
Repeat 2 18 95 106 17 92 118
Repeat 3 11.6 19 89 106 8 22 81 95
Repeat 4 9.5 24 95 115 8 23 97 107
Repeat 5 22 10 121 157
n (number of 
valid QCs) 13 17 16 15 13 17 17 17
Average 9.1 21 94 114 9.2 20 96 113
SD 2.2 3 16 14 3.8 5 16 23
Inter-assay
%CV 25 15 17 12 41 24 16 20
Inter-assay variance melatonin RIA. SD=Standard deviation. Invalided duplicates were removed and 
are represented by blank cells.
201
Subjects
assayed low medium high X -high
(U
I Q
D
1 Q
<D
1 Q00 1 Q00 |j•^ 3 C5ÛB a
u
Q
ID 144/149 9 1 14 22 3 12 75 4 89 23 26 8.7
ID141/143 8 18 3 17 84 3 4 103 8 7 7.6
ID 126/129 8 2 28 24 3 11 113 7 6 126 5 4 5.2
ID 136/163 6 3 54 21 2 10 100 3 3 122 12 10 3.9
ID 160/166 10 2 20 22 1 5 109 23 22 120 7 5 7.9
ID 131/146 17 3 19 113 17 15 126 9 7 2.5
ID 132/134 11 17 2 12 85 6 7 95 5 5 10.7
ID 107/109 15 4 27 28 6 22 106 12 11 123 19 15 10.5
ID 124 /127 6 1 18 20 5 23 115 15 13 116 9 8 5.4
ID 110/121 7 18 3 15 74 10 14 86 13 15 7.3
ID 130/169 6 21 4 18 106 4 4 150 1 1 6.1
ID 112/114 8 1 13 14 1 7 65 10 4.4
ID 100/102 15 3 23 24 3 11 79 4 5 92 6 6 4.4
Repeat 1 2 19 4 19 83 3 4 101 7 7 2.4
Repeat 2 2 18 1 7 93 2 2 112 7 7 1.7
Repeat 3 10 3 27 20 5 25 85 6 7 101 7 7 2.2
Repeat 4 9 1 14 23 2 7 96 3 3 111 7 6 7.7
Repeat 5 16 8 48 135 17 163 10 5.9
n (number of 
valid QCs)
16 18 17 18
Average 8 20 97 111
SD 3.6 3.3 17.1 23.1
Inter-assay
%CV 43 16 18 21
Intra-assay variance melatonin RIA. SD=Standard deviation. Missing values caused by invalid 
measurements or by missing data points are represented by blank cells.
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Appendix D: Quality coutrol leptin RIA
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Before Assay After Assay
1
g
vi
oo
<N
1
2
1
CO
1
1
os
V00
01
1
m(N
i
CO
1
ID 144(lean)+ID114 (lean) + ID 3.8 16.5 0.9 3.9 16.3 0.7
146 (OW) + ID121 (T2DM)
ID 127(lean) + ID 141 (lean) + 3.6 14.7 1 3.3 13.2 0.9
ID 143 (OW) + ID 132 (T2DM)
ID 166 (OW) + ID 160 (OW) +
3.7 9.1 0.78 3.5 15.8 0.8
ID 109 (T2DM) + ID 102 (lean)
ID 149 (T2DM) + ID131
(T2DM) + ID 169 (0W ) + 4.3 16.7 1 4.9 16.6 1
ID 126 (lean)
ID 129 (OW) +  ID107(OW) +
15 1 1 4 3 17 9 0 8
ID130 (T2DM)+ ID 124 (lean)
ID 100 (lean) + ID134
(T2DM )+D112(T2DM ) + 4.6 16.4 1.3 3.8 15 0.9
ID 163 (lean)
ID 110 (OW) + ID136 (T2DM) 4 17.8 1 3.7 14.7 0.9
N (number of valid QCs) 6 7 7 7 7 7
Average 4 15.2 1 3.9 15.5 0.9
SD 0.4 2.9 0.2 0.5 1.4 0.1
Inter-assay %CV 10 19 16 13 9 10
Inter-assay variance. Leptin RIA. Empty cells represent invalid measurements.
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2.8-5.9 [ng/ml] 11-23 [ng/ml] Internal
Standard
1QCO (D1 8 (D1Qm
« I
O àû
"g a
ID 144(lean)+ID114 
(lean) + ID 146 (OW) +  
ID 121 (T2DM)
3.9 0.2 0.1 16.4 1.3 0.1 0.8 1.8 2.3 0.3
ID 127(lean) + ID141 
(lean) +  ID 143 (OW) +  
ID 132 (T2DM)
3.5 0.5 0.1 14 1.2 0.1 0.9 1.4 1.5 0.7
ID 166 (OW) +  ID160 
(OW) + ID 109 (T2DM) 
4- ID 102 (lean)
3.6 0.2 0.1 13.6 4.2 0.3 0.8 1.6 2 0.2
ID 149 (T2DM) + 
ID131(T2DM) + ID169 
(OW) + ID126 (lean)
4.6 0.5 0.1 16.7 1.5 0.1 1 2.3 2.3 0.4
ID 129 (OW) + 
ID107(OW) + ID130 
(T2DM)+ ID124 (lean)
4.3 0.1 0.0
2
16.1 1.4 0.1 1 2 2.1 0.5
ID 100 (lean) + 
ID134(T2DM)+D112 
(T2DM) + ID163(lean)
4.2 0.5 0.1 15.7 1.3 0.1 1.1 1.7 1.5 0.4
ID 110(O W ) + ID136  
(T2DM)
3.9 0.3 0.1 16.3 1.9 0.1 0.9 1.6 1.8 0.2
N (number of valid 
QCs)
7 7 7
Average 4 15.5 0.9
SD 0.4 1.24 0.1
Inter-assay %CV 10 8 12
Intra-assay variance. Leptin RIA.
205
Appendix E: SAS programs
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Cosinor Fit
D a t a  D a t a ;  i n f i l e  " c : \ s i m o n e \ d a t a . t x t "  d l m = ' 0 9 ' x  / *  * /
f i r s t o b s = l ; i n p u t  T im e  V a l u e ; P e r i o d  = 2 4 ;  T i m e l n P e r i o d  = 
m o d ( T i m e , p e r i o d ) ; r u n ;
p r o c  p r i n t  d a t a = D a t a ;  v a r  T im e  V a l u e  T i m e l n P e r i o d ;  r u n ;
p r o c  n l i n  d a t a = S i m o n e  b e s t = 2 0  M a x i t e r = 1 0 0 0 0  O U T E S T = I t t e r ;
P e r i o d  =  2 4 ;  P e r i o d  = 2 4 ;  p i = c o n s t a n t ( ' p i ' ) ;  p a r m s  M e s o r = 0  
A c r o p h a s e = 0  A m p l i t u d e = 0  D a m p in g  =  2 5 ;  
m o d e l  V a l u e =  ( M e s o r + A m p l i t u d e * c o s ( ( ( 2 * p i ) * (T im e  
A c r o p h a s e ) ) / P e r i o d ) ) * e x p ( - T i m e / D a m p i n g ) ;
o u t p u t  o u t = F i t  p r e d i c t e d = P r e d i c t e d  p a r m s = M e s o r  A c r o p h a s e  A m p l i t u d e  
D a m p in g ;  r u n ;
SYMBOLl V=STAR C=RED;SYMB0L2 V=PLUS C=BLUE L =1  I = J O I N ;  p r o c  g p l o t  
d a t a = F i t ; P l o t  v a l u e * t i m e i n p e r i o d  = 1 p r e d i c t e d * t i m e i n p e r i o d  = 2  
/ o v e r l a y ;  P l o t  v a l u e * t i m e  =  1 p r e d i c t e d * t i m e  =  2  / o v e r l a y ;  r u n ;  
p r o c  p r i n t  d a t a = F i t ;  v a r  M e s o r  A c r o p h a s e  A m p l i t u d e  D a m p in g  P r e d i c t e d ;  
r u n ;
P r o c  e x p o r t  d a t a = F i t  o u t f i l e  =  " c : \ S i m o n e \ F i t t e d  v a l u e s . x l s "  
DBMS=EXCEL2000 REPLACE; R U N ;
P r o c  s q l ;  C r e a t e  t a b l e  I t t e r S u m m a r y  a s
S e l e c t  _ S T A T U S _ ,  M e s o r ,  A c r o p h a s e ,  A m p l i t u d e ,  D a m p in g  f r o m  I t t e r
w h e r e  _ T Y P E _  =  ' F IN A L ’ ;
q u i t ;
P r o c  e x p o r t  d a t a = I t t e r S u m m a r y  o u t f i l e  =  " c : \ s i m o n e \ P a r a m e t e r
e s t i m a t e s . x l s "  DBMS=EXCEL2000 REPLACE; R U N ;
q u i t ;
Procedure mixed
D a t a  C e l l D a t a ;  i n f i l e  " c : \ S i m o n e \ d a t a . t x t "  d l m = ' 0 9 ' x ;  i n p u t  T im e  
G r u p p e  M e l a t o n i n ;  r u n ;
p r o c  s o r t  d a t a  =  C e l l D a t a ;  b y  G r u p p e  T i m e ;  r u n ;  
p r o c  m e a n s  d a t a  =  C e l l D a t a ;  v a r  M e l a t o n i n ; c l a s s  G r u p p e ;  r u n ;  
p r o c  p r i n t  d a t a = C e l l D a t a ;  v a r  T im e  G r u p p e  M e l a t o n i n ;  r u n ;  
p r o c  u n i v a r i a t e  d a t a = C e l l D a t a  n o r m a l ;  v a r  M e l a t o n i n ;  HISTOGRAM 
M e l a t o n i n / n o r m a l  ( c o l o r = r e d  w = 5 ) ; r u n ;
o d s  g r a p h i c s  o n ;  o d s  c s v  f i l e  =  " c : \ s i m o n e \ d a t a  r e s u l t s  2 w a y . c s v " ;  
p r o c  m i x e d  d a t a  =  C e l l D a t a  b o x p l o t  m a x i t e r = 5 0 0 ;  c l a s s  T im e  G r u p p e ;  
m o d e l  M e l a t o n i n  =  T im e  G r u p p e  T i m e * G r u p p e ;  I s m e a n s  G r u p p e  /  p d i f f  
c l  a l p h a = 0 . 0 5 ;  I s m e a n s  T im e  /  p d i f f  c l  a l p h a = 0 . 0 5 ;  I s m e a n s  
T i m e * G r u p p e  /  p d i f f  c l  a l p h a = 0 . 0 5 ;  
o d s  o u t p u t  i n f l u e n c e  = i n f l l ; r u n ;
o d s  g r a p h i c s  o f f ;  o d s  c s v  c l o s e ;  o d s  g r a p h i c s  o n ;  o d s  c s v  f i l e  =  
" c : \ S i m o n e \ d a t a  r e s u l t s  1 - w a y . c s v " ;  p r o c  m i x e d  d a t a  = C e l l D a t a  
b o x p l o t  m a x i t e r = 5 0 0 ;  b y  D i f s t a t e ;  c l a s s  T im e ;  m o d e l  G r u p p e  =  T i m e ;  
I s m e a n s  T im e  /  p d i f f  c l  a l p h a = 0 . 0 5 ;  o d s  o u t p u t  i n f l u e n c e  = i n f 1 1 ;  
r u n ;  o d s  g r a p h i c s  o f f ;  o d s  c s v  c l o s e ;  q u i t ;
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Appendix F: Murine genooiic DNA
standard calculation
208
Murine genomic DNA standard calculation
It is generally not possible to use DNA as a standard for absolute quantification of 
RNA because there is no control for the efficiency of the reverse transcription step.
Calculation of the number of single strands copies per pi.
The mouse genome is 3.42x10^base pairs [èp]. The mass of DNA [m] per genome
was calculated with the formula m = genomesizei  ipp) 14.096x10“^ ' —
bp.
One double strand mouse genome DNA weights 3.8 pg, and therefore one copy of the 
genes of interest (except for genes which exist in duplets).
Genomic mouse DNA: 209 pg/ml
Used 40.91 pi for the first solution: 8.552 pg and therefore 2250526315.79 single 
strands / in 40.91 pi. (Yun et al, 2006)
SS in 5 pi Dilution
25 005 847.95 100 000
2 500 58A8 10 000
250 058.48 1 000
25 005.84 100
2 500.58 10
0 0
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Appendix G: Take outs qtPCR
210
Pre-adipocytes
1 t à
Co
1 1 1 1
Q
g
1
é i 1
C)
2.4Hi2#liii 1.4 5.1liiii iiiiiiisi 1.1WBM 1.2 1.4 1.43.4.114:2*52§mm##052:#l#:::52i::::ii:52mmM#;i#3:M#:i#2 5.1###52 4.44.2wm■;7;1 5.1wmm::i:;ii:0;l IlHlilmil 10.1#!#:A2###:52:i:ill5:2Mmn 5.25.2wmmn mNmm::#Ëlom#:#12/1 10.1l:::::i2:i :#l:#:52mMm 10.1 10.17.210:1ii2i:imBAIi::d2l##l5:dw§m 13.3 7.1 7.5 10.1111122 11.110.142:1:14M 16.1 16.1 16.1!#:m:5:l 10.1:ii:ll:01li:ll22 13.3 12.1
12.116.1 WÊM 17.4 16.1iiiiiii iliii 13.3liiiil 13.3
13.3 llilii 16.1 16.1
16.1 iiiisif
16.1
Adipocytes
Î t à Co t 1 1 1 g
1è04 I04
I
i 1
>
6.3I|6f3III##liiiibi 2.1 3.1 1.1.itliiiii 4.2 2.1 5.1IIIIIIIK 3.1 2.1 2.1
17 1272|ib!i 10.1 liiiiëi 3.4 10.1iiiiiii# 3.1iiiiiiidiiiiiiiiiiiiiiiiiiiiiiii 3.4 3.4
iiiii 102#127:1iiioi 4.2 17.1ii:i;iiBioii 5.1iiiiliidffl! 1029ÊMIB|||i@ 5.4
12.4 18.3 12.1IIIIII## liiiiiilliliiliiiiiliiiii# 12.1 12.1i|i|ti|27:il 6.3
iiiiii 0252 8.3 192 10.2 17.1 17.1 17.1
17.3 111261 10.1 12.1 18.3 18.3
17,1 13.1
17.4iiiiiii 17.1
19.4 14.4
17.1
18.3
Missing data point because of missing RNA highlighted in grey.
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Appendix H: AütibodieS
212
Primary antibodies
All listed antibodies were used to detect proteins by the Western blot method as 
described. All antibodies were polyclonal.
Detected protein
Order 
number / 
name
Reactivity Producer
Detected
protein
[kDa]
murine PERI PERU-A mouse aDiagnostic 120
murine PER2 PER21-A mouse aDiagnostic 126
murine PER3 PER31-A mouse aDiagnostic 111
human PER3 
human PER3
1889
1890
human
human
Malcolm v.
Schantz 
(Surrey, UK) 
Malcolm v. 
Schantz
111
111
human PER3 PER32-A human a  Diagnostic 111
REV-ERBa #2124 H, M, R, Mk Cell signaling 80
BMALl PAl-523 M ,R Millipore 72
PER 3 (2, 5 and 8) Custommade human Abd Serotec 111
ACTIN MAB1501 all Millipore 42
The antibodies 1889 and 1890 were produced by innoculation o f the immunizing peptide 
(H)MVVQEMKKYFPC(OH).
213
Monoclonal PER3 antibodies
The antibodies were custom made by AbD serotec using the AgX antigen expression 
service. These were monoclonal antibodies from the HuCAL antibody library (Frisch 
et a l, 2003, Sun et al, 2003).
Secondary antibodies
Detected
species
Ordering
number Origin Dilution Producer
rabbit
goat
A0545
SC-2020
goat
donkey
1:5000-
1:10000
1:5000
sigma 
Santa Cruz
human 0500-0099 goat 1:5000 AbD Serotec
All antibodies are tagged with Horseradish Peroxidase.
Control peptides
Absorbed
protein
Ordering
number Producer
PER3 Per31-P aDiagnostic
PER2 Per21-P aDiagnostic
PERI Perll-P aDiagnostic
PERI SC-7724 P Santa Cruz
All control peptides were used in a dilution o f 1:1000.
Detection reagents for Western blots
ECL Western Blotting Detection 
Reagents (ECL) GE Healthcare Life Science
214
Protein standards
Color Prestained Molecular Weight Marker Mix, with bands from 16 kDa to 210
kDa (Pierce, Rockford, USA) prepared according to the manufacturer’s specification.
Fragment sizes: 210 kDa, 110 kDa, 80 kDa, 47 kDa, 32 kDa, 25 kDa and 16 kDa 
Prestained SDS-PAGE Standards, Broad Range, with bands from 7 kDa to 199 kDa 
(Bio Rad, Hercules, USA) ready to use.
Fragment sizes: 199 kDa, 116 kDa, 97 kDa, 54 kDa, 37 kDa, 29 kDa, 20 kDa and 
7 kDa
3-Color Protein Molecular weight, with bands from 7 kDa to 223 kDa
(Pierce, Rockford, USA) lyophilized.
Fragment sizes: 223 kDa, 110 kDa, 83 kDa, 47 kDa, 32 kDa, 26k Da and 16 kDa 
TriChrome ranger Prestained Protein Molecular Weight Marker Mix
(Pierce, Rockford, USA) lyophilized
205 kDa, 112 kDa, 77.8 kDa, 47 kDa, 30.8 kDa, 23.8 kDa, 15.5 kDa
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Appendix I: Medium / Reagent dilutions
216
All reagents were filtered sterile by passing through a 0.22 pm filter, if necessary.
A 1 pg/pl stock solution of interferon-y (Millipore) was prepared in DMEM:F12 
(Invitrogen). Another 1:250 dilution in DMEM:F12 medium led to a 4 ng/pl. 200 pi 
aliquots of the 4 ng/pl solution were stored at -20°C.
The dexmethasone (DEX, sigma) stock solution of 20 pg/ml was prepared in ethanol. 
This stock solution was diluted 1:50 in DMEM:F12 to gain a 50 pM solution. 
Aliquots of 1ml were stored at -20°C.
A 50 mM stock solution of 3-isobutylmethyIxanthine (IBMX) (Sigma) was prepared 
in DMSO. 100 pi aliquots were stored at -20°C.
Rosiglitazone (Alexa) 10 mM stock solution was prepared in DMSO. 200 pi aliquots 
were stored protected from light at 4°C.
Human transferin (Fisher) was bought as a 4 mg/ml solution. 1.5 ml aliquots were 
stored at -20°C.
A stock solution of 4 mg/ml insulin (Invitrogen) was purchased. 200 pi aliquots were 
stored at -20°C.
Cortisol (Sigma) was re-suspended in advanced DMEM:F12 to produce a 10 mM 
stock solution. A 1:100 dilution in advanced DMEM:F12 resulted in a 100 pM 
solution.
Triiodthyronine (T3, Sigma) was re-suspended in 0.1 M NaOH to obtain a 100 pM 
stock-solution.
Ascorbic acid to prevent the oxidation and therefore inactivation of adrenaline was 
dissolved in assay buffer (Zen-bio) at a concentration of 400 pM. Adrenaline (Sigma) 
was dissolved at 400 pM in assay buffer (Zen-bio) with 400 pM ascorbic acid.
Isoproterenol was used in the lipolysis kit as a positive control. The provided stock 
solution is 100 mM in DMSO. 1 pi in 10 ml assay buffer of this stock solution was 
used to obtain a 1 pM solution.
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Appendix!: Participant pre-screee data
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Appendix K: Leptin lîlRNA 
and plasma leptin
220
L e a n
ID 100 ID 102
rSO
-40
-30
-20
-10
7 13 19 1 77 13 19 1
ID114
D)
C
Q.
0)
03
(/)
CO
rSO
-40
J - 3 0
-20
-10
7 13 19 1 77 13 19 1
ID126
7 13 19 1 7 13 19 1 7
ID 141
rSO
-40
-30
-20
-10
7 13 19 1 77 13 19 1
r5 0
-40
-30
-20
-10
7 13 19 17 13 19 1 7
ID 124
rSO
-40
-30
-20
-10
7 13 19 1 7 13 19 1 7
ID 127
rSO
8-
-40
6-
-30
4-
-20
-10 2-
-0 0-
50
-40
-30
-20
-10
0
7 13 19 1 7 13 19 1 7
ID144
r5 0
-40
y Al»
-30
-20
-10
7 13 19 17 13 19 1 7
P <  0.0001 fo r all o f the  co s in o r fits
time [h]
CD
T3
z>
3
O
3
U>'
CD
Q.
O>
Tl
D
%
'UP
C/)
221
ow
ID 107 ID 110
25-1
-80
20-
-60
15-
-40
-20
7 13 19 1
ID 121
D)
C
Q-
0)
05
CO
03
25-1
-80
20-
-6015-
-40
10-
-20
7 13
ID143
25-1
-80
20-
-6015-
-40
10 -
-20
7 13
ID 160
25-1
-80
20-
-6015-
10-
-20
7 13 19 1 13 19
ID 166
25-,
-80
-6020-
-40
-20
7 13r
-80
-60
-40
-2 0
7 13 19 1 7 13 19 1 7
ID129
25-,
-80
20-
-6015-
-40
10 -
-20
7 13 19 1
ID 146
25-,
-80
20-
-60
15-
-40
10-
-2 0
7 13 19
ID163
25-,
-80
20 -
15-
-40
10-
-20
7 13 19
ID169
25-,
-80
20-
-60
15-
-40
1 0 -
-205 * >
7 13 19 13 19r
CD
“D
z>
3
O
3
5L
U)'
CD
o_
CD>
u
D
%
1/P
C/)
p < 0.0001 for all of the cosinor fits
t im e [h]
2 2 2
T 2 D M
ID 109 ID112
rSO30-1
- 60
20-
-40
10-
-20
7 13 19 1 77 13 19 1
80 30
20-
0 0
ID 130
O)
c
o_
E
rSO
-60
-40
-20
7 13 19 1 77 13 19 1
ID 132
(/)
CO
Q .
rSO
-60
20 -
-40
-20
7 13 19 1 77 13 19 1
ID 136
r8080-1
-6060-
-4040-
-2020 -
7 13 19 1 77 13 19 1
I
-20
7 13 19 1 7 13 19 1 7
ID131
30-1 r80
25- -60
20 - -40
-20
7 13 19 1 7 13 19 1 7
ID 134
r80
30-
20 -
-40
10 -
7 13 19 1 7 13 19 1 7
ID149
CD
" D
5'
3
73
œ
CD
Q_
Q>
“□
D
%
C/)
c / )
r8030-1
-70
20 -
-60
10-
-50
7 13 19 1 7 13 19 1 7c
p < 0,0001 for all of the cosinor fits
t ime [h]
223
Appendix L: Presentations, personal 
development and publications
224
Peer Reviewed Papers
Identification and functional dissection o f localization signals 
within ataxin-3
Antony, Paul Michel Aloyse, Mantele, Simone, Mollenkopf, Phillip, Boy, Jana, Kehlenbach, Ralph H., Riess, Olaf, 
Schmidt, Thorsten
Spinocerebellar ataxia type 3 (SCA3) or Machado-Joseph disease (MJD) belongs to a group of 
autosomal dominant neurodegenerative diseases, which are caused by the expansion o f a polyglutamine 
repeat in the affected protein, in this case ataxin-3. Ataxin-3 is mainly localized in the cytoplasm; 
however, one hallmark o f SCA3 is the formation o f ataxin-3-containing protein aggregates in the 
nucleus of neurons. Currently, it is not known how mutant ataxin-3 translocates into the nucleus. We 
performed localization assays o f recently proposed and novel potential signals, functionally confirmed 
the activity o f a nuclear localization signal, identified two novel nuclear export signals (NES 77 and 
NES 141), and determined crucial amino acids. In addition, we demonstrate the relevance o f the 
identified signals for the intracellular localization o f the N- and C-terminus o f ataxin-3. Our findings 
stress the importance o f investigating the mechanisms, which influence the intracellular distribution o f 
ataxin-3 during the pathogenesis o f SCA3.
2009, Neurobiology of Disease, 36: 2; 280-292
Rhythmic diurnal gene expression in human adipose tissue from 
individuals who are lean, overweight, and type 2 diabetic.
Otway DT, Mantele S, Bretschneider S, Wright J, Trayhurn P, Skene DJ, Robertson MD, Johnston JD.
OBJECTIVE Previous animal studies suggest a functional relationship between metabolism, type 2 
diabetes, and the amplitude of daily rhythms in white adipose tissue (WAT). However, data 
interpretation is confounded by differences in genetic background and diet or limited sampling points. 
We have taken the novel approach of analyzing serial human WAT biopsies across a 24-h cycle in 
controlled laboratory conditions. RESEARCH DESIGN AND METHODS Lean (n = 8), 
overweight/obese (n = II) , or overweight/obese type 2 diabetic (n = 8) volunteers followed a strict 
sleep-wake and dietary regimen for 1 week prior to the laboratory study. They were then maintained in 
controlled light-dark conditions in a semirecumbent posture and fed hourly during wake periods. 
Subcutaneous WAT biopsies were collected every 6 h over 24 h, and gene expression was measured by 
quantitative PCR. RESULTS Lean individuals exhibited significant (P < 0.05) temporal changes o f 
core clock (PERI, PER2, PER3, CRY2, BM ALI, and DBP) and metabolic (REVERBa, RIP 140, and 
PG C la) genes. The BMALI rhythm was in approximate antiphase with the other clock genes. It is 
noteworthy that there was no significant effect (P > 0.05) of increased body weight or type 2 diabetes 
on rhythmic gene expression. CONCLUSIONS The robust nature o f these rhythms and their relative 
phasing indicate that WAT now can be considered as a peripheral tissue suitable for the study o f in 
vivo human rhythms. Comparison of data between subject groups clearly indicates that obesity and 
type 2 diabetes are not related to the amplitude o f rhythmic WAT gene expression in humans 
maintained under controlled conditions.
2011, Diabetes, 60: 5; 1577-1588
225
Time-of-day variation in human plasma metabolites: an 
untargeted liquid chromatography-mass spectrometry 
metabolomics approach
Joo Ern Ang\ Victoria Revel?, Anuska Mann ,^ Simone Mantele^ Danniella T. Otway ,^ Jonathan D. Johnston^, Alfred 
E. Thumser, Debra J. Skene^, Florence Raynaud’.
’Cancer Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, 
Sutton, Surrey SM2 5NG, UK
^Chronobiology, Division of Biochemical Sciences, Faculty of Health and Medical Sciences, University of Surrey, 
Guildford, Surrey GU2 7XH, UK
In revision
Daily rhythms o f plasma melatonin, but not plasma leptin or 
leptin mRNA, vary between lean, obese and type 2 diabetic men
s. Mantele’, D.T. Otway’, B.Middleton’, S.Bretschneider’, J. Wright’, P. Trayhurn ,^ M.D. Robertson’, D.J. Skene, 
J.D. Johnston’.
1. Faculty of Health and Medical Sciences, University of Surrey, UK, 2. School of Clinical Sciences, University of 
Liverpool, UK
In revision
Poster and oral presentations at conferences
® S. Mantele, A. Poliandri, R. White, M. Parker, DJ. Skene, J.D. Johnston. 
Poster: Rhythms in white adipose pre-Adipocytes and adipocytes UK Clock 
meeting, Oxford, 19* May 2009
® S. Mantele, A. Poliandri, R. White, M. Parker, D.J. Skene, J.D. Johnston. 
Foster: Rhythms in white adipose pre-Adipocytes and adipocytes UK Clock 
meeting, London, 12* Nov 2009
® S. Mantele, A. Poliandri, R. White, M. Parker, D.J. Skene, J.D. Johnston. 
Poster: Rhythms in white adipose pre-adipocytes and adipocytes UK Adipose 
tissue discussion group meeting, Manchester, 4* Dec 2009
e S. Mantele, A. Poliandri, R. White, M. Parker, D.J. Skene, J.D. Johnston. 
Poster: Rhythms in white adipose pre-Adipocytes and adipocytes. Festival of 
research University of Surrey, Guildford, 9* June 2009
S. Mantele, A. Poliandri, R. White, M. Parker, D.J. Skene, J.D. Johnston. 
Poster: Rhythms in white adipose pre-Adipocytes and adipocytes UK Adipose 
tissue discussion group meeting, Oxford, 7* Dec 2010
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o s. Mantele, A. Poliandri, R. White, M. Parker, DJ. Skene, J.D. Johnston. 
Poster: Rhythms in white adipose pre-Adipocytes and adipocytes UK clock 
club meeting 2010, Stevenage, 17* June, 2010
o Oral: Clocks in fat cells
Postgraduate research conference 2010, University of surrey. Guildford, 23- 
24* Sept 2010
® S. Mantele, A. Poliandri, R. White, M. Parker, D.J. Skene, J.D. Johnston.
Poster: Rhythms in white adipose pre-Adipocytes and adipocytes. Festival of 
research University of Surrey, Guildford, 6* July 2010
® Oral: My PhD project
Poster: S. Mantele, A. Poliandri, R. White, M. Parker, D.J. Skene, J.D. 
Johnston. Rhythms in white adipose pre-Adipocytes and adipocytes 
5* Euclock and 19* European PhD School for Chronobiology, 2010,
Bangalore India, 2"^-8* October 2010
® S. Mantele, A. Poliandri, R. White, M. Parker, D.J. Skene, J.D. Johnston.
Poster: Rhythms in white adipose pre-Adipocytes and adipocytes UK clock 
club meeting 2011, Guildford, 11* April 2011
® S. Mantele, D.T. Otway, B. Middleton, S. Bretschneider, J. Wright, P.
Trayhurn, M.D. Robertson, D.J. Skene, J.D. Johnston. Division: Biochemical 
Sciences, Theme: Sleep, Chronobiology and Neurodisorders
Poster: Daily rhythms of plasma melatonin, but not plasma leptin or leptin 
mRNA, vary between lean, overweight and type 2 diabetic humans. Festival of 
research University of Surrey, Guildford, 5* July 2011
® S. Mantele, D.T. Otway, B. Middleton, S. Bretschneider, J. Wright, P.
Trayhurn, M.D. Robertson, D.J. Skene, J.D. Johnston 
Poster: Daily rhythms of plasma melatonin, but not plasma leptin or leptin 
mRNA, vary between lean overweight and type 2 diabetic humansEBRS, 
Oxford, 20* -  26* Aug 2011
o Florence Raynaud, Joo Em Ang, Anuska Mann, Simone Mantele, Danni 
Otway, Jonathan Johnston, Victoria Revell, Alfred Thumser, Debra J. Skene
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Poster: Time-of-day variation in human plasma metabolites: an untargeted 
liquid chromatography-mass spectrometry metabolomics approach. 
Metabomeeting 2011 Helsinki Congress Paasitomi, September 25-28* 2001, 
Helsinki Finland
Attended conferences without presentation
• UK Clock Club meeting 2008 Edinburgh
• Multidisciplinary Dissection of Sleep Phenotypes in Animals and Humans,
2011, University of Surrey
Demonstrating / Teaching
• Practical Biochemistry and chemistry 2, Dr. Thumser: 2010 and 2011: 24h in 
total
• Practical cell and molecular biology. Dr. Archer: 2009, 2010,2011 45h in total 
plus correction of student reports
® Practical Biochemistry and chemistry 2/ Practical cell and molecular biology. 
Dr. Johnston: 2010: 24h
® Undergraduate students were instructed by me in the western blot method in 
their final year projects.
Lectures / Trainings
Undergraduate level lecture Biological rhythms (2009)
Radiation protection Induction Course (2009)
Essential Good clinical practice, Brookwood International Acadamy of 
Healthcare research (2009)
Basic Life Support, back to life (2009)
Student Personal Learning and Study Hub (SPLASH) courses: Planning your 
skills development (13.10.2008) -  Analysing data using Excel I (27.1.2009) -  
Support your research through thinking (24.2.2009) -  Presenting your research 
at conferences (24.3.2009) -  Getting published -  Maximise the using and 
impact of your research.
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University intern meetings and presentations
o Regular attended general lab meetings of the chronobiology groups 
o Presented joumal clubs
© Presented my work at the PhD seminar series of the Biochemistry Division. 
• Attended seminars hosted by different faculties
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